Page last updated: 2024-11-05

tranexamic acid and Blood Loss, Postoperative

tranexamic acid has been researched along with Blood Loss, Postoperative in 633 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research Excerpts

ExcerptRelevanceReference
"Administration of intravenous tranexamic acid significantly improved swelling, pain and lower ROM restriction in patients undergoing ACL reconstruction."9.69The effect of tranexamic acid injection during anterior cruciate ligament reconstruction surgery on postoperative bleeding, pain and swelling. ( Akbari-Aghdam, H; Entezari, R; Mousavi, H, 2023)
" We included controlled trials, either randomized (RCT) or non-randomized studies of intervention (NRSI) comparing the effects of intravenous tranexamic acid (TXA) treatment with placebo/no treatment on postoperative blood loss, pain VAS score, elbow ROM, and complications, in patients who underwent open or closed elbow arthrolysis surgery."9.41Does tranexamic acid diminish hemorrhage and pain in open elbow arthrolysis? a systematic review and meta-analysis. ( Daliri, M; Ebrahimzadeh, MH; Khayami, A; Moradi, A; Nejat, MH; Sadeghi, M, 2023)
"Tranexamic acid (TXA) is widely used in surgery for adolescent idiopathic scoliosis (AIS) and has been proved to be efficacious in reducing intraoperative blood loss (IBL) and the transfusion rate."9.41The effect of multiple-dose oral versus intravenous tranexamic acid in reducing postoperative blood loss and transfusion rate after adolescent scoliosis surgery: a randomized controlled trial. ( Liu, LM; Song, YM; Wang, L; Wang, LN; Xiu, P; Yang, X; Zhang, Z; Zhou, ZJ, 2021)
"To indicate whether combined topical and intravenous (IV) administration of tranexamic acid (TXA) could further reduce the blood loss after surgery for adolescent idiopathic scoliosis (AIS) compared with IV-TXA alone."9.41Combined topical and intravenous administration of tranexamic acid further reduces postoperative blood loss in adolescent idiopathic scoliosis patients undergoing spinal fusion surgery: a randomized controlled trial. ( Dong, Y; Li, Q; Liang, J; Shen, J; Tong, B; Zhao, H, 2021)
"This study was designed to compare the effect of intravenous tranexamic acid (TXA) and prostaglandin analogue on reducing PPH resulted from uterine atony in women undergoing C section or vaginal delivery."9.27The Effect of Tranexamic Acid on Preventing Post-partum Hemorrhage Due to Uterine Atony: A Triple-blind Randomized Clinical Trial. ( Ahmadi, M; Nikbakht, R; Zargar, M, 2018)
"Preincision administration of 10 mg/kg of tranexamic acid significantly improved the surgical field during cleft palate repair."9.20Evaluation of the Efficacy of Tranexamic Acid on the Surgical Field in Primary Cleft Palate Surgery on Children-A Prospective, Randomized Clinical Study. ( Durga, P; Gunnam, P; Gurajala, I; Raavula, P; Ramachandran, G; Reddy, M; Upputuri, O; Veerabathula, P, 2015)
"The purpose of this systematic review and meta-analysis of randomized controlled trials (RCTs) and non-RCTs was to gather data to evaluate the efficacy and safety of tranexamic acid (TXA) versus placebo after a scoliosis surgery."8.95Efficacy and safety of tranexamic acid in reducing blood loss in scoliosis surgery: a systematic review and meta-analysis. ( Xu, BS; Yuan, QM; Zhao, ZH, 2017)
"To evaluate the association of treatment with nebulized tranexamic acid (TXA) with rates of operative intervention in post-tonsillectomy hemorrhage (PTH)."8.31Treatment of post-tonsillectomy hemorrhage with nebulized tranexamic acid: A retrospective study. ( Elghouche, AN; Hasnain, F; Matt, BH; Shay, EO; Shin, TJ; Ye, MJ, 2023)
" The purpose of this study was to compare the effects of intra-articular (IA) administration of tranexamic acid (TXA), an anti-fibrinolytic commonly used in TKA, and ALM chondroprotective solution on postoperative inflammation and joint tissue healing in a rat model of knee implant surgery."8.02Comparison of intra-articular administration of adenosine, lidocaine and magnesium solution and tranexamic acid for alleviating postoperative inflammation and joint fibrosis in an experimental model of knee arthroplasty. ( Biros, E; Dlaska, C; Dobson, GP; Hazratwala, K; Letson, HL; McEwen, P; Morris, JL; Wilkinson, M, 2021)
"Tranexamic acid (TXA) has gained increasing recognition in plastic surgery as a dependable adjunct capable of minimizing blood loss, ecchymosis, and edema."8.02Local Infiltration of Tranexamic Acid (TXA) in Liposuction: A Single-Surgeon Outcomes Analysis and Considerations for Minimizing Postoperative Donor Site Ecchymosis. ( Banuelos, J; Molinar, VE; Tran, NV; Weissler, JM, 2021)
"Evaluate nebulized tranexamic acid (TXA) as a treatment to reduce the need for an operation to control a post-tonsillectomy hemorrhage (PTH)."8.02Post-tonsillectomy hemorrhage control with nebulized tranexamic acid: A retrospective cohort study. ( Earley, MA; Erwin, DZ; Goldstein, NA; Heichel, PD; McEvoy, TP; Meyer, AD; Wright, LM, 2021)
"The aim of the present study was to investigate whether an innovative way of administering tranexamic acid (TXA), that is, injecting it retrogradely through the drain and clamping it for 1 h, can reduce postoperative bleeding after degenerative lumbar scoliosis surgery."7.96Topical Injection of Tranexamic Acid via a Drain Plus Drain-Clamping to Reduce Blood Loss in Degenerative Lumbar Scoliosis Surgery. ( Chang, L; Liang, JQ; Liu, HZ; Liu, XY; Rong, TH; Tan, MS; Zhao, H, 2020)
"To investigate the effectiveness and safety of intravenous tranexamic acid for reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis (TSS)."7.88The efficacy and safety of tranexamic acid in reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis: A retrospective observational study. ( Huang, X; Huang, Y; Liu, T; Qiao, F; Xu, X; Xue, P; Yang, J, 2018)
"The major concern with the use of tranexamic acid is that it may promote a hypercoagulable state and increase the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), particularly when chemical thromboprophylaxis is not used."7.85Chemical Thromboprophylaxis Is Not Necessary to Reduce Risk of Thromboembolism With Tranexamic Acid After Total Hip Arthroplasty. ( Kim, JS; Kim, YH; Park, JW, 2017)
"To investigate the incidence of postoperative generalized seizures in patients undergoing aortic valve replacement (AVR) under extracorporeal circulation, who received either high-dose tranexamic acid (TXA) or epsilon aminocaproic acid (EACA) as an antifibrinolytic agent."7.77High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. ( Beyersdorf, F; Keyl, C; Lehane, C; Stampf, S; Trenk, D; Uhl, R; Wiesenack, C, 2011)
"Tranexamic acid (TXA) has been widely applied in total knee arthroplasty (TKA) to significantly reduce perioperative blood loss and improve knee function recovery in patients after surgery."7.30Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study. ( Wang, CC; Wu, T; Zhang, GQ; Zhang, LT; Zhou, LB, 2023)
"No tranexamic acid was administered to the control group."7.30[Effects of Tranexamic Acid on Perioperative Blood Loss and Wound Hematoma Development in Lumbar Spine Surgery: a Prospective Randomized Study]. ( Hrabálek, L; Jablonský, J; Novák, V; Stejskal, P; Trnka, Š; Wanek, T, 2023)
" The current study aimed to determine whether tranexamic acid (TXA) in combination with pressure dressing reduce the amount of blood loss, the rate of incision-related complications, and the rate of readmission for patients undergoing surgeries to release GMC."7.11Tranexamic acid combined with compression dressing reduces blood loss in gluteal muscle contracture surgery. ( Huang, Q; Huang, Z; Ma, J; Pei, F; Shen, B; Zhou, Z, 2022)
"Tranexamic acid (TXA) has been shown to reduce perioperative blood loss in elective orthopedic surgery."7.01Topical tranexamic acid in hip fractures: a randomized, placebo-controlled double-blinded study. ( Cheong, Y; Costain, D; Elder, G; Fera, L; Fraser, B; Kelly, A; Slagel, B, 2021)
"A total of 100 patients with intertrochanteric fractures undergoing surgery were enrolled and randomly allocated to the TXA group in which patients (75."6.90Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial. ( Huang, Y; Jiang, LF; Wu, LD; Xu, NW; Zhang, JJ; Zhang, Y; Zhou, D; Zhou, XD, 2019)
" Other secondary variables were total blood loss, hidden blood loss, transfusion rate, average hospital stay, complications, adverse events, and mortality."6.90Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study). ( Aguilera, X; Bosch, A; Camacho-Carrasco, P; Castillón, P; González, JC; Hernández, JA; Jordan, M; Martínez-Zapata, MJ; Mora, JM; Prat-Fabregat, S; Rodriguez-Arias, A; Ruiz, L; Salomó, M, 2019)
"Administration of intravenous tranexamic acid significantly improved swelling, pain and lower ROM restriction in patients undergoing ACL reconstruction."5.69The effect of tranexamic acid injection during anterior cruciate ligament reconstruction surgery on postoperative bleeding, pain and swelling. ( Akbari-Aghdam, H; Entezari, R; Mousavi, H, 2023)
" Tranexamic acid was administered before the surgical incision in "pre-induction groups" (1 and 2), and just before the tourniquet release in "pre-release groups" (3 and 4)."5.51Clinical trial to determine whether the timing of tranexamic acid administration influences perioperative bleeding in total knee arthroplasty. ( Bisbe, E; Luis, C; Moreno, CE; Pardo, A; Santiveri, X; Teixell, C, 2022)
"Tranexamic acid (TXA) is an antifibrinolytic drug that is used for uncontrolled bleeding of various origin."5.48Effect of tranexamic acid on intra- and postoperative haemorrhage in dogs with surgically treated hemoperitoneum. ( Jud Schefer, RS; Olgiati, L; Sigrist, N, 2018)
" The best administration route and dosage should be further studied."5.48[Preliminary analysis of the effect of different administration routes of tranexamic acid on blood loss after total hip arthroplasty for female femur neck fractures]. ( Lin, ZQ; Luo, GG; Xie, HF; Yao, JC; Zhang, HZ, 2018)
"Tranexamic acid (TXA) is an antifibrinolytic agent that can be used to reduce blood loss in total knee arthroplasty (TKA) patients."5.43Intraarticular Administration of Tranexamic Acid is Safe and Effective in Total Knee Arthroplasty Patients at High-Risk for Thromboembolism. ( Chughtai, M; Delanois, RE; Gwam, C; Khlopas, A; Mistry, JB; Mont, MA; Mudaliar, PP; Tangri, V; Thomas, M, 2016)
" We included controlled trials, either randomized (RCT) or non-randomized studies of intervention (NRSI) comparing the effects of intravenous tranexamic acid (TXA) treatment with placebo/no treatment on postoperative blood loss, pain VAS score, elbow ROM, and complications, in patients who underwent open or closed elbow arthrolysis surgery."5.41Does tranexamic acid diminish hemorrhage and pain in open elbow arthrolysis? a systematic review and meta-analysis. ( Daliri, M; Ebrahimzadeh, MH; Khayami, A; Moradi, A; Nejat, MH; Sadeghi, M, 2023)
"Tranexamic acid (TXA) is widely used in surgery for adolescent idiopathic scoliosis (AIS) and has been proved to be efficacious in reducing intraoperative blood loss (IBL) and the transfusion rate."5.41The effect of multiple-dose oral versus intravenous tranexamic acid in reducing postoperative blood loss and transfusion rate after adolescent scoliosis surgery: a randomized controlled trial. ( Liu, LM; Song, YM; Wang, L; Wang, LN; Xiu, P; Yang, X; Zhang, Z; Zhou, ZJ, 2021)
"To indicate whether combined topical and intravenous (IV) administration of tranexamic acid (TXA) could further reduce the blood loss after surgery for adolescent idiopathic scoliosis (AIS) compared with IV-TXA alone."5.41Combined topical and intravenous administration of tranexamic acid further reduces postoperative blood loss in adolescent idiopathic scoliosis patients undergoing spinal fusion surgery: a randomized controlled trial. ( Dong, Y; Li, Q; Liang, J; Shen, J; Tong, B; Zhao, H, 2021)
"The aim of this study was to evaluate the effects of a high initial-dose (60 mg/kg) intravenous tranexamic acid (IV-TXA) on fibrinolysis and inflammation after total knee arthroplasty (TKA)."5.34The antifibrinolytic and anti-inflammatory effects of a high initial-dose tranexamic acid in total knee arthroplasty: a randomized controlled trial. ( Huang, Q; Huang, W; Lei, YT; Pei, FX; Xie, JW, 2020)
"An initial retrospective study suggested that tranexamic acid (TXA) administration increased the incidence of seizures in paediatric patients undergoing cardiac surgery."5.30Safety and efficacy of tranexamic acid in paediatric cardiac surgery: study protocol for a double-blind randomised controlled trial. ( Hu, S; Hua, Z; Jia, Y; Li, S; Liu, J; Ran, J; Shi, J; Wang, R; Wang, X; Wang, Y; Yan, F; Yan, J; Yuan, S; Zhang, Y; Zhang, Z; Zhao, Y; Zheng, Z, 2019)
"This study was designed to compare the effect of intravenous tranexamic acid (TXA) and prostaglandin analogue on reducing PPH resulted from uterine atony in women undergoing C section or vaginal delivery."5.27The Effect of Tranexamic Acid on Preventing Post-partum Hemorrhage Due to Uterine Atony: A Triple-blind Randomized Clinical Trial. ( Ahmadi, M; Nikbakht, R; Zargar, M, 2018)
"Systemic administration of TXA can effectively reduce the postoperative blood loss which results in lower rate of transfusion requirement and wound hematoma in minimally invasive TKA patients when rivaroxaban is used for thromboprophylaxis."5.24The Efficacy of Combined Use of Rivaroxaban and Tranexamic Acid on Blood Conservation in Minimally Invasive Total Knee Arthroplasty a Double-Blind Randomized, Controlled Trial. ( Chen, B; Huang, CC; Kuo, FC; Lin, PC; Wang, JW; Yen, SH, 2017)
"Compared with intravenous application, topical application of tranexamic acid could also effectively reduce total blood loss and hidden blood loss, postoperative blood transfusion rate in primary total hip arthroplasty, while does not increase the risk of DVT."5.22[Comparison of different modes of using tranexamic acid administration on reducing hidden blood loss in total hip arthroplasty]. ( Chen, XJ; Ni, JR; Wang, LX, 2016)
"Preincision administration of 10 mg/kg of tranexamic acid significantly improved the surgical field during cleft palate repair."5.20Evaluation of the Efficacy of Tranexamic Acid on the Surgical Field in Primary Cleft Palate Surgery on Children-A Prospective, Randomized Clinical Study. ( Durga, P; Gunnam, P; Gurajala, I; Raavula, P; Ramachandran, G; Reddy, M; Upputuri, O; Veerabathula, P, 2015)
" Systematic review and meta-analysis to determine the bleeding rates associated with tranexamic acid, desmopressin, platelet transfusion, plasma transfusion and recombinant activated factor VII, for patients with unclassified bleeding disorders undergoing surgery, childbirth or with menorrhagia."5.12Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies. ( Desborough, MJR; Doree, C; Lowe, GC; Obaji, S; Thomas, W, 2021)
"The purpose of this systematic review and meta-analysis of randomized controlled trials (RCTs) and non-RCTs was to gather data to evaluate the efficacy and safety of tranexamic acid (TXA) versus placebo after a scoliosis surgery."4.95Efficacy and safety of tranexamic acid in reducing blood loss in scoliosis surgery: a systematic review and meta-analysis. ( Xu, BS; Yuan, QM; Zhao, ZH, 2017)
"To evaluate the association of treatment with nebulized tranexamic acid (TXA) with rates of operative intervention in post-tonsillectomy hemorrhage (PTH)."4.31Treatment of post-tonsillectomy hemorrhage with nebulized tranexamic acid: A retrospective study. ( Elghouche, AN; Hasnain, F; Matt, BH; Shay, EO; Shin, TJ; Ye, MJ, 2023)
"The use of tranexamic acid (TXA) in posterior lumbar interbody fusion (PLIF) surgery is believed to be beneficial for reducing intraoperative blood loss, postoperative drainage volume (PDV), and length of hospital stay (LOS)."4.31Postoperative clinical outcomes with and without short-term intravenous tranexamic acid after posterior lumbar interbody fusion: A prospective cohort study. ( Ji, X; Shi, L; Tian, F; Wang, X, 2023)
" The purpose of this study was to compare the effects of intra-articular (IA) administration of tranexamic acid (TXA), an anti-fibrinolytic commonly used in TKA, and ALM chondroprotective solution on postoperative inflammation and joint tissue healing in a rat model of knee implant surgery."4.02Comparison of intra-articular administration of adenosine, lidocaine and magnesium solution and tranexamic acid for alleviating postoperative inflammation and joint fibrosis in an experimental model of knee arthroplasty. ( Biros, E; Dlaska, C; Dobson, GP; Hazratwala, K; Letson, HL; McEwen, P; Morris, JL; Wilkinson, M, 2021)
"Tranexamic acid (TXA) has gained increasing recognition in plastic surgery as a dependable adjunct capable of minimizing blood loss, ecchymosis, and edema."4.02Local Infiltration of Tranexamic Acid (TXA) in Liposuction: A Single-Surgeon Outcomes Analysis and Considerations for Minimizing Postoperative Donor Site Ecchymosis. ( Banuelos, J; Molinar, VE; Tran, NV; Weissler, JM, 2021)
"Evaluate nebulized tranexamic acid (TXA) as a treatment to reduce the need for an operation to control a post-tonsillectomy hemorrhage (PTH)."4.02Post-tonsillectomy hemorrhage control with nebulized tranexamic acid: A retrospective cohort study. ( Earley, MA; Erwin, DZ; Goldstein, NA; Heichel, PD; McEvoy, TP; Meyer, AD; Wright, LM, 2021)
"The aim of the present study was to investigate whether an innovative way of administering tranexamic acid (TXA), that is, injecting it retrogradely through the drain and clamping it for 1 h, can reduce postoperative bleeding after degenerative lumbar scoliosis surgery."3.96Topical Injection of Tranexamic Acid via a Drain Plus Drain-Clamping to Reduce Blood Loss in Degenerative Lumbar Scoliosis Surgery. ( Chang, L; Liang, JQ; Liu, HZ; Liu, XY; Rong, TH; Tan, MS; Zhao, H, 2020)
"To investigate the effectiveness and safety of intravenous tranexamic acid for reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis (TSS)."3.88The efficacy and safety of tranexamic acid in reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis: A retrospective observational study. ( Huang, X; Huang, Y; Liu, T; Qiao, F; Xu, X; Xue, P; Yang, J, 2018)
"The major concern with the use of tranexamic acid is that it may promote a hypercoagulable state and increase the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), particularly when chemical thromboprophylaxis is not used."3.85Chemical Thromboprophylaxis Is Not Necessary to Reduce Risk of Thromboembolism With Tranexamic Acid After Total Hip Arthroplasty. ( Kim, JS; Kim, YH; Park, JW, 2017)
" We sought to determine if its reintroduction was still pertinent given the widespread administration of tranexamic acid, another antifibrinolytic shown to reduce bleeding and transfusions."3.83Major transfusions remain frequent despite the generalized use of tranexamic acid: an audit of 3322 patients undergoing cardiac surgery. ( Hardy, JF; Noiseux, N; Prieto, I; Stevens, LM, 2016)
" In the present study we evaluated the hemostatic effects of tranexamic acid (TXA) to decrease bleeding tendency and transfusion requirements in high-risk patients following transapical aortic valve implantation (TA-AVI)."3.81Prophylactic intraoperative tranexamic acid administration and postoperative blood loss after transapical aortic valve implantation. ( Choi, YH; Deppe, AC; Kuhn, E; Madershahian, N; Pfister, R; Rudolph, T; Scherner, M; Slottosch, I; Wahlers, T, 2015)
"This case report discusses enucleation of a central dentigerous cyst in a 72-year old male on long-term low dose aspirin therapy."3.78Management of a dentigerous cyst in a medically compromised geriatric patient: a case report. ( Bains, R; Bains, VK; Loomba, A; Loomba, K, 2012)
"To investigate the incidence of postoperative generalized seizures in patients undergoing aortic valve replacement (AVR) under extracorporeal circulation, who received either high-dose tranexamic acid (TXA) or epsilon aminocaproic acid (EACA) as an antifibrinolytic agent."3.77High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. ( Beyersdorf, F; Keyl, C; Lehane, C; Stampf, S; Trenk, D; Uhl, R; Wiesenack, C, 2011)
"Tranexamic acid (TXA) has been widely applied in total knee arthroplasty (TKA) to significantly reduce perioperative blood loss and improve knee function recovery in patients after surgery."3.30Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study. ( Wang, CC; Wu, T; Zhang, GQ; Zhang, LT; Zhou, LB, 2023)
"No tranexamic acid was administered to the control group."3.30[Effects of Tranexamic Acid on Perioperative Blood Loss and Wound Hematoma Development in Lumbar Spine Surgery: a Prospective Randomized Study]. ( Hrabálek, L; Jablonský, J; Novák, V; Stejskal, P; Trnka, Š; Wanek, T, 2023)
"To evaluate the efficacy and safety of perioperative cryotherapy combined with intra-articular injection of tranexamic acid (TXA) in total knee arthroplasty (TKA) and explore a new strategy of enhanced recovery after TKA."3.30Efficacy of perioperative cryotherapy combined with intra-articular injection of tranexamic acid in total knee arthroplasty. ( Huang, W; Huang, X; Li, F; Liu, W; Shi, W; Yin, D, 2023)
"This study aimed to evaluate the effect of temperature intervention combined with tranexamic acid (TXA) on perioperative blood loss during spinal fusion and accelerated rehabilitation."3.30The efficacy of temperature intervention combined with tranexamic acid in reducing blood loss and accelerating recovery during spinal fusion. ( Huang, X; Huang, Y; Li, F; Liang, B; Yin, D, 2023)
"The primary outcome was postoperative blood loss, and the secondary outcomes were postoperative PRC transfusion and complications."3.11Adjunctive Topical Tranexamic Acid for Blood Salvage Does Not Reduce Postoperative Blood Loss Compared with Placebo in Patients Who Undergo Palliative Decompressive Spinal Metastasis Surgery: A Randomized Controlled Trial. ( Atthakomol, P; Maethungkul, R; Murakami, H; Phanphaisarn, A; Phinyo, P; Sangsin, A, 2022)
" The current study aimed to determine whether tranexamic acid (TXA) in combination with pressure dressing reduce the amount of blood loss, the rate of incision-related complications, and the rate of readmission for patients undergoing surgeries to release GMC."3.11Tranexamic acid combined with compression dressing reduces blood loss in gluteal muscle contracture surgery. ( Huang, Q; Huang, Z; Ma, J; Pei, F; Shen, B; Zhou, Z, 2022)
"Preoperative TXA is safe and effective in reducing blood loss during and after high-risk CD."3.11Safety and efficacy of preoperative tranexamic acid in reducing intraoperative and postoperative blood loss in high-risk women undergoing cesarean delivery: a randomized controlled trial. ( Al-Asmar, A; Al-Mohamady, M; El Mahy, M; Maged, AM; Rund, NMA; Shalaby, MA, 2022)
"Tranexamic acid is a lysine synthetic derivate that inhibits fibrinolysis and diminishes the bleeding by blocking the five lysine-binding sites for plasminogen."3.11Use of Tranexamic Acid in Liposculpture: A Double-Blind, Multicenter, Randomized Clinical Trial. ( Bayter, JE; Cala, L; Cardenas-Camarena, L; Domínguez-Millan, R; Duran, H; Hoyos, AE; Lopez, A; Mogollon, IR; Perez, M; Talleri, G, 2022)
"Tranexamic acid (TXA) has shown significant reductions in blood loss and transfusion rates in total knee arthroplasty (TKA)."3.01Multimodal Peri-articular Injection with Tranexamic Acid can reduce postoperative blood loss versus Intravenous Tranexamic Acid in Total Knee Arthroplasty: A Randomized Controlled Trial. ( Lin, J; Peng, HM; Qian, WW; Wang, W; Wang, WD; Weng, XS, 2021)
"Tranexamic acid was topically administered to some patients."3.01Impact of direct oral anticoagulants on bleeding tendency and postoperative complications in oral surgery: a systematic review of controlled studies. ( Götrick, B; Holst, J; Johansson, K; Naimi-Akbar, A; Tranæus, S, 2023)
"Tranexamic acid (TXA) has drawn growing interest over the last decade for its benefit in optimizing post-operative bleeding, yet its role in bariatric surgery is poorly understood."3.01Role of Tranexamic Acid (TXA) in Preventing Bleeding Following Sleeve Gastrectomy: a Systematic Review and Meta-analysis. ( Karmali, S; Koloszvari, N; Kung, J; Mocanu, V; Neville, A; Verhoeff, K; Walsh, C; Wilson, H, 2023)
"Its role in reducing postoperative blood loss in breast surgery remains unclear."3.01The Effects of Tranexamic Acid in Breast Surgery: A Systematic Review and Meta-Analysis. ( Huynh, MNQ; McRae, MC; McRae, MH; Voineskos, S; Wong, CR, 2023)
"Intraoperative and postoperative blood loss is a major risk in head and neck (H&N) surgery."3.01A systematic review on the efficacy of tranexamic acid in head and neck surgery. ( Coulson, C; Jamshaid, M; Jamshaid, W; Muzaffar, J; Nieto, H; Sharma, N, 2023)
"Tranexamic acid was the only agent that demonstrated a significantly lower risk of developing postoperative bleeding events (OR 0."3.01The effect of different hemostatic agents following dental extraction in patients under oral antithrombotic therapy: a network meta-analysis. ( Arunjaroensuk, S; Jiaranuchart, S; Mahardawi, B; Pimkhaokham, A; Somboonsavatdee, A; Tompkins, KA, 2023)
"Tranexamic acid (TXA) is an antifibrinolytic drug associated with reduced blood loss in a range of surgical specialties, including neurosurgery, orthopedic surgery, and cardiac surgery."3.01Systematic review and meta-analysis of topical tranexamic acid in spine surgery. ( Ambati, VS; Chan, AK; Chou, D; Izima, C; Sampath, SG; Tang, AJ, 2023)
"Tranexamic acid (TXA) is an antifibrinolytic agent shown to decrease intraoperative bleeding, reduce transfusions, and improve outcomes across multiple specialties."3.01Effects of Intravenous Tranexamic Acid During Rhytidectomy: A Randomized, Controlled, Double-Blind Pilot Study. ( Alloju, LM; Cohen, JC; Glasgold, MJ; Glasgold, RA, 2021)
"This study aimed to evaluate the optimal dosage of topical tranexamic acid (TXA) considering the efficacy and safety for controlling bleeding after total knee arthroplasty (TKA)."3.01Optimal dose of topical tranexamic acid considering efficacy and safety in total knee arthroplasty: a randomized controlled study. ( Han, HS; Kim, JK; Lee, DY; Lee, MC; Park, JY; Ro, DH, 2021)
"Tranexamic acid (TXA) is an antifibrinolytic agent used to reduce bleeding in major surgical procedures."3.01Evaluation of efficacy and safety of systemic and topical intra-articular administration of tranexamic acid in primary unilateral total hip arthroplasty. ( Gažová, A; Jaroslav, V; Juraj, M; Kyselovič, J; Šteňo, B; Žufková, V, 2021)
"Tranexamic acid (TXA) has been shown to reduce perioperative blood loss in elective orthopedic surgery."3.01Topical tranexamic acid in hip fractures: a randomized, placebo-controlled double-blinded study. ( Cheong, Y; Costain, D; Elder, G; Fera, L; Fraser, B; Kelly, A; Slagel, B, 2021)
"A total of 297 patients with chronic subdural hematoma underwent initial burr hole surgery at our hospital from April 2014 to March 2018."2.94Prospective Study on the Efficacy of Orally Administered Tranexamic Acid and Goreisan for the Prevention of Recurrence After Chronic Subdural Hematoma Burr Hole Surgery. ( Natori, Y; Yamada, T, 2020)
"Tranexamic acid (TXA) has been shown to be effective in reducing blood loss after total knee replacement."2.94Topical tranexamic acid in cemented primary total knee arthroplasty without tourniquet: a prospective randomized study. ( Bustamante Suarez de Puga, D; Martínez Gimenez, E; Mas Martinez, J; Morales Santias, M; Sanz-Reig, J; Verdu Román, C, 2020)
"However, there was significantly lower postoperative blood loss with TXA (29."2.94Tranexamic acid for the Latarjet procedure: a randomized controlled trial. ( Hurley, ET; Lim Fat, D; Mullett, H; Pauzenberger, L, 2020)
"Tranexamic acid (TXA) has been shown to reduce blood loss and transfusion requirements in patients undergoing orthopaedic surgery."2.94Intravenous tranexamic acid reduces blood loss and transfusion requirements after periacetabular osteotomy. ( DelPizzo, K; Dodwell, E; Levack, AE; McLawhorn, AS; Nguyen, J; Sink, E, 2020)
"To explore the hemostatic effect of intra-articular administration of tranexamic acid (TXA) combined with knee flexion in total knee arthroplasty (TKA)."2.94Reduction of Blood Loss by Intra-articular Injection of Tranexamic Acid Combined with Knee and Hip Flexion at 45° During Primary Total Knee Arthroplasty: A Randomized Controlled Trial. ( Cai, DZ; Huo, KP; Tan, JS; Yang, JQ; Yang, L; Zhao, L, 2020)
"A total of 100 patients with intertrochanteric fractures undergoing surgery were enrolled and randomly allocated to the TXA group in which patients (75."2.90Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial. ( Huang, Y; Jiang, LF; Wu, LD; Xu, NW; Zhang, JJ; Zhang, Y; Zhou, D; Zhou, XD, 2019)
" Other secondary variables were total blood loss, hidden blood loss, transfusion rate, average hospital stay, complications, adverse events, and mortality."2.90Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study). ( Aguilera, X; Bosch, A; Camacho-Carrasco, P; Castillón, P; González, JC; Hernández, JA; Jordan, M; Martínez-Zapata, MJ; Mora, JM; Prat-Fabregat, S; Rodriguez-Arias, A; Ruiz, L; Salomó, M, 2019)
"Tranexamic acid (TXA) has been widely used in total knee arthroplasty (TKA) for blood loss reduction."2.90Intra-Articular Tranexamic Acid Mitigates Blood Loss and Morphine Use After Total Knee Arthroplasty. A Randomized Controlled Trial. ( Galassi, M; Laoruengthana, A; Pongpirul, K; Rasamimongkol, S; Rattanaprichavej, P; Weerakul, S, 2019)
" However, the optimal oral dosage regimen to achieve maximum blood-loss reduction remains unclear."2.90Finding the Optimal Regimen for Oral Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial. ( Luo, ZY; Pei, FX; Wang, D; Wang, HY; Zeng, WN; Zhou, ZK, 2019)
"Eligible patients with trochanteric fractures surgically treated by dynamic hip screw and proximal anti-rotating intramedullary nail between March 2016 and October 2017 were enrolled in the study."2.90Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial. ( Chen, F; Jiang, Z; Li, M; Zhu, X, 2019)
"Additional reduction of postoperative blood loss may further reduce exposure to allogeneic blood products."2.90Reduced perioperative blood loss in children undergoing craniosynostosis surgery using prolonged tranexamic acid infusion: a randomised trial. ( D'Amore Lindholm, A; Fenger-Eriksen, C; Hvas, AM; Juul, N; Krogh, L; Nørholt, SE; Rasmussen, M; Tarpgaard, M; von Oettingen, G, 2019)
"Postoperative nasal bleeding is a common complication of septoplasty and may lead to painful procedure of nasal packing to stop bleeding."2.90Effect of single-dose intravenous tranexamic acid on postoperative nasal bleed in septoplasty. ( Adeel, M; Akhtar, S; Faraz, Q; Nawaz, A; Zakir, I; Zaman, SU, 2019)
"Tranexamic acid (TXA) is proven to reduce blood loss following total knee arthroplasty (TKA), but there are limited data on the impact of similar dosing regimens in revision TKA."2.902019 Mark Coventry Award: A multicentre randomized clinical trial of tranexamic acid in revision total knee arthroplasty: does the dosing regimen matter?. ( Abdel, MP; Bini, S; Calkins, TE; Culvern, C; Darrith, B; Della Valle, CJ; Fillingham, YA; Malkani, AL; Padgett, DE; Schwarzkopf, R; Sershon, RA, 2019)
"Outcomes assessed are intraoperative and postoperative blood loss, hematocrit, allogenic blood transfusion, and deep vein thrombosis (DVT), postoperatively."2.87Effectiveness and Safety of Batroxobin, Tranexamic Acid and a Combination in Reduction of Blood Loss in Lumbar Spinal Fusion Surgery. ( Dumpa, SR; Kanna, RM; Nagabhushan, RM; Shanmuganathan, R; Shetty, AP; Subramanian, B, 2018)
"Tranexamic acid has been shown to be effective for minimizing perioperative blood loss in liposuction."2.87Use of Tranexamic Acid to Reduce Blood Loss in Liposuction. ( Cansancao, AL; Cansancao, B; Condé-Green, A; David, JA; Vidigal, RA, 2018)
"TRAC-24 will help to determine whether an extended TXA dosing regimen can further reduce blood loss following primary THA and TKA."2.87Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a ( Adams, C; Agus, A; Bell, J; Benson, G; Beverland, D; Bryce, L; Campbell, C; Dorman, A; Eggleton, A; Gardner, E; Hill, J; Hogg, R; Magill, P; Martin, U; McFarland, M; Mockford, B; Molloy, D; Murphy, L; O'Hagan, S; Phair, G, 2018)
"Only one patient in IV group exhibited deep venous thrombosis."2.87Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration. ( Cao, C; Li, DH; Li, LL; Meng, WK; Pei, FX; Wang, D; Wang, HY; Zeng, WN; Zhou, ZK, 2018)
"To compare postoperative blood loss after intravenous and intraarticular tranexamic acid injection in patients of bilateral total knee arthroplasty."2.87Blood loss after intraarticular and intravenous tranexamic acid in total knee arthroplasty. ( Ahmad, S; Ahmed, A; Ahmed, S; Aziz, A; Javed, S, 2018)
" Secondary outcomes were calculated blood loss, number of units transfused during hospitalization, and incidence of adverse events at 30 and 90 days including thromboembolic event, wound complications, reoperation, hospital readmission, and all-cause mortality."2.84Tranexamic Acid Safely Reduced Blood Loss in Hemi- and Total Hip Arthroplasty for Acute Femoral Neck Fracture: A Randomized Clinical Trial. ( Cross, WW; Houdek, MT; Pagnano, MW; Sems, SA; Watts, CD, 2017)
"Tranexamic acid is a proven drug used for reduction of intraoperative blood loss in spinal surgery."2.84The effectiveness of low-dose and high-dose tranexamic acid in posterior lumbar interbody fusion: a double-blinded, placebo-controlled randomized study. ( Hey, HWD; Hong, SJ; Juh, HS; Kim, CK; Kim, HJ; Kim, HS; Kim, KT; Kim, YC, 2017)
"The total blood loss and postoperative blood loss were significantly lower in groups B and C without any difference between them."2.84Efficacy of a Single Dose and an Additional Dose of Tranexamic Acid in Reduction of Blood Loss in Total Knee Arthroplasty. ( Cai, M; Ge, W; Li, S; Sun, Q; Wu, J; Yu, X, 2017)
"Tranexamic acid has been used both topically and systemically and plays a vital role in pediatric cardiac surgery by reducing blood loss and blood product requirement."2.84Topical and low-dose intravenous tranexamic acid in cyanotic cardiac surgery. ( Deodhar, S; Gandhi, H; Pandya, H; Patel, H; Patel, J; Prajapati, M, 2017)
"v, a maintenance dosage of 2 mg/kg/h TA, or an equivalent volume of normal saline."2.84Tranexamic acid reduces perioperative blood loss of posterior lumbar surgery for stenosis or spondylolisthesis: A randomized trial. ( Jiang, D; Ou, Y; Quan, Z; Shi, H; Zhao, Z; Zhu, Y, 2017)
"The combined (IV (intravenous) + topical) use of tranexamic acid (TXA) has been shown to be a safe method and more effective than single (IV or topical) application."2.84The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. ( Akkaya, M; Basaran, SH; Bozkurt, M; Cankaya, D; Dasar, U; Satilmis, AB, 2017)
"Tranexamic acid results in lower bleeding irrespective of the mode of administration compared to control group."2.84A randomized control trial to evaluate the effectiveness of intravenous, intra-articular and topical wash regimes of tranexamic acid in primary total knee arthroplasty. ( Jin, C; Park, YJ; Prakash, J; Seon, JK; Song, EK, 2017)
"Tranexamic acid is an antifibrinolytic that has been shown to reduce blood loss and the need for transfusions when administered intravenously in total hip arthroplasty."2.84Oral and Intravenous Tranexamic Acid Are Equivalent at Reducing Blood Loss Following Total Hip Arthroplasty: A Randomized Controlled Trial. ( Della Valle, CJ; Fillingham, YA; Gerlinger, TL; Kayupov, E; Moric, M; Okroj, K; Plummer, DR, 2017)
" Antifibrinolytic drugs are part of a multifaceted approach aimed at reducing bleeding, though sufficiently sized pediatric studies are sparse, and dosing algorithms are heterogeneous."2.82Antifibrinolytic Drugs for the Prevention of Bleeding in Pediatric Cardiac Surgery on Cardiopulmonary Bypass: A Systematic Review and Meta-analysis. ( Hunt, BJ; Murdoch, IA; Sangaran, DP; Siemens, K; Tibby, SM, 2022)
"Tranexamic acid has been increasingly used for blood conservation in cardiac surgery."2.82Tranexamic acid reduces postoperative blood loss in Chinese pediatric patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis. ( He, LX; Yao, YT; Zou, ZY, 2022)
" Moreover, TXA use is safe in terms of incidence of symptomatic DVT and TE."2.82Combined Administration of Systemic and Topical Tranexamic Acid for Total Knee Arthroplasty: Can It Be a Better Regimen and Yet Safe? A Randomized Controlled Trial. ( Jain, NP; Nisthane, PP; Shah, NA, 2016)
"Tranexamic acid is an antifibrinolytic agent that has shown to effectively reduce bleeding complications within other surgical and medical areas."2.82Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial. ( Bergholt, T; Moeller, C; Ottesen, B; Ravn, P; Schouenborg, L; Settnes, A; Topsoee, MF, 2016)
"Tranexamic acid can be effective at decreasing blood loss and transfusion requirements associated with total hip arthroplasty (THA), but few studies have compared the efficacy of different intravenous dosing regimes."2.82Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: A double-blind, randomized controlled trial of different doses. ( Kang, P; Ma, J; Pei, F; Wang, C; Xie, J; Yue, C, 2016)
"Tranexamic acid (TXA) is a synthetic antifibrinolytic agent successfully used intravenously (IV) to reduce blood loss after total knee arthroplasty (TKA)."2.82The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost? ( Della Valle, CJ; Fillingham, YA; Gerlinger, TL; Kayupov, E; Moric, M; Plummer, DR, 2016)
"Fixed dose of TXA for patients undergoing simultaneous bilateral TKAs was effective and safe in reducing total blood loss and allogeneic blood transfusion needs without any additional thromboembolic risk."2.82Effectiveness and Safety of Fixed-Dose Tranexamic Acid in Simultaneous Bilateral Total Knee Arthroplasty: A Randomized Double-Blind Controlled Trial. ( Cao, X; Chen, X; Guo, K; Yang, C; Zhu, J; Zhu, Q, 2016)
"The optimal dosage and timing of tranexamic acid (TXA) in total knee arthroplasty (TKA) are undetermined."2.82Multiple Boluses of Intravenous Tranexamic Acid to Reduce Hidden Blood Loss After Primary Total Knee Arthroplasty Without Tourniquet: A Randomized Clinical Trial. ( Ma, J; Pei, F; Xie, J; Yao, H; Yue, C, 2016)
" The objective of this trial was to assess the efficacy and safety of intravenous (IV) administration combined with topical administration of TXA regarding postoperative blood loss and transfusion rates in patients treated with primary unilateral total hip arthroplasty."2.82Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration. ( Bin, S; Fuxing, P; Jing, Y; Pengde, K; Yi, Z; Zongke, Z, 2016)
"No deep vein thrombosis was detected through Doppler ultrasound examination."2.80The reduction in blood loss with intra-articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized controlled trial. ( Ding, PJ; Li, J; Lv, YM; Yang, Y; Ying-Ze, Z, 2015)
"TXA treatment without drainage during TKA reduces the amount of blood transfusions required without increasing the rate of adverse events."2.80Safety and efficacy of intra-articular tranexamic acid injection without drainage on blood loss in total knee arthroplasty: A randomized clinical trial. ( Cao, JG; Li, ZJ; Liu, J; Sun, ZH; Wang, CG, 2015)
"Tranexamic acid is an antifibrinolytic agent which blocks plasmin-mediated fibrin degradation."2.80[The Effect of Tranexamic Acid on Blood Loss after Primary Unilateral Total Knee Arthroplasty. Prospective Single-Centre Study]. ( Mezera, V; Musil, D; Pertlíček, J; Sadovský, P; Stehlík, J, 2015)
"27 %, p = 0."2.79Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial. ( Chang, CB; Kang, YG; Kim, TK; Lee, JH; Lee, SH; Seo, ES; Yun, JH, 2014)
"Tranexamic acid resulted in a lower mean maximum decline in postoperative hemoglobin levels when compared to placebo (P = 0."2.79Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. ( Cassatt, KB; Garton, AS; Kincaid-Cinnamon, KA; Lemke, JH; Martin, JG; Westendorf, DS, 2014)
"Tranexamic acid is an antifibrinolytic drug used widely to prevent bleeding."2.79Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty. ( Bhatty, S; Gulati, A; Paul, R; Rajoli, SR; Saini, R; Soni, A, 2014)
"Intraoperative and postoperative blood loss were compared between the two groups."2.78Tranexamic acid reduces postoperative blood loss of degenerative lumbar instability with stenosis in posterior approach lumbar surgery: a randomized controlled trial. ( Bi, Y; Chen, Y; Fan, R; Guo, M; Hua, Z; Liu, J; Piao, M; Ren, W; Wang, Q; Xiang, L; Yu, H, 2013)
"234."2.78Effect of tranexamic acid on reducing postoperative blood loss in combined hypotensive epidural anesthesia and general anesthesia for total hip replacement. ( Cho, CH; Kim, JS; Lee, YC; Park, SJ, 2013)
"The tranexamic acid regimen was a bolus of 10 mg/kg followed by a maintenance of 10 mg·kg(-1)·h(-1) throughout the surgery."2.78[Effectiveness and safety of tranexamic acid in patients receiving on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation]. ( Li, LH; Shi, J; Wang, GY; Wang, YF; Xue, QH; Yuan, S, 2013)
" Secondary outcomes were the calculated hidden blood loss, transfusion rate, preoperative and postoperative hemoglobin, number of blood units transfused, adverse events, and mortality."2.78Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. ( Aguilera, X; Bosch, A; Celaya, F; Fernández, JA; Gich, I; González, JC; Jordan, M; Martínez, N; Martinez-Zapata, MJ; Maymó, RM; Monllau, JC; Urrútia, G, 2013)
"Recently, a number of studies using intra-articular application of tranexamic acid (IA-TXA), with different dosage and techniques, successfully reduced postoperative blood loss in total knee replacement (TKR)."2.78Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial. ( Chanplakorn, P; Kawinwonggowit, V; Mulpruek, P; Sa-Ngasoongsong, P; Wechmongkolgorn, S; Wibulpolprasert, B; Wongsak, S; Woratanarat, P, 2013)
"The objective of this study was to conduct a population pharmacokinetic analysis and develop a model to predict an effective TXA dosing regimen for children with craniosynostosis undergoing cranial remodelling procedures."2.78Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery. ( Goobie, SM; Meier, PM; Pereira, LM; Samant, S; Sethna, NF; Soriano, SG; Zurakowski, D, 2013)
"Ecallantide is a recombinant peptide in the same class as aprotinin that inhibits plasma kallikrein, a major component of the contact coagulation and inflammatory cascades."2.77A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial). ( Bokesch, PM; Grocott, HP; Levy, JH; Mazer, CD; Smith, PK; Szabo, G; Vetticaden, S; Wheeler, A; Wojdyga, R, 2012)
"Tranexamic acid is a simple means of reducing postoperative blood loss in THR, without increased risk of thromboembolism when associated to rivaroxaban thromboprophylaxis."2.77Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients. ( Clavé, A; Dumser, D; Fazilleau, F; Lacroix, J, 2012)
" However, controversy persists regarding the dosage and timing of administration of this drug during surgery."2.77The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective? ( Chen, WS; Hsu, CH; Huang, CC; Lin, PC; Wang, JW, 2012)
"Several methods reportedly reduce postoperative blood loss and avoid homologous blood transfusion with traditional TKA approaches, but it is unclear these reductions apply to a minimally invasive technique."2.76Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. ( Charoencholvanich, K; Siriwattanasakul, P, 2011)
"The postoperative blood loss was reduced in the 1."2.75Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. ( Abrishami, A; Chung, F; De Silva, Y; El Beheiry, H; Gandhi, R; Mahomed, NN; Muhammad Ovais Hasan, S; Roderick Davey, J; Syed, KA; Wong, J, 2010)
"Twenty-four-hour postoperative blood loss was significantly less in the tranexamic acid group compared with the control group (471 +/- 182 v 844 +/- 303)."2.74Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery. ( Attar, AS; Mirzaee, A; Shirdel, A; Taghaddomi, RJ, 2009)
"Tranexamic acid has been suggested to be as effective as aprotinin in reducing blood loss and transfusion requirements after cardiac surgery."2.74Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. ( Bruggemans, EF; Dion, RA; Engbers, FH; Klautz, RJ; Later, AF; Maas, JJ; Versteegh, MI, 2009)
"Tranexamic acid was more effective than autotransfusion in reducing postoperative blood loss and allogeneic transfusions after coronary bypass."2.73Effects of tranexamic acid and autotransfusion in coronary artery bypass. ( Davoodi, S; Madani-Civi, M; Mehr-Aein, A, 2007)
"Tranexamic acid does not seem to be a useful adjunct in myomectomy if given according to the described protocol in this study."2.73Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study. ( Caglar, GS; Haberal, A; Kayikcioglu, F; Tasci, Y, 2008)
"Tranexamic acid was used to reduce postoperative drainage and allogenic blood transfusion requirements in patients undergoing on-pump primary coronary bypass surgery."2.73Tranexamic acid and primary coronary artery bypass surgery: a prospective study. ( Maddali, MM; Rajakumar, MC, 2007)
" In Group A, 1 g of tranexamic acid dissolved in 250 ml of normal saline was intravenously infused before deflation of the tourniquet; another intravenous administration of the same drug of the same dosage was given 3 hours later."2.73[Clinical comparative studies on effect of tranexamic acid on blood loss associated with total knee arthroplasty]. ( Gao, Z; Yu, J; Zhang, F, 2007)
" Few studies found adverse events, and no difference in incidence or type of adverse events was seen between the antifibrinolytic and the placebo group."2.72Efficacy and Safety of Antifibrinolytic Drugs in Pediatric Surgery: A Systematic Review. ( Fenger-Eriksen, C; Hansen, AK; Hovgesen, NT; Hvas, AM; Larsen, JB, 2021)
"The placebo group had a greater postoperative blood loss (median (25th to 75th percentile) 12 h after surgery (540 (350-750) vs 300 (250-455) mL, P = 0."2.72A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting. ( Bauemann, C; Kalil, RA; Nesralla, IA; Pereira, JB; Santos, AT, 2006)
"Sixteen patients with haemophilia who required dental scaling participated in this pilot study."2.71Effectiveness in controlling haemorrhage after dental scaling in people with haemophilia by using tranexamic acid mouthwash. ( Boyle, CA; Fiske, J; Lee, AP; Savidge, GF, 2005)
"The volume of postoperative blood loss was recorded at two-hour intervals for the first twelve hours and then again at twenty-four hours, and the values were compared between the two groups."2.71Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty. ( Fuji, T; Masuhara, K; Yamasaki, S, 2005)
"Tranexamic acid appears to be an effective and economic drug for reduction of blood loss in cemented primary hip arthroplasty for osteoarthritis."2.71Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. ( Korkala, OL; Niskanen, RO, 2005)
"Case material included 25 patients with hemophilia (9 children and 16 adults) with high-responding inhibitors and 3 patients with acquired factor VIII inhibitors."2.70Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors. ( Baudo, F; Gringeri, A; Morfini, M; Rocino, A; Santagostino, E; Scaraggi, FA, 2001)
"Tranexamic acid has traditionally been used to treat post-operative bleeding."2.69The effect of tranexamic acid (cyclokapron) on blood loss after third molar extraction under a day case general anaesthetic. ( Harris, M; Senghore, N, 1999)
"Tranexamic acid was given at the end of the operation and 3 hours later."2.69Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. ( Benoni, G; Fredin, H; Lethagen, S; Nilsson, P, 2000)
"Tranexamic acid (TXA) has been widely used during on-pump coronary artery bypass graft (CABG) surgery owing to its antifibrinolytic effect."2.66Intravenous Tranexamic Acid Decreases Blood Transfusion in Off-Pump Coronary Artery Bypass Surgery: A Meta-analysis. ( An, H; Feng, Y; Sun, L, 2020)
"Tranexamic acid (TXA) is a widely used antifibrinolytic agent worldwide and whether TXA influences ACT value in cardiac surgical patients remains unknown."2.66The effect of tranexamic acid on the values of activated clotting time in patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis. ( He, LX; Tan, JC; Yao, YT, 2020)
" Furthermore, it is safe and does not increase the risk of thrombotic events."2.61The Efficacy and Safety of Intravenous Tranexamic Acid in Reducing Surgical Blood Loss in Posterior Lumbar Interbody Fusion for the Adult: A Systematic Review and a Meta-Analysis. ( Chen, L; Chen, R; Gong, M; Liu, G; Xiang, Z, 2019)
"Tranexamic acid (TXA) is an antifibrinolytic agent that reduces bleeding and transfusion in a broad number of adult and pediatric surgeries, as well as in trauma and obstetrics."2.61Tranexamic acid and perioperative bleeding in children: what do we still need to know? ( Faraoni, D; Goobie, SM, 2019)
"Tranexamic acid (TXA) is an antifibrinolytic medication that can reduce perioperative blood loss in TKA."2.58Intra-articular Tranexamic Acid in Primary Total Knee Arthroplasty: Meta-analysis. ( Capps, SG; Moskal, JT, 2018)
"Tranexamic acid (TXA) has been widely used to decrease transfusion rate in joint replacement surgery."2.58A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery. ( Bai, J; Chen, P; He, J; Liang, Y; Wang, J; Zhang, P, 2018)
"A total of 59 participants with haemophilia undergoing dental extraction were involved."2.55Preventing perioperative bleeding in patients with inherited bleeding disorders. ( Beacher, N; Watterson, C, 2017)
"Tranexamic acid (TXA) is a synthetic anti-fibrinolytic agent commonly used for the prevention and treatment of bleeding disorders."2.55Manifestation of tranexamic acid toxicity in chronic kidney disease and kidney transplant patients: A report of four cases and review of literature. ( Chow, KM; Kwan, BC; Leung, CB; Li, PK; Ma, TK; Szeto, CC, 2017)
"Correction of craniosynostosis may require extensive surgical interventions with related intra and postoperative complications especially hemorrhage."2.53Surgical treatment of craniosynostosis in infants: open vs closed repair. ( Erb, TO; Meier, PM, 2016)
"Tranexamic acid (TXA) is an antifibrinolytic drug widely used to reduce blood loss during joint replacements, including total knee arthroplasty (TKA) and total hip arthroplasty (THA)."2.53Topical versus systemic tranexamic acid after total knee and hip arthroplasty: A meta-analysis of randomized controlled trials. ( Chen, Y; Chen, Z; Cui, S; Li, Z; Yuan, Z, 2016)
" No significant difference in deep vein thrombosis (DVT), pulmonary embolism, or other adverse events among the study groups."2.52Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials. ( Liu, SL; Meng, T; Wang, P; Wu, Q; Zhang, HA; Zhou, X, 2015)
"Tranexamic acid (TXA) is an antifibrinolytic drug used to reduce bleeding in mortality risk situations such as trauma."2.52Efficiency of tranexamic acid in perioperative blood loss in hip arthroplasty: a systematic literature review and meta-analysis. ( Díaz Quijano, DM; Pinzón-Florez, CE; Vélez Cañas, KM, 2015)
" The question addressed was: what dose of tranexamic acid is most effective and safe for adult patients undergoing cardiac surgery? Altogether 586 papers were found using the reported search, of which 12 represented the best evidence to answer the clinical question."2.52What dose of tranexamic acid is most effective and safe for adult patients undergoing cardiac surgery? ( Dearman, C; Hodgson, S; Larvin, JT, 2015)
" Both topical and intravenous administration of TXA, in a variety of dosing regimens, has proven effective."2.52Tranexamic Acid in Hip and Knee Arthroplasty. ( Melvin, JS; Sierra, RJ; Stryker, LS, 2015)
"The present meta-analysis indicated that intra-articular injection of TXA in patients undergoing TKA may reduce total blood loss and the need for blood transfusions, particularly when a high dosage of TXA is used (≥30 mg/ml), without any increase in the risk of post-operative DVT."2.50Reduced blood loss after intra-articular tranexamic acid injection during total knee arthroplasty: a meta-analysis of the literature. ( Wei, C; Yan, G; Ying-Ze, Z; Yuejv, L; Zhao-Yu, C, 2014)
"Tranexamic acid is a synthetic antifibrinolytic drug."2.50Tranexamic acid - a useful drug in ENT surgery? ( Robb, PJ, 2014)
"Meanwhile TA is recommended to reduce deep vein thrombosis and pulmonary embolism following TKA."2.49Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials. ( Chen, C; Fu, DJ; Guo, L; Yang, L, 2013)
" Analysis of data is complicated as the dosing scheme, especially for tranexamic acid, varies extremely and the agents are highly overdosed in most relevant trials."2.47Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era. ( Koster, A; Schirmer, U, 2011)
" A total of 19 trials were eligible: 18 used intravenous administration, one also evaluated oral dosing and one trial evaluated topical use."2.47Tranexamic acid in total knee replacement: a systematic review and meta-analysis. ( Alshryda, S; Blenkinsopp, J; Mason, JM; Nargol, A; Sarda, P; Sukeik, M, 2011)
" Further studies are needed to clarify the neurological risk, appropriate indications and dosing of tranexamic acid."2.46Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies. ( Bland, JM; Ngaage, DL, 2010)
"Tranexamic acid was usually added for mucosal surgery."2.41Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease. ( Griffioen, A; Harrington, C; Lee, CA; Nitu-Whalley, IC, 2001)
"However, hemarthrosis is the most common complication in arthroscopic surgery, which has potential adverse effects on postoperative rehabilitation."1.91Topical administration of tranexamic acid reduces postoperative blood loss and inflammatory response in knee arthroscopic arthrolysis: a retrospective comparative study. ( Chen, G; Fu, W; Li, J; Li, Q; Tang, X; Xiong, Y; Yao, L; You, M, 2023)
"The primary outcomes were postoperative blood loss and the composite incidence of mortality and morbidities during hospitalization."1.91The efficacy and safety of intravenous administration of tranexamic acid in patients undergoing cardiac surgery: Evidence from a single cardiovascular center. ( He, LX; Jiang, JJ; Lin, PS; Ma, J; Tian, LJ; Yao, YT; Yu, YP; Zhang, Y, 2023)
"Tranexamic acid (TXA) has long been the antifibrinolytic hemostatic drug of choice for orthopedic surgery."1.91Efficacy and safety of using aminocaproic acid and tranexamic acid during the perioperative period for treating trochanteric fractures in elderly femurs. ( Haibier, A; Qin, Q; Ran, J; Ren, Z; Yusufu, A; Zhang, Z; Zhou, Y, 2023)
"Tranexamic acid (TXA) is an antifibrinolytic drug that reduces blood loss in patients that undergo Total knee arthroplasty (TKA)."1.91Benefits of Tranexamic Acid in Total Knee Arthroplasty: A Classification and Regression Tree Analysis in Function of Instrumentation, BMI, and Gender. ( Carvalho, MM; Cruz, H; Fontes, AP; Marreiros, A; Oliveira, T; Pereira, EG; Sacramento, T; Sousa, JP; Viegas, R, 2023)
"Tranexamic acid (TXA) is an antifibrinolytic agent for reducing blood loss and allogenic blood transfusion."1.72The Efficiency of Simultaneous Systemic and Topical Use of Tranexamic Acid in Spinal Fusion Surgery. ( Akbas, A; Erdogan, U; Sari, S, 2022)
"Intraoperative blood loss and postoperative drain collection of the TXA group, ANH combined with TXA group were statistically lower than those in the control group and ANH group (P < 0."1.72Acute normovolemic hemodilution in combination with tranexamic acid is an effective strategy for blood management in lumbar spinal fusion surgery. ( Fang, X; Li, Y; Zhang, Y, 2022)
"Tranexamic acid (TXA) has been shown to decrease perioperative blood loss, transfusions, and cost in patients undergoing resection of aggressive bone tumors and endoprosthetic reconstruction."1.72Tranexamic acid improves early postoperative mobilization in cancer patients undergoing endoprosthetic reconstruction. ( Bombardier, B; Haase, DR; Kimbrel, B; Mersereau, EJ; Rosenthal, HG; Sweeney, KR; Templeton, KJ, 2022)
"This study aimed to evaluate the efficacy and safety of intravenous combined with topical application of tranexamic acid (TXA) in reducing blood loss in opening wedge high tibial osteotomy (OWHTO)."1.72Efficacy and safety of intravenous combined with topical administration of tranexamic acid in reducing blood loss in opening wedge high tibial osteotomy procedure: A retrospective case-control study. ( Fu, X; Huang, JM; Luo, W; Ma, XL; Wu, J, 2022)
"The aim of the study is to compare weight-based versus standard dosing of intravenous (IV) tranexamic acid (TXA) for blood loss and transfusion amount in total knee arthroplasty (TKA) without a tourniquet."1.72Comparison of weight-based versus standard dosing of tranexamic acid for blood loss and transfusion amount in knee arthroplasty without tourniquet. ( Çarkcı, E; Çerci, MH; Guler, O; Gümüşsuyu, G; Öztürk, Ç, 2022)
"Ninety-two hemophilia A patients who underwent total knee arthroplasty in our center were included."1.72Hidden blood loss of total knee arthroplasty in hemophilia arthritis: an analysis of influencing factors. ( Lv, SJ; Shen, SN; Tong, PJ; Wu, DX, 2022)
"Tranexamic acid (TXA) is an antifibrinolytic drug that can be used to treat and prevent bleeding."1.72 ( Bosselmann, K; Keck, M; Lohmeyer, JA; Müller-Wittig, S; Wittig, KS, 2022)
"Tranexamic acid (1 g) was administered intravenously to all patients in both study groups."1.72Use of tranexamic acid may reduce the need for routine tourniquet use in total knee arthroplasty. ( Akdoğan, BM; Akdoğan, M; Atilla, HA; Çatma, MF; Gülsoy, A; Öztürk, A, 2022)
"Tranexamic acid (TXA) has proven to be safe in elective and traumatic femoral hemiarthroplasty; however, its use has not been investigated in oncologic patients."1.62Use of tranexamic acid is not associated with complications following bipolar hemiarthroplasty for metastatic disease. ( Houdek, MT; Owen, A; Rose, PS; Wellings, EP; Wyles, CC; Yuan, BJ, 2021)
"Disusing CSD significantly reduced postoperative blood loss and transfusion requirement without increasing postoperative pain and surgical wound complications in cementless SBTHA with concurrent administration of intravenous TXA."1.62Effects of disusing closed suction drainage in simultaneous bilateral total hip arthroplasty: A retrospective cohort study. ( Lee, Y; Lim, SJ; Park, CW; Park, YS; Won, JY; Yoo, I, 2021)
"0, was employed to analyze demographics including surgical traits, blood loss, drainage, length of hospital stays (LOS), blood biochemical indices, prethrombotic state molecular markers, coagulation function, and adverse events."1.62Safety and Efficacy of Topical Administration of Tranexamic Acid in High-Risk Patients Undergoing Posterior Lumbar Interbody Fusion Surgery. ( Cai, T; Chen, D; Feng, X; Shi, P; Wang, J; Wang, S; Wang, Y; Zhang, L; Zhang, W, 2021)
"Tranexamic acid (TXA) is an effective blood management strategy, as it competitively inhibits the activation process of plasminogen and prevents fibrinolytic enzymes from degrading fibrin."1.62Comparison of topical and intravenous Tranexamic acid for high tibial osteotomy: A retrospective study. ( Bian, J; Deng, B; Li, S; Wang, G; Wang, Z; Yuan, L; Zhang, Y; Zhao, X, 2021)
"Tranexamic acid (TXA) is an antifibrinolytic agent used to reduce blood loss in orthopaedic procedures."1.56Tranexamic Acid in Patients With Cancer Undergoing Endoprosthetic Reconstruction: A Retrospective Review. ( Haase, DR; Rosenthal, HG; Sweeney, KR; Templeton, KJ, 2020)
"To investigate whether intravenous combined with topical administration of tranexamic acid (TXA) is superior to intravenous administration alone in terms of blood loss, incision complications, functional recovery, and pain relief in high tibial osteotomy (HTO)."1.56Intravenous Combined with Topical Tranexamic Acid Administration Has No Additional Benefits Compared with Intravenous Administration Alone in High Tibial Osteotomy: A Retrospective Case-Control Study. ( Guo, X; Li, S; Liu, P; Lu, Q; Luo, D; Miao, Z; Zhang, M, 2020)
" Our study indicates that the local administration of TXA/DEP is safe and more effective than the administration of TXA alone in treating trochanteric femoral fractures."1.56Safety and efficacy of tranexamic acid with epinephrine for prevention of blood loss following surgery for trochanteric femoral fractures. ( Hu, Y; Xie, L; Xu, X; Yu, H, 2020)
"Primary endpoint was the postoperative blood loss within 24 hours."1.56Postoperative administration of tranexamic acid as approach to reduce blood loss after open-heart surgery. ( Matschke, K; Meissner, F; Plötze, K; Waldow, T, 2020)
" Previous studies have established the efficacy of TXA in TKA, however here are limited direct comparison studies available and the dosing regimens vary."1.56Higher doses of topical tranexamic acid safely improves immediate functional outcomes and reduces transfusion requirement in total knee arthroplasty. ( Tan, C; Wang, L; Wu, C, 2020)
"There was no significant difference in postoperative blood loss between the tranexamic acid group and the control group."1.56[Analysis of hemostatic effect of intra-articular injection of tranexamic acid after minimally invasive unicompartmental knee arthroplasty]. ( Dong, F; Qian, PK; Sun, BF; Wu, XF; Xu, F; Yin, ZF; Zhang, JB, 2020)
"Thirty-four patients with haemophilia A undergoing 24 TKA and 18 THA were evaluated in this retrospective study (No."1.51Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia. ( Huang, Q; Huang, ZY; Ma, J; Pei, FX; Shen, B; Zeng, HJ; Zhou, ZK, 2019)
"A young girl with constant exotropia was planned for surgery."1.51Factor XIII deficiency leading to preseptal haematoma post-strabismus surgery. ( Badakere, A; Jain, M; Kekunnaya, R, 2019)
"Tranexamic acid (TXA) is an effective blood salvage agent that reduces perioperative blood loss in conventional total knee arthroplasty (TKA)."1.51Tranexamic Acid Reduces Total Blood Loss and Inflammatory Response in Computer-Assisted Navigation Total Knee Arthroplasty. ( Chou, WY; Hsu, YH; Ko, JY; Kuo, SJ; Siu, KK; Wu, KT, 2019)
" The incidence of adverse events was evaluated in the perioperative period and at 1 month follow-up."1.51Short-term safety of tranexamic acid use in posterior cervical decompression and fusion surgery. ( Burks, JD; Gjolaj, JP; Green, BA; Lugo-Pico, JG; Madhavan, K; Perez-Roman, RJ; Sheinberg, D, 2019)
"This study demonstrated that intra-articular 1 g TXA administration during TKA is safe and effective for reducing blood loss and blood transfusion without increasing VTE risk."1.51Intra-articular 1 g tranexamic acid administration during total knee arthroplasty is safe and effective for the reduction of blood loss and blood transfusion. ( Furumatsu, T; Hino, T; Kamatsuki, Y; Kodama, Y; Masuda, S; Miyazawa, S; Okazaki, Y; Ozaki, T, 2019)
"Tranexamic acid has been shown to be effective in reducing blood loss after total hip replacement."1.48Matched cohort study of topical tranexamic acid in cementless primary total hip replacement. ( Bustamante Suarez de Puga, D; Martínez Gimenez, E; Mas Martinez, J; Morales Santias, M; Sanz-Reig, J; Verdu Román, C, 2018)
"Tranexamic acid (TXA) is an antifibrinolytic drug that is used for uncontrolled bleeding of various origin."1.48Effect of tranexamic acid on intra- and postoperative haemorrhage in dogs with surgically treated hemoperitoneum. ( Jud Schefer, RS; Olgiati, L; Sigrist, N, 2018)
"Postoperative hemorrhage was managed successfully by repacking with Gelfoam impregnated with tranexamic acid powder in most patients."1.48Management of dental extractions in patients on warfarin and antiplatelet therapy. ( Hsue, SS; Lin, LH; Lu, SY, 2018)
"The intravenous TXA would reduce postoperative blood loss and transfusion requirements without increasing thromboembolic complications in open-wedge HTO."1.48Tranexamic acid is effective for blood management in open-wedge high tibial osteotomy. ( Bae, SH; Kim, GB; Kim, HJ; Kim, KI, 2018)
"Male appeared to suffer more surgical blood loss than female."1.48Blood loss of total knee arthroplasty in osteoarthritis: an analysis of influential factors. ( Hu, Y; Li, Q; Shi, ZJ; Torsha, TT; Wei, BG; Xiao, J; Zhang, XS, 2018)
" The best administration route and dosage should be further studied."1.48[Preliminary analysis of the effect of different administration routes of tranexamic acid on blood loss after total hip arthroplasty for female femur neck fractures]. ( Lin, ZQ; Luo, GG; Xie, HF; Yao, JC; Zhang, HZ, 2018)
"Tranexamic acid (TXA) has been associated with decreased blood loss and transfusion after total hip arthroplasty (THA) and total knee arthroplasty (TKA)."1.46Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty. ( Barfield, WR; Demos, HA; Lin, ZX; Pellegrini, VD; Robertson, DC; Wilson, SH, 2017)
"To compare postoperative blood loss, amount of allogeneic blood transfusion, removal time of drainage tube, length of hospital stay, and complications associated with tranexamic acid (TXA)."1.46Efficacy and Safety of Topical Use of Tranexamic Acid in Reducing Blood Loss During Primary Lumbar Spinal Surgery: A Retrospective Case Control Study. ( Chen, X; Jiang, P; Li, S; Li, Z; Ren, Z; Sheng, L; Xu, D; Zhang, X; Zhuang, Q, 2017)
" This study used a low-dose pharmacokinetic TXA dosing protocol and assessed its ability to limit perioperative blood loss for craniosynostosis repairs."1.46Reducing Postoperative Bleeding After Craniosynostosis Repair Utilizing a Low-Dose Transexamic Acid Infusion Protocol. ( Andrews, BT; Hansen, JK; Lydick, AM; Wyatt, MM, 2017)
"TISSEEL fibrin sealant does not reduce postoperative blood loss or transfusions; however, IV TXA reduced postoperative transfusions compared with TISSEEL and control."1.46An Aprotinin Containing Fibrin Sealant Does Not Reduce Blood Loss in Total Hip Arthroplasty. ( Bohl, DD; Kearns, SM; Kuhar, HN; Levine, BR, 2017)
" However, the optimal dosing regimen remains undetermined."1.46Quantitative efficacy of topical administration of tranexamic acid on postoperative bleeding in total knee arthroplasty. ( Ge, W; Jiang, Q; Shi, D; Xu, R, 2017)
"Parameters associated with postoperative blood loss were compared to the prolongation of closure time and medication use."1.46Limitations of Preoperative PFA-200 as a Predictor of Postoperative Blood Loss in Total Knee Arthroplasty: According to Use of Tranexamic Acid. ( Jeon, Y; Kang, SY; Kim, MH; Lee, WI, 2017)
"This study aimed to compare the efficacy of intravenous administration of tranexamic acid for reducing blood loss in total knee arthroplasty at different dosage time."1.46The Efficacy Comparison of Tranexamic Acid for Reducing Blood Loss in Total Knee Arthroplasty at Different Dosage Time. ( Cai, M; Gong, J; Nie, X; Sun, Q; Yu, X, 2017)
"Intra- and postoperative blood loss was compared between the groups."1.46High-dose tranexamic acid reduces intraoperative and postoperative blood loss in posterior lumbar interbody fusion. ( Iwasaki, M; Kushioka, J; Maeno, T; Matsumoto, T; Okuda, S; Yamasaki, R; Yamashita, T, 2017)
"Tranexamic acid was superior to fibrin sealant in decreasing allogeneic transfusion requirements (0 vs."1.46Tranexamic acid versus fibrin sealant in primary total hip replacement: a comparative study. ( Borbora, A; Kumar, G; Mahmood, A; Peter, V; Sawalha, S, 2017)
"Tranexamic acid has been reported to be safer with topical administration than with intravenous administration in total knee arthroplasty."1.43Comparison between topical and intravenous administration of tranexamic acid in primary total hip arthroplasty. ( Fukumori, N; Kawano, S; Kitajima, M; Mawatari, M; Sonohata, M; Ueno, M, 2016)
"Tranexamic acid (TXA) has proven its efficacy in reducing blood loss and the need for blood transfusions in patients who have undergone a total knee arthroplasty (TKA) surgical procedure."1.43Does tranexamic acid reduce blood loss and transfusion rates in unicompartmental knee arthroplasty? ( Pongcharoen, B; Ruetiwarangkoon, C, 2016)
"There were no deep venous thrombosis or thromboembolic complications in any group."1.43A comparative, retrospective study of peri-articular and intra-articular injection of tranexamic acid for the management of postoperative blood loss after total knee arthroplasty. ( Dai, K; Mao, Z; Wang, Y; Yan, M; Yue, B, 2016)
"Tranexamic acid (TXA) is an antifibrinolytic agent that can be used to reduce blood loss in total knee arthroplasty (TKA) patients."1.43Intraarticular Administration of Tranexamic Acid is Safe and Effective in Total Knee Arthroplasty Patients at High-Risk for Thromboembolism. ( Chughtai, M; Delanois, RE; Gwam, C; Khlopas, A; Mistry, JB; Mont, MA; Mudaliar, PP; Tangri, V; Thomas, M, 2016)
"Tranexamic acid (TXA) has shown safety and efficacy in reducing blood loss associated with various surgical procedures."1.42Does Tranexamic Acid Reduce Blood Loss and Transfusion Requirements Associated With the Periacetabular Osteotomy? ( Baca, GR; Clohisy, JC; Keith, AD; Schoenecker, PL; Wingerter, SA, 2015)
"Low-dose IA-TXA application in TKR with prolonged clamping drain method is a safe and effective blood conservative technique with only minimal systemic absorption and without significant increase in systemic absorption over time."1.42An In Vivo Study of Low-Dose Intra-Articular Tranexamic Acid Application with Prolonged Clamping Drain Method in Total Knee Replacement: Clinical Efficacy and Safety. ( Angchaisukisiri, P; Aryurachai, K; Chanplakorn, P; Jittorntam, P; Kawinwonggowit, V; Panpikoon, T; Sa-ngasoongsong, P; Uthadorn, K; Wongsak, S, 2015)
"Tranexamic acid (TXA) is an antifibrinolytic that reduces blood loss and transfusion rates in total joint arthroplasty."1.40Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty. ( Adams, MJ; Dalury, DF; Kelley, TC; Tucker, KK, 2014)
"Tranexamic acid (TA) has been reported to reduce blood loss after total joint arthroplasty; however, the literature is sparse in evaluating its efficacy in simultaneous bilateral total knee arthroplasty (TKA)."1.40Evaluation of the efficacy and safety of tranexamic acid for reducing blood loss in bilateral total knee arthroplasty. ( Bloomfield, MR; DiIorio, TM; Irizarry, AM; Karam, JA; Sharkey, PF, 2014)
" Intravenous administration of 1 g of TXA pre-operatively and administration of 1 g before tourniquet release is an effective and safe method of reducing blood loss in TKA."1.40Repeated doses of intravenous tranexamic acid are effective and safe at reducing perioperative blood loss in total knee arthroplasty. ( Dai, W; Shi, P; Xu, Q; Yang, Y; Yao, Z; Zhang, C; Zhou, J, 2014)
"When tranexamic acid was administered, the need for transfusions was lower (difference statistically significant)."1.40Intravenous use of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. ( Atzori, F; Debiasi, F; Massè, A; Revello, S; Sabatini, L; Scotti, L, 2014)
"Tranexamic acid was routinely given to all patients repaired on ECMO for 24 hours perioperatively after 2003."1.38Congenital diaphragmatic hernia: to repair on or off extracorporeal membrane oxygenation? ( Bax, KM; Houmes, RJ; Keijzer, R; Rycus, P; Sluijter, I; Tibboel, D; van de Ven, KP; van den Hout, L; Wilschut, DE, 2012)
"The rate of avoidance of ABTs, postoperative blood loss, and complications (DVT/PE, skin problems) were examined."1.37Efficient strategy for controlling postoperative hemorrhage in total knee arthroplasty. ( Hoshino, Y; Sasanuma, H; Sekiya, H; Sugimoto, N; Takada, H; Takatoku, K, 2011)
"Although the fourfold risk for seizures using TXA was not significant, we currently use EACA in paediatric cardiac surgery."1.37Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. ( Breuer, T; Gertler, R; Hapfelmeier, A; Hess, J; Lange, R; Martin, K; Schreiber, C; Wiesner, G, 2011)
"IV tranexamic acid was also administered to reduce intraoperative blood loss."1.35Routine preoperative coagulation screening detects a rare bleeding disorder. ( Anne, KK; Durga, P; Jonnavithula, N; Pochiraju, R; Ramachandran, G, 2009)
" All the patients received specific hemostasis/coagulation management based on (a) routine use of tranexamic acid, (b) heparin dose-response monitoring, thromboelastography, platelet (PLT) function analysis in a select population of patients, and (c) use of fresh frozen plasma (FFP), PLTs, and desmopressin according to the hemostasis/coagulation profile."1.35Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery. ( Ballotta, A; Castelvecchio, S; Conti, D; Isgrò, G; Ranucci, M; Romitti, F, 2009)
"Aprotinin treatment was associated with an increased use of plasma and platelet transfusion and an increased risk for postoperative dialysis, but not with other adverse outcomes, including short-term mortality."1.35Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study. ( Hjortdal, VE; Jakobsen, CJ; Johnsen, SP; Søndergaard, F, 2009)
"The postoperative blood loss was significantly higher in all tirofiban-patients (A-C) compared to a group of CABG-patients without tirofiban."1.35CABG-procedures in patients with pretreatment with the GPIIb/IIIa-receptor antagonist tirofiban (Aggrastat): modification of perioperative management? ( Boeken, U; Feindt, P; Gams, E; Kurt, M; Litmathe, J, 2008)
"Dental extraction in hemophiliacs is associated with a high risk of bleeding."1.33Management options for dental extraction in hemophiliacs: a study of 55 extractions (2000-2002). ( Berthier, AM; De Mello, G; Frachon, X; Garnier, J; Hourdin-Eude, S; Lejeune, S; Mézière, X; Pommereuil, M; Quéro, J, 2005)
"Glanzmann's thrombasthenia is a congenital hemorrhagic disorder transmitted as an autosomal recessive trait and characterized by altered production and/or assembly of the platelet membrane glycoprotein IIb/IIIa receptor."1.33Perioperative management of a heterozygous carrier of Glanzmann's thrombasthenia submitted to coronary artery bypass grafting with cardiopulmonary bypass. ( Barbato, L; Casati, V; D'Angelo, A; Grasso, MA; Panzeri, E; Rossi, E; Spagnolo, S, 2006)
"A 42-year-old female with von Willebrand's disease was managed with desmopressin and tranexamic acid to aid haemostasis following a vaginal hysterectomy."1.31Severe hyponatraemia secondary to desmopressin therapy in von Willebrand's disease. ( Bertholini, DM; Butler, CS, 2000)

Research

Studies (633)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's17 (2.69)18.2507
2000's92 (14.53)29.6817
2010's363 (57.35)24.3611
2020's161 (25.43)2.80

Authors

AuthorsStudies
Peng, HM1
Wang, W5
Lin, J2
Weng, XS1
Qian, WW1
Wang, WD1
Kuo, CC1
DeGiovanni, JC1
Carr, MM1
Lee, MJ1
Kim, JK2
Tang, J1
Ming, JM1
Chua, ME1
Jiang, W2
Fu, M3
Dong, W1
Zhou, N1
Shen, J3
Zhang, X7
Hao, J2
Siemens, K1
Sangaran, DP1
Hunt, BJ1
Murdoch, IA1
Tibby, SM1
Alsubaie, HM1
Abu-Zaid, A1
Sayed, SI1
Pathak, KA1
Almayouf, MA1
Albarrak, M1
Aldhahri, SF1
Al-Qahtani, KH1
Xue, CX1
Yao, YF1
Lv, H3
Cheng, L3
Jing, JH1
Wang, Z2
Huang, Q6
Liu, L1
Lu, Y1
Zhang, C3
Ma, T1
Li, Z9
Wang, Q2
Xue, H1
Zhang, K3
Erdogan, U1
Sari, S1
Akbas, A1
Xu, H2
Xie, J6
Yang, J4
Huang, Z5
Wang, D6
Pei, F10
Maethungkul, R1
Atthakomol, P1
Phinyo, P1
Phanphaisarn, A1
Murakami, H1
Sangsin, A1
Peña Borras, JJ1
Pajares Moncho, A1
Puig, J1
Mateo Rodríguez, E1
López Forte, C1
Peña Pérez, L1
Moreno Pachón, J1
Gabaldón Conejos, T1
Pérez Artacho, J1
Ferrer Gómez, C1
Férez Martí, A1
López Cantero, M1
de Andrés Ibáñez, J1
Yee, DK1
Wong, JSH1
Fang, E1
Wong, TM1
Fang, C1
Leung, F1
Morris, JL1
Letson, HL1
McEwen, P1
Biros, E1
Dlaska, C1
Hazratwala, K1
Wilkinson, M1
Dobson, GP1
Liu, J7
Lei, Y5
Liao, J1
Liang, X2
Hu, N2
Huang, W5
Zins, JE1
Dutton, JW1
Wang, H5
Wu, X1
Li, Y4
Zhang, Y8
Fang, X1
Ma, J7
Zhou, Z2
Shen, B7
Haase, DR2
Mersereau, EJ1
Kimbrel, B1
Bombardier, B1
Templeton, KJ2
Rosenthal, HG2
Sweeney, KR2
Zou, ZY1
He, LX3
Yao, YT3
Shalaby, MA1
Maged, AM1
Al-Asmar, A1
El Mahy, M1
Al-Mohamady, M1
Rund, NMA1
Bierke, S1
Häner, M1
Bentzin, M1
Park, HU1
Petersen, W1
Luo, W1
Fu, X1
Huang, JM1
Wu, J3
Ma, XL2
Guler, O1
Çarkcı, E1
Çerci, MH1
Gümüşsuyu, G1
Öztürk, Ç1
Shen, SN1
Wu, DX1
Lv, SJ1
Tong, PJ1
Balik, M1
Kosina, J1
Husek, P1
Pacovsky, J1
Brodak, M1
Cecka, F1
Hoyos, AE1
Duran, H1
Cardenas-Camarena, L1
Bayter, JE1
Cala, L1
Perez, M1
Lopez, A1
Talleri, G1
Domínguez-Millan, R1
Mogollon, IR1
Mousavi, H1
Akbari-Aghdam, H1
Entezari, R1
Chen, C6
Ye, YY1
Chen, YF1
Yang, XX1
Liang, JQ2
Liang, GY1
Zheng, XQ1
Chang, YB1
Kanhere, AP1
Lambrechts, MJ1
Issa, TZ1
Karamian, BA1
Hendow, CJ1
Reddy, YC1
Slota, PJ1
D'Antonio, ND1
Kaye, ID1
Canseco, JA1
Woods, BI1
Hilibrand, AS1
Kepler, CK1
Vaccaro, AR1
Schroeder, GD1
Lech, P1
Michalik, M1
Waczyński, K1
Osowiecka, K1
Dowgiałło-Gornowicz, N1
Qi, MT1
Wang, SY1
Wang, LT1
Chen, XW1
Zhan, WH1
Zhu, XF1
Schertz, K1
Karam, O1
Demetres, M1
Mayadunna, S1
Faraoni, D6
Nellis, ME1
Khadivi, M1
Saghebdoust, S1
Moghadam, N1
Zarei, M1
Moosavi, M1
Ataei, H1
Jafarieh, A1
Borghei, A1
Shafizadeh, M1
Eslamian, M1
Jouibari, MF1
Kordi, R1
Rostami, M1
Keck, M1
Bosselmann, K1
Müller-Wittig, S1
Wittig, KS1
Lohmeyer, JA1
Johansson, K1
Götrick, B1
Holst, J1
Tranæus, S1
Naimi-Akbar, A1
Kim, MK1
Ko, SH1
Nam, YC1
Jeon, YS1
Kwon, DG1
Ryu, DJ1
Turan, K1
Muratoğlu, OG1
Ergün, T1
Çabuk, H1
Ertürer, RE1
Brito, RM1
Oliveira, CMB1
Moura, ECR1
Campelo, GP1
Lima, RC1
Fe, CSM1
Sousa, TM1
Oliveira, EJSG1
Dibai Filho, AV1
Leal, PDC1
Luis, C1
Pardo, A1
Moreno, CE1
Teixell, C1
Santiveri, X1
Bisbe, E1
Zhao, CC1
Chen, LY1
Chen, CJ1
Wang, QR1
Li, QH1
Kang, PD1
Hanke, J1
Mendel, T1
Wingert, M1
Schenk, P1
Heinecke, M1
Wilharm, A1
Akdoğan, M1
Öztürk, A3
Çatma, MF1
Akdoğan, BM1
Gülsoy, A1
Atilla, HA1
Weng, N3
Gou, Y3
Kuang, F3
Lotan, R2
Lengenova, S2
Rijini, N2
Hershkovich, O2
Ye, L1
Guan, J1
Wang, X4
Chen, X6
Lu, H2
Xiao, Y1
Dai, X1
Wu, M1
Ma, S1
Sun, X1
Li, L5
Tan, Y1
Xia, Y1
Bailey, CR1
Zhou, LB1
Wang, CC2
Zhang, LT1
Wu, T1
Zhang, GQ1
Anyaehie, UE1
Eyichukwu, GO1
Muoghalu, ON1
Emina, BK1
Ede, O1
Anetekhai, WI1
G Nwosu, AD1
Iseki, T3
Kanto, R1
Onishi, S1
Yoshiya, S2
Tachibana, T1
Nakayama, H1
Hao, S1
Li, H2
Liu, S3
Meng, S1
Wang, L5
Yang, H2
Zhang, L5
Dong, S1
Mocanu, V1
Wilson, H1
Verhoeff, K1
Kung, J1
Walsh, C1
Koloszvari, N1
Neville, A1
Karmali, S1
Huynh, MNQ1
Wong, CR1
McRae, MC1
Voineskos, S1
McRae, MH1
Li, J4
You, M1
Yao, L1
Fu, W1
Li, Q5
Chen, G2
Tang, X2
Xiong, Y1
Jamshaid, W1
Jamshaid, M1
Coulson, C1
Sharma, N1
Muzaffar, J1
Nieto, H1
Xiao, C1
Gao, Z2
Yu, W1
Yao, K1
Cao, Y1
Long, N1
Zhang, S2
Jiang, Y1
Sipos, K1
Kämäräinen, S1
Kauhanen, S1
Lin, PS1
Tian, LJ1
Jiang, JJ1
Yu, YP1
Ye, S1
Chen, M1
Luo, Y2
Zhao, C2
Kang, P4
Stejskal, P1
Trnka, Š1
Hrabálek, L1
Wanek, T1
Jablonský, J1
Novák, V1
't Hart, JWH1
Noordman, BJ1
Wijnand, JMA2
Biter, LU2
Verbrugge, SJC2
Birnie, E1
Dunkelgrun, M2
Huisbrink, J2
Apers, JA2
Yusufu, A1
Haibier, A1
Ren, Z3
Qin, Q1
Zhang, Z3
Zhou, Y2
Ran, J2
de Abreu de Vasconcellos, SJ1
Souza Dos Santos Marques, R1
Gomes Magalhães de Melo, E1
Silva de Almeida, C1
de Almeida Góes Silva, JV1
de Almeida Souza, LM1
Martins-Filho, PR2
Shin, TJ1
Hasnain, F1
Shay, EO1
Ye, MJ1
Matt, BH1
Elghouche, AN1
Huang, X5
Li, F2
Shi, W1
Liu, W3
Yin, D2
Mahardawi, B1
Jiaranuchart, S1
Arunjaroensuk, S1
Tompkins, KA1
Somboonsavatdee, A1
Pimkhaokham, A1
Dawoud, M1
Al-Husseiny, M1
Helal, O1
Elsherbini, M1
Abdel-Rasheed, M1
Sediek, M1
Izima, C1
Sampath, SG1
Tang, AJ1
Ambati, VS1
Chou, D1
Chan, AK1
Nejat, MH1
Khayami, A1
Daliri, M1
Ebrahimzadeh, MH1
Sadeghi, M2
Moradi, A1
Sermet, M1
Ozsoy, MS1
Ji, X1
Shi, L2
Tian, F1
Huang, Y3
Liang, B2
Zhou, XD1
Jiang, LF1
Zhang, JJ1
Zhou, D1
Wu, LD1
Xu, NW1
Yao, RZ1
Gao, WQ1
Wang, BW1
Wang, GL1
Wu, CX1
A-Mu, YD1
Bai, J2
Zhang, P3
Liang, Y3
Wang, J4
Wang, Y9
Zhao, X2
Releken, Y1
Yang, Z2
Bradley, KE1
Ryan, SP1
Penrose, CT1
Grant, SA1
Wellman, SS3
Attarian, DE2
Green, CL3
Risoli, T1
Bolognesi, MP2
Huang, ZY1
Zeng, HJ1
Zhou, ZK6
Pei, FX7
Morales-Avalos, R2
Ramos-Morales, T2
Espinoza-Galindo, AM2
Garay-Mendoza, D1
Peña-Martínez, VM2
Marfil-Rivera, LJ1
Garza-Ocañas, L1
Acosta-Olivo, C2
Cerda-Barbosa, JK1
Valdés-González, NL1
Vílchez-Cavazos, F2
Meshram, P1
Palanisamy, JV2
Seo, JY1
Lee, JG1
Kim, TK4
Pan, DQ1
Chen, LL1
Sun, B1
Yu, Z1
Ge, JB1
Miao, MF1
Lostak, J1
Gallo, J1
Slavik, L1
Zapletalova, J1
Balaz, L1
Barzilai, M1
Kirgner, I1
Steimatzky, A1
Salzer Gotler, D1
Belnick, Y1
Shacham-Abulafia, A1
Avivi, I1
Raanani, P1
Yahalom, V1
Nakav, S1
Varon, D1
Yussim, E1
Bachar, GN1
Spectre, G1
Wang, HY4
Luo, ZY4
Ockerman, A2
Vanhaverbeke, M2
Miclotte, I2
Belmans, A2
Vanassche, T2
Politis, C2
Jacobs, R2
Verhamme, P2
Richards, JE1
Samet, RE1
Koerner, AK1
Grissom, TE1
Yamada, T1
Natori, Y1
Jain, M1
Kekunnaya, R1
Badakere, A1
Thakur, A1
Gupta, S1
Thakur, JS1
Minhas, RS1
Azad, RK1
Vasanthalakshmi, MS1
Sharma, DR1
Mohindroo, NK1
Jia, Y2
Shi, J6
Yuan, S3
Wang, R1
Zhao, Y1
Hua, Z2
Yan, J1
Li, S6
Zheng, Z3
Hu, S1
Yan, F2
Rong, TH1
Liu, HZ1
Tan, MS1
Zhao, H3
Liu, XY1
Chang, L1
Fishman, J1
Hussain, M1
Fisher, E1
Lei, YT1
Xie, JW1
Wu, KT1
Siu, KK1
Ko, JY1
Chou, WY1
Kuo, SJ1
Hsu, YH1
Yu, X3
Xie, L2
Zheng, W1
Clarius, M1
Clarius, LM1
Rodriguez-Merchan, EC1
Assadi, T1
Leeman, M1
Zhou, C1
Sun, H1
Pan, W1
Sun, L1
An, H1
Feng, Y1
Lu, Q1
Guo, X1
Zhang, M1
Miao, Z1
Luo, D1
Liu, P1
Tandogan, RN1
Polat, M1
Beyzadeoglu, T1
Karabulut, E1
Yildirim, K1
Kayaalp, A1
Cohen, JC1
Glasgold, RA1
Alloju, LM1
Glasgold, MJ1
Morales Santias, M2
Mas Martinez, J2
Sanz-Reig, J2
Martínez Gimenez, E2
Verdu Román, C2
Bustamante Suarez de Puga, D2
Ausen, K2
Hagen, AI1
Østbyhaug, HS1
Olafsson, S1
Kvalsund, BJ1
Spigset, O2
Pleym, H4
Xu, X2
Yu, H2
Hu, Y2
Teoh, WY1
Tan, TG1
Ng, KT1
Ong, KX1
Chan, XL1
Hung Tsan, SE1
Wang, CY1
Ma, H1
Yao, H2
Zhang, T1
Wan, C1
Hurley, ET1
Lim Fat, D1
Pauzenberger, L1
Mullett, H1
Gómez-Aparicio, MDS1
Gómez-Barbero, P1
Blas-Dobón, JA1
Villar-Blanco, A1
Morales-Suárez-Varela, M1
Rodrigo-Pérez, JL1
Qi, X1
Xiao, W1
Xue, Q2
Meissner, F1
Plötze, K2
Matschke, K2
Waldow, T2
Zhang, B3
Zhang, W3
Xu, J3
Ding, J1
Abdallah, AA1
Sallam, AA1
Arafa, MS1
Henawy, AT1
Ma, QM1
Han, GS1
Li, BW1
Li, XJ1
Jiang, T2
Jeong, JH1
Chang, MJ1
Kang, SB1
Park, HJ1
Lee, KH1
Chang, CB2
Deng, Z1
Sheng, P1
Xu, D4
He, A1
Liao, W1
Kang, Y1
Ni, J1
Zhang, J5
Jiang, J1
Dang, X1
Shi, Z1
Grzelecki, D1
Dudek, P1
Okoń, T1
Marczak, D1
Kordasiewicz, B1
Sibiński, M1
Kowalczewski, J1
Ashkenazi, I2
Schermann, H2
Gold, A2
Lin, R1
Pardo, I1
Steinberg, E1
Sternheim, A1
Snir, N2
Klement, MR2
Padua, FG1
Li, WT1
Detweiler, M1
Parvizi, J1
Joy, SM1
Karthikeyan, P1
Ma, D2
Wen, L2
Pan, J2
He, B1
Xu, S1
Ou, Y3
Zhao, J1
Wu, C1
Tan, C1
Levack, AE1
McLawhorn, AS1
Dodwell, E1
DelPizzo, K1
Nguyen, J1
Sink, E1
Park, JY1
Lee, DY1
Ro, DH1
Han, HS1
Lee, MC1
Weissmann, KA1
Lafage, V1
Barrios Pitaque, C1
Lafage, R1
Descazeaux, FM1
Tan, JC1
Yang, L6
Jia, X1
Kang, J1
Turan, S1
Bingöl, O1
Khiabani, K1
Ahmadfar, M1
Labafchi, A1
Gosheh, MR1
Samieirad, S1
Gurel, R1
Chechik, O1
Warschawski, Y1
Schwarzkopf, R2
Wang, LN1
Yang, X1
Liu, LM1
Xiu, P1
Zhou, ZJ1
Song, YM1
Yang, JQ1
Tan, JS1
Huo, KP1
Zhao, L1
Cai, DZ1
Hayward, CPM1
Tasneem, S1
Rivard, GE1
Wu, XF1
Yin, ZF1
Sun, BF1
Dong, F1
Qian, PK1
Zhang, JB1
Xu, F1
Zufferey, PJ1
Lanoiselée, J1
Graouch, B1
Vieille, B1
Delavenne, X1
Ollier, E1
Touzopoulos, P1
Arvanitidis, K1
Filidou, E1
Tilkeridis, K1
Karanikas, M1
Kolios, G1
Ververidis, A1
Owen, A1
Wellings, EP1
Wyles, CC1
Yuan, BJ1
Rose, PS1
Houdek, MT2
Weissler, JM1
Banuelos, J1
Molinar, VE1
Tran, NV1
García-Pedro, JA1
Morcos-Sandino, M1
Silva-Ramos, HNG1
Rodríguez-Torres, RA1
Yen, SH2
Lin, PC3
Wu, CT1
Wang, JW3
Yi, Z2
Yan, L1
Haibo, S1
Yuangang, W1
Mingyang, L1
Yuan, L2
Bin, S2
Ayan, NRS1
Akalın, Y2
Çevik, N1
Sağlıcak, H1
Güler, BO1
Othman, Y1
Melebeck, F1
Daubresse, F1
Burton, H1
Mossadegh, S1
McCarthy, R1
Park, CW1
Lim, SJ1
Yoo, I1
Lee, Y1
Won, JY1
Park, YS1
Kizilkurt, T1
Bayram, S1
Ekinci, M2
Ayik, Ö1
Ergin, ÖN1
Öztürk, İ1
Wang, F2
Wang, C3
Chu, P1
Vanhove, J1
Meyns, J1
Nadjmi, N1
Van Hemelen, G1
Winderickx, P1
Shi, P2
Cai, T1
Chen, D1
Wang, S3
Feng, X1
Cui, H1
Yu, S1
Ruan, J1
Sun, Z1
Chen, S1
Fan, C1
Desborough, MJR1
Obaji, S1
Lowe, GC1
Doree, C1
Thomas, W1
Kopitkó, C1
Czermann, R1
Orosz, M1
Hangody, G1
Kiss, D1
Szabó, Z1
Hangody, L1
Erwin, DZ1
Heichel, PD1
Wright, LM1
Goldstein, NA1
McEvoy, TP1
Earley, MA1
Meyer, AD1
Hui, S1
Peng, Y1
Tao, L1
Yang, Y3
Du, Y2
Zhuang, Q3
Juraj, M1
Jaroslav, V1
Gažová, A1
Žufková, V1
Kyselovič, J1
Šteňo, B1
Hovgesen, NT1
Larsen, JB1
Fenger-Eriksen, C2
Hansen, AK1
Hvas, AM2
Pereira, EG1
Carvalho, MM1
Oliveira, T1
Sacramento, T1
Cruz, H1
Viegas, R1
Fontes, AP1
Marreiros, A1
Sousa, JP1
Chen, Q1
Zhou, Q2
Feng, J1
Zhang, Q1
Ren, Y1
Chen, L3
Wei, P1
Lin, JA1
Cui, HD1
Hong, Y1
Lyu, SJ1
Dong, Y1
Liang, J2
Tong, B1
Costain, D1
Elder, G1
Fraser, B1
Slagel, B1
Kelly, A1
Cheong, Y1
Fera, L1
Bian, J1
Deng, B1
Wang, G4
Lin, YK1
Tsai, SW1
Wu, PK1
Chen, CM1
Yang, JC1
Chen, CF1
Chen, WM1
Watterson, C1
Beacher, N1
Essola, L1
Kouégnigan Rérambiah, L1
Obame, R1
Issembè, H1
Sima Zué, A1
Demos, HA1
Lin, ZX1
Barfield, WR2
Wilson, SH1
Robertson, DC1
Pellegrini, VD1
Lopez-Picado, A2
Albinarrate, A2
Barrachina, B2
Moskal, JT2
Capps, SG1
Biedermann, JS1
Rademacher, WMH1
Hazendonk, HCAM1
van Diermen, DE1
Leebeek, FWG1
Rozema, FR1
Kruip, MJHA1
Yang, C3
Liu, R1
Dawes, TJ1
Price, S1
Milojevic, M1
Kappetein, AP1
Head, SJ1
Myles, PS1
Smith, JA1
Painter, T1
Jimenez-Rivera, JJ1
Iribarren-Sarrías, JL1
Martínez-Sanz, R1
Wang, DS1
Mazer, CD3
Orser, BA1
Prieto, HA1
Vincent, HK1
Deen, JT1
Iams, DA1
Parvataneni, HK1
Sheng, L2
Jiang, P2
Xu, B1
Xie, X1
Hansen, JK1
Lydick, AM1
Wyatt, MM1
Andrews, BT1
Watts, CD1
Sems, SA1
Cross, WW1
Pagnano, MW1
Kearns, SM1
Kuhar, HN1
Bohl, DD1
Levine, BR1
Nagabhushan, RM1
Shetty, AP1
Dumpa, SR1
Subramanian, B1
Kanna, RM1
Shanmuganathan, R1
Xu, R1
Shi, D1
Ge, W2
Jiang, Q1
Kim, KT1
Kim, CK1
Kim, YC1
Juh, HS1
Kim, HJ2
Kim, HS1
Hong, SJ1
Hey, HWD1
Lacko, M1
Cellar, R1
Schreierova, D1
Vasko, G1
Peres-Da-Silva, A1
Nickel, BT1
Seyler, TM1
Jeon, Y1
Lee, WI1
Kang, SY1
Kim, MH1
Li, GL1
Li, YM1
Lei, J1
Cong, Y1
Zhuang, Y1
Wei, X1
Fu, Y1
Wei, W1
Wang, P2
Wen, S1
Huang, H1
Han, S1
Dai, WL1
Zhou, AG1
Zhang, H2
Yozawa, S1
Ogawa, H1
Matsumoto, K1
Akiyama, H1
Cornell, C1
Hobbs, JC1
Welsby, IJ1
Dhakal, IB1
Boese, CK1
Centeno, L1
Walters, RW1
Dai, Z1
Chu, H1
Liu, JL2
Zeng, WN6
Wang, FY2
Gong, XY1
Tan, ZJ1
Jia, XL1
Ni, JR1
Wang, LX1
Chen, XJ1
Ji, JJ1
Yang, ZQ1
Zhao, YL1
Tan, L1
Wei, J1
Li, R2
Qiu, D1
Wei, M2
Mu, X1
Zeng, Y4
Si, H1
Li, C1
Wu, Y3
Tian, S1
Shen, Z1
Liu, Y2
Peng, A1
Sierra, RJ3
Smith, HM2
Junejo, F1
Akhtar, MI1
Hamid, M1
Ahmed, SS1
Minai, F1
Amanullah, M1
Arora, M1
Singh, S1
Gupta, V1
Dongre, A1
Shetty, V1
Zirk, M1
Zinser, M1
Buller, J1
Bilinsky, V1
Dreiseidler, T1
Zöller, JE1
Kreppel, M1
Tsukada, S1
Wakui, M1
Cansancao, AL1
Condé-Green, A1
David, JA1
Cansancao, B1
Vidigal, RA1
Li, YS1
Chen, CY1
Chen, CH2
Yao, ZK1
Sung, YH1
Lin, KC1
Tarng, YW1
Hsu, CJ1
Renn, JH1
Sigrist, N1
Olgiati, L1
Jud Schefer, RS1
White, CC1
Eichinger, JK1
Friedman, RJ2
Zargar, M1
Nikbakht, R1
Ahmadi, M1
Yin, S1
Zhong, H1
Mu, P1
El Beheiry, H2
Lubberdink, A1
Clements, N1
Dihllon, K1
Sharma, V1
Chaudhary, FA1
Pervaz, Z1
Ilyas, S1
Niaz, MN1
Polanco-García, M1
Capielo, AM1
Miret, X1
Chamero, A1
Sainz, J1
Revilla, E1
Guinjoan, A1
Arranz, T1
Mariani, P1
Buttaro, MA1
Slullitel, PA1
Comba, FM1
Zanotti, G1
Ali, P1
Piccaluga, F1
Tarabrin, OA1
Tyutrin, II1
Gavrichenkov, DG1
Shcherbakov, SS1
Mazurenko, AI1
Turenko, AV1
Das, S1
Moon, KH2
Kim, DH2
Passarelli, PC1
De Angelis, P1
Pasquantonio, G1
Manicone, PF1
Verdugo, F1
D'Addona, A1
Akman, B1
Şaylı, U1
Güven, M1
Altıntaş, F1
Meng, WK3
Hill, J1
Magill, P1
Dorman, A1
Hogg, R1
Eggleton, A1
Benson, G1
McFarland, M1
Murphy, L1
Gardner, E1
Bryce, L1
Martin, U1
Adams, C1
Bell, J1
Campbell, C1
Agus, A1
Phair, G1
Molloy, D1
Mockford, B1
O'Hagan, S1
Beverland, D1
Maak, TG1
Lu, SY1
Lin, LH1
Hsue, SS1
Zhao, KC1
Zhao, MM1
Zhao, DX1
Cao, C1
Li, LL1
Li, DH1
Karampinas, PK1
Megaloikonomos, PD1
Lampropoulou-Adamidou, K1
Papadelis, EG1
Mavrogenis, AF1
Vlamis, JA1
Pneumaticos, SG1
He, J1
Chen, P1
Kim, KI2
Kim, GB1
Bae, SH1
Cao, G1
Yamaguchi, A1
Goto, K1
Kawai, T1
Kuroda, Y1
Sano, K1
Matsuda, S1
Arslan, A1
Görmeli, G1
Schwarz, W1
Ruttan, T1
Bundick, K1
Filipek, DR1
Hu, Q1
Li, M2
Bao, X1
Zhong, J1
Ahmed, S1
Ahmed, A1
Ahmad, S1
Javed, S1
Aziz, A1
Gong, M1
Liu, G1
Chen, R1
Xiang, Z1
Gao, X1
Guo, J1
Ji, H2
Koizumi, M1
Ishimaru, M1
Matsui, H1
Fushimi, K1
Yamasoba, T1
Yasunaga, H1
Wu, YG1
Hu, QS1
Bao, XC1
Xiong, HZ1
Bai, L1
Fang, Z1
Yu, ZP1
Liu, LX1
Yu, QP1
Sagiv, O1
Rosenfeld, E1
Kalderon, E1
Barazani, TB2
Zloto, O1
Martinowitz, U4
Ben Simon, GJ1
Zilinsky, I2
Jordan, M3
Aguilera, X3
González, JC3
Castillón, P1
Salomó, M1
Hernández, JA1
Ruiz, L1
Mora, JM1
Camacho-Carrasco, P1
Prat-Fabregat, S1
Bosch, A2
Rodriguez-Arias, A2
Martínez-Zapata, MJ3
Xue, P1
Liu, T1
Qiao, F1
Wei, BG1
Zhang, XS1
Torsha, TT1
Xiao, J1
Shi, ZJ1
Luo, GG1
Lin, ZQ1
Xie, HF1
Yao, JC1
Zhang, HZ1
Felli, L1
Revello, S2
Burastero, G1
Gatto, P1
Carletti, A1
Formica, M1
Alessio-Mazzola, M1
Wolfson, TS1
Novikov, D1
Chen, KK1
Kim, KY1
Anoushiravani, AA1
Deshmukh, AJ1
Lajam, CM1
Visentin, D1
Ahuja, K1
Haik, J1
Sahu, J1
Mishra, N1
Concina, C1
Crucil, M1
Fabbro, S1
Gherlinzoni, F1
Steinhaus, ME1
Buksbaum, J1
Eisenman, A1
Kohli, M1
Fragomen, AT1
Rozbruch, SR1
Laoruengthana, A1
Rattanaprichavej, P1
Rasamimongkol, S1
Galassi, M1
Weerakul, S1
Pongpirul, K1
Yuan, Y1
Zhang, HJ1
Luo, H1
Chen, Y3
Gombár, C1
Gálity, H1
Bácsi, M1
Sisák, K1
Durgut, F2
Erkocak, OF2
Aydin, BK2
Ozdemir, A1
Gulec, A1
Tugrul, AI1
Goobie, SM2
Kashyap, S1
Mahajan, S1
Lal, M1
Habbab, LM2
Hussain, S1
Power, P1
Bashir, S1
Gao, P1
Semelhago, L2
VanHelder, T1
Parry, D1
Chu, V1
Lamy, A2
Chen, F1
Jiang, Z1
Zhu, X1
D'Amore Lindholm, A1
Nørholt, SE1
von Oettingen, G1
Tarpgaard, M1
Krogh, L1
Juul, N1
Rasmussen, M1
Anthony, SG1
Patterson, DC1
Cagle, PJ1
Poeran, J1
Zubizarreta, N1
Mazumdar, M1
Galatz, LM1
Kwak, DK1
Jang, CY1
Rhyu, SH1
Hwang, JH1
Yoo, JH1
Perez-Roman, RJ1
Lugo-Pico, JG1
Burks, JD1
Madhavan, K1
Sheinberg, D1
Green, BA1
Gjolaj, JP1
Zaman, SU1
Zakir, I1
Faraz, Q1
Akhtar, S1
Nawaz, A1
Adeel, M1
Kaplan, A1
Wisniewski, M1
Waters, JH2
Yazer, MH1
Fillingham, YA3
Darrith, B1
Calkins, TE1
Abdel, MP1
Malkani, AL3
Padgett, DE1
Culvern, C1
Sershon, RA1
Bini, S1
Della Valle, CJ3
Feng, S1
Lv, Z1
Qu, Z1
Chen, H1
Xue, C1
Zhu, M1
Guo, K2
Wu, P1
Riaz, O1
Aqil, A1
Asmar, S1
Vanker, R1
Hahnel, J1
Brew, C1
Grogan, R1
Radcliffe, G1
Tille, E1
Mysliwietz, J1
Beyer, F1
Postler, A1
Lützner, J1
Tammachote, N1
Raphiphan, R1
Kanitnate, S1
Kamatsuki, Y1
Miyazawa, S1
Furumatsu, T1
Kodama, Y1
Hino, T1
Okazaki, Y2
Masuda, S1
Ozaki, T1
Craik, JD1
Ei Shafie, SA1
Kidd, AG1
Twyman, RS1
Kelley, TC1
Tucker, KK1
Adams, MJ1
Dalury, DF2
Fu, DJ1
Guo, L1
Abdel-Aleem, H1
Alhusaini, TK1
Abdel-Aleem, MA1
Menoufy, M1
Gülmezoglu, AM1
Ma, YQ1
Zhang, YC1
Godier, A2
Samama, CM3
Susen, S1
Kang, YG1
Seo, ES1
Lee, JH1
Yun, JH1
Lee, SH2
Oremus, K1
Sostaric, S1
Trkulja, V1
Haspl, M1
Wang, JJ1
Chen, GJ1
Huang, YG1
Luo, AL1
Miao, Q1
Ortmann, E1
Besser, MW1
Klein, AA1
Albirmawy, OA1
Saafan, ME1
Shehata, EM1
Basuni, AS1
Eldaba, AA1
Fan, R1
Bi, Y1
Piao, M1
Guo, M1
Ren, W1
Xiang, L1
Wind, TC1
Panteli, M1
Papakostidis, C1
Dahabreh, Z1
Giannoudis, PV1
Shahid, A1
Khan, A1
Guerrero-Domínguez, R1
Padilla-Morales, V1
Montero-López, N1
Marenco de la Fuente, ML1
Konig, G1
Hamlin, BR2
Tarabarin, OA1
Tkachenko, AI1
Salekh, EN1
Kushnir, OS1
Zarutskiĭ, IaL1
Tuchkov, AV1
Lee, YC1
Park, SJ1
Kim, JS2
Cho, CH1
Karam, JA1
Bloomfield, MR1
DiIorio, TM1
Irizarry, AM1
Sharkey, PF1
Antinolfi, P1
Innocenti, B1
Caraffa, A1
Peretti, G1
Cerulli, G1
Wang, YF1
Xue, QH1
Wang, GY1
Li, LH1
Gilbody, J1
Dhotar, HS1
Perruccio, AV1
Davey, JR1
Blanié, A2
Rosencher, N4
Fisher, C1
Mo, A1
Warrillow, S1
Smith, C1
Jones, D1
Dahuja, A1
Dahuja, G1
Jaswal, V1
Sandhu, K1
Flanagan, D1
Martin, JG1
Cassatt, KB1
Kincaid-Cinnamon, KA1
Westendorf, DS1
Garton, AS1
Lemke, JH1
Urrútia, G1
Gich, I1
Maymó, RM1
Martínez, N1
Monllau, JC2
Celaya, F2
Fernández, JA2
Delanois, RE2
Mont, MA4
Ripollés-de Ramón, J1
Muñoz-Corcuera, M1
Bravo-Llatas, C1
Bascones-Martínez, A1
Sa-Ngasoongsong, P2
Wongsak, S2
Chanplakorn, P2
Woratanarat, P1
Wechmongkolgorn, S1
Wibulpolprasert, B1
Mulpruek, P1
Kawinwonggowit, V2
Jauregui, JJ1
Issa, K1
Kapadia, BH1
Banerjee, S1
Harwin, SF1
Zhao-Yu, C1
Yan, G1
Wei, C1
Yuejv, L1
Ying-Ze, Z2
Chang, CH1
Chang, Y1
Chen, DW1
Ueng, SW1
Lee, MS1
Raveendran, R1
Wong, J2
Shi, S1
Ji, B1
Broekema, FI1
van Minnen, B1
Jansma, J1
Bos, RR1
Chen, JY2
Rikhraj, IS1
Tay, DK1
Chin, PL2
Chia, SL2
Lo, NN2
Yeo, SJ2
Esfandiari, BR1
Bistgani, MM1
Kabiri, M1
Panni, AS1
Cerciello, S1
Vasso, M1
Del Regno, C1
Patel, JN1
Spanyer, JM1
Smith, LS2
Huang, J1
Yakkanti, MR1
Yue, C3
Yang, P1
Soni, A1
Saini, R1
Gulati, A1
Paul, R1
Bhatty, S1
Rajoli, SR1
Lv, YM1
Ding, PJ1
Hinder, D1
Tschopp, K1
Bagsby, DT1
Hur, J1
Robb, PJ1
Xu, Q1
Zhou, J1
Dai, W1
Yao, Z1
Olmos Rodríguez, M1
Ballester Hernández, JA1
Arteta Bárcenas, MT1
Rodríguez Cerezo, A1
Vidarte Ortiz de Artiñano, MA1
Veiga Alameda, C1
Fischer, Q1
Huisse, MG1
Voiriot, G1
Caron, C1
Lepage, L1
Dilly, MP1
Nataf, P1
Ajzenberg, N1
Kirsch, M1
Alshryda, S3
Sukeik, M3
Sarda, P2
Blenkinsopp, J2
Haddad, FS2
Mason, JM3
Jang, B1
Kao, M1
Bohm, MT1
Harris, IA2
Chen, DB2
MacDessi, SJ3
Sabatini, L1
Atzori, F1
Scotti, L1
Debiasi, F1
Massè, A1
Izvin, AI1
Kuznetsova, NE1
Siniakov, AIu1
Slover, J1
Bosco, J1
Oiartzabal, I1
López-Ariznabarreta, C1
Molano, J1
Wu, Q1
Zhang, HA1
Liu, SL1
Meng, T1
Zhou, X1
DiGioia, AM1
Plakseychuk, AY1
Levison, TJ1
Soares, EC2
Costa, FW1
Bezerra, TP1
Nogueira, CB1
de Barros Silva, PG1
Batista, SH1
Sousa, FB2
Sá Roriz Fonteles, C1
Durga, P2
Raavula, P1
Gurajala, I1
Gunnam, P1
Veerabathula, P1
Reddy, M1
Upputuri, O1
Ramachandran, G2
Lin, SY1
Fu, YC1
Huang, PJ1
Chang, JK1
Huang, HT1
Carvalho, LH1
Frois Temponi, E1
Machado Soares, LF1
Gonçalves, MB1
Paiva Costa, L1
Tavares de Souza, ML1
Pinzón-Florez, CE1
Vélez Cañas, KM1
Díaz Quijano, DM1
Upadhyay, S1
Raza, HK1
Xu, GJ1
Han, Z1
Ma, JX1
Jiang, X1
Xie, S1
Wang, K1
Nawabi, DH1
Ali Shah, MU1
Asghar, MI1
Siddiqi, R1
Chaudhri, MS1
Janjua, AM1
Iqbal, A1
Rozen, L1
Willems, A1
Torres, CS1
Pereira, LM2
Demulder, A1
Van der Linden, P1
Warner, CG1
Gao, F3
Sun, W3
Guo, W3
Ishii, Y1
Noguchi, H1
Sato, J1
Tsuchiya, C1
Toyabe, S1
Madershahian, N1
Scherner, M1
Pfister, R1
Rudolph, T1
Deppe, AC1
Slottosch, I1
Kuhn, E1
Choi, YH1
Wahlers, T1
Hinarejos, P1
Leal, J1
Pelfort, X1
Puig-Verdie, Ll1
Wingerter, SA1
Keith, AD1
Schoenecker, PL1
Baca, GR1
Clohisy, JC1
Hodgson, S1
Larvin, JT1
Dearman, C1
Wang, CG1
Sun, ZH1
Cao, JG1
Li, ZJ1
Averbukh, VM1
Dzhafarova, MZ1
Bebchuk, GB1
Avdeeva, KS1
Fossmark, R1
Maruyama, M1
Holt, JB1
Miller, BJ1
Callaghan, JJ1
Clark, CR1
Willenborg, MD1
Noiseux, NO1
Sizer, SC1
Cherian, JJ1
Elmallah, RD1
Pierce, TP1
Beaver, WB1
Li, W1
Bai, G1
Henry, J1
McFarland, A1
Wu, H1
Fu, P1
Ding, Z1
Melvin, JS1
Stryker, LS1
Jain, NP1
Nisthane, PP1
Shah, NA1
Uthadorn, K1
Panpikoon, T1
Jittorntam, P1
Aryurachai, K1
Angchaisukisiri, P1
Choudhuri, P1
Biswas, BK1
Gordon, E1
Butler, RB1
Mock, L1
Dumas, B1
Eftekharian, HR1
Rajabzadeh, Z1
Chakravartty, S1
Sarma, DR1
Chang, A1
Patel, AG1
Simonazzi, G1
Bisulli, M1
Saccone, G1
Moro, E1
Marshall, A1
Berghella, V1
North, WT2
Mehran, N2
Davis, JJ2
Silverton, CD2
Weir, RM2
Laker, MW2
van Galen, KP1
Engelen, ET1
Mauser-Bunschoten, EP1
van Es, RJ1
Schutgens, RE1
Ueno, M1
Sonohata, M1
Fukumori, N1
Kawano, S1
Kitajima, M1
Mawatari, M1
Pongcharoen, B1
Ruetiwarangkoon, C1
Prakash, J4
Chand, S1
Pertlíček, J1
Stehlík, J1
Sadovský, P1
Musil, D1
Mezera, V1
Öztaş, S1
Şahin, N1
Özkan, Y1
Otuzbir, A1
Avcu, B1
Goyal, N1
Kaul, R1
Topsoee, MF1
Bergholt, T1
Ravn, P1
Schouenborg, L1
Moeller, C1
Ottesen, B1
Settnes, A1
Liu, KL1
Chen, IH1
Wen, SH1
Serrano Mateo, L1
Goudarz Mehdikhani, K1
Cáceres, L1
Lee, YY1
Gonzalez Della Valle, A1
Whiting, DR1
Duncan, CM1
Erb, TO1
Meier, PM2
Appelmann, I1
Kreher, S1
Parmentier, S1
Wolf, HH1
Bisping, G1
Kirschner, M1
Bergmann, F1
Schilling, K1
Brümmendorf, TH1
Petrides, PE1
Tiede, A1
Matzdorff, A1
Griesshammer, M1
Riess, H1
Koschmieder, S1
Aggarwal, AK1
Singh, N1
Sudesh, P1
Ma, TK1
Chow, KM1
Kwan, BC1
Leung, CB1
Szeto, CC1
Li, PK1
Ranta, S1
Blombäck, M1
Magnusson, M1
He, S1
Drakos, A1
Raoulis, V1
Karatzios, K1
Doxariotis, N1
Kontogeorgakos, V1
Malizos, K1
Varitimidis, SE1
Reina, N1
Fennema, P1
Hourlier, H1
Stowers, MD1
Munro, JT1
Hill, AG1
Kang, JS1
Kim, BS1
Yang, SJ1
Stevens, LM1
Noiseux, N1
Prieto, I1
Hardy, JF1
Kayupov, E2
Plummer, DR2
Moric, M2
Gerlinger, TL2
Uğurlu, M1
Aksekili, MA1
Çağlar, C1
Yüksel, K1
Şahin, E1
Akyol, M1
Ma, X1
Zhu, Y2
Cao, X1
Zhu, Q1
Zhu, J1
Nielsen, CS1
Jans, Ø1
Ørsnes, T1
Foss, NB1
Troelsen, A2
Husted, H3
May, JH1
Rieser, GR1
Williams, CG1
Markert, RJ1
Bauman, RD1
Lawless, MW1
Tzatzairis, TK1
Drosos, GI1
Kotsios, SE1
Ververidis, AN1
Vogiatzaki, TD1
Kazakos, KI1
Jing, Y1
Zongke, Z1
Pengde, K1
Fuxing, P1
Babis, GC1
Liu, H1
Xiong, W1
Chua, S1
Shin, YS1
Yoon, JR1
Lee, HN1
Park, SH1
Lee, DH1
Akgül, T1
Büget, M1
Salduz, A1
Edipoğlu, İS1
Küçükay, S1
Şen, C1
Sun, Q2
Nie, X1
Gong, J1
Cai, M2
Pinsornsak, P1
Rojanavijitkul, S1
Chumchuen, S1
Guzel, Y1
Gurcan, OT1
Golge, UH1
Dulgeroglu, TC1
Metineren, H1
Kim, YH1
Park, JW1
Song, EK2
Seon, JK2
Seol, YJ1
Park, YJ2
Jin, C2
Silvetti, S1
Crivellari, M1
Castiglioni, A1
Landoni, G1
Zangrillo, A1
Alfieri, O4
Koster, A2
Bolliger, D1
Tanaka, KA1
Chen, B1
Huang, CC2
Kuo, FC1
Weng, K1
Bi, Q1
Liu, F1
Queiroz, SI1
Alves, HS1
de Assis, GM1
Conceicao, TS1
Germano, AR1
da Silva, JS1
Spanyer, J1
Patel, J2
Emberton, E1
Chen, Z1
Cui, S1
Yuan, Z1
Mao, Z1
Yue, B1
Yan, M1
Dai, K1
Lim, GB1
de Vasconcellos, SJ1
de Santana Santos, T1
Reinheimer, DM1
Faria-E-Silva, AL1
de Melo, MF1
Blaine, KP1
Press, C1
Lau, K1
Sliwa, J1
Rao, VK1
Hill, C1
Kushioka, J1
Yamashita, T1
Okuda, S1
Maeno, T1
Matsumoto, T1
Yamasaki, R1
Iwasaki, M1
Maniar, RN2
Singhi, T2
Patil, A1
Kumar, G3
Maniar, P1
Singh, J1
Yuan, QM1
Zhao, ZH1
Xu, BS1
Taksaudom, N1
Siwachat, S1
Tantraworasin, A1
Amour, J1
Garnier, M1
Szymezak, J1
Le Manach, Y1
Helley, D1
Bertil, S1
Ouattara, A1
Riou, B1
Gaussem, P1
Gwam, C1
Mistry, JB1
Chughtai, M1
Thomas, M1
Mudaliar, PP1
Khlopas, A1
Tangri, V1
Baruah, RK1
Borah, PJ1
Haque, R1
Nakura, N1
Hirakawa, K1
Takayanagi, S1
Saito, A1
Tsuji, K1
Tamaki, Y1
Ochiai, S1
Mihara, M1
Prajapati, M1
Patel, H1
Gandhi, H1
Deodhar, S1
Pandya, H1
Shi, H1
Jiang, D2
Quan, Z1
Zhao, Z1
Mahmood, A1
Sawalha, S1
Borbora, A1
Peter, V1
Hu, KZ1
Sun, HY1
Sui, C1
Yu, CC1
Gao, WJ1
Yang, JS1
Gu, H1
Md, MZ1
Sun, K1
Hao, DJ1
Vara, AD1
Koueiter, DM1
Pinkas, DE1
Gowda, A1
Wiater, BP1
Wiater, JM1
Cankaya, D1
Dasar, U1
Satilmis, AB1
Basaran, SH1
Akkaya, M1
Bozkurt, M1
Badenoch, A1
Sharma, A1
Gower, S1
Selzner, M1
Srinivas, C1
Wąsowicz, M1
McCluskey, SA1
Moo, IH1
Pang, HN1
Tay, DKJ1
Okroj, K1
Mehtani, A1
Lee, SY1
Chong, S1
Balasubramanian, D1
Na, YG1
Acar, MA1
Casati, V6
Romano, A1
D'Angelo, A5
Mengistu, AM1
Röhm, KD1
Boldt, J1
Mayer, J1
Suttner, SW1
Piper, SN1
Taneja, R1
Fernandes, P1
Marwaha, G1
Cheng, D2
Bainbridge, D1
Bellamy, L3
Chabbouh, T1
Arnaout, L1
Ozier, Y1
Elwatidy, S1
Jamjoom, Z1
Elgamal, E1
Zakaria, A1
Turkistani, A1
El-Dawlatly, A1
Breuer, T2
Martin, K3
Wilhelm, M1
Wiesner, G3
Schreiber, C3
Hess, J2
Lange, R2
Tassani, P2
Henry, D1
Carless, P1
Fergusson, D1
Laupacis, A1
Jonnavithula, N1
Pochiraju, R1
Anne, KK1
Taghaddomi, RJ1
Mirzaee, A1
Attar, AS1
Shirdel, A1
Wiseman, DM1
Meidler, R1
Lyahovetsky, Y1
Kurman, E1
Horn, S1
Nur, I1
Katznelson, R1
Djaiani, GN1
Karski, J2
Sekhavat, L1
Tabatabaii, A1
Dalili, M1
Farajkhoda, T1
Tafti, AD1
Ranucci, M1
Castelvecchio, S1
Romitti, F1
Isgrò, G1
Ballotta, A1
Conti, D1
Later, AF1
Maas, JJ1
Engbers, FH1
Versteegh, MI1
Bruggemans, EF1
Dion, RA1
Klautz, RJ1
Fuentes García, D1
Ramírez Muñoz, G1
Gram, J1
Sirgo, G1
Morales, P1
Rello, J1
Fawzy, H1
Elmistekawy, E1
Bonneau, D1
Latter, D1
Errett, L1
Krutzsch, D1
Wils, M1
Madrid, C1
Sanz, M1
Colomina, MJ1
Bagó, J1
Fuentes, I1
Jakobsen, CJ1
Søndergaard, F1
Hjortdal, VE1
Johnsen, SP1
Kazemi, SM1
Mosaffa, F1
Eajazi, A1
Kaffashi, M1
Daftari Besheli, L1
Bigdeli, MR1
Zanganeh, RF1
McMullan, V1
Alston, RP2
Fritsch, N1
Pouquet, O1
Roux, B1
Abdelmoumen, Y1
Janvier, G1
Ngaage, DL1
Bland, JM1
MacGillivray, RG1
Tarabichi, SB1
Hawari, MF1
Raoof, NT1
Eubanks, JD1
Senay, S1
Toraman, F1
Karabulut, H1
Alhan, C1
Royston, D1
Sasanuma, H1
Sekiya, H1
Takatoku, K1
Takada, H1
Sugimoto, N1
Hoshino, Y1
Raghunathan, K1
Connelly, NR1
Kanter, GJ1
Schirmer, U1
Gungorduk, K1
Yıldırım, G1
Asıcıoğlu, O1
Gungorduk, OC1
Sudolmus, S1
Ark, C1
Abrishami, A1
Mahomed, NN1
Roderick Davey, J1
Gandhi, R1
Syed, KA1
Muhammad Ovais Hasan, S1
De Silva, Y1
Chung, F1
Vonk, AB1
Meesters, MI1
Schats, J1
Romijn, JW1
Jansen, EK1
Boer, C1
Gertler, R2
Hapfelmeier, A1
Adler Ma, SC1
Brindle, W1
Burton, G1
Gallacher, S1
Hong, FC1
Manelius, I1
Smith, A1
Ho, W1
Bhattacharya, K1
Chevet, I1
Remérand, F1
Couvret, C1
Baud, A1
Pouplard, C1
Rosset, P1
Laffon, M1
Fusciardi, J1
Keyl, C1
Uhl, R1
Beyersdorf, F1
Stampf, S1
Lehane, C1
Wiesenack, C1
Trenk, D1
Wahba, A3
Vonk, A1
Bidstrup, B1
Bonnet, MP1
Tesnière, A1
Mignon, A1
Sterner, A1
MacGuill, M1
Hörer, J1
Vogt, M1
Charoencholvanich, K1
Siriwattanasakul, P1
Sepah, YJ1
Umer, M1
Ahmad, T1
Nasim, F1
Chaudhry, MU1
Umar, M1
Spegar, J1
Vanek, T2
Snircova, J1
Fajt, R2
Straka, Z2
Pazderkova, P1
Maly, M2
Bokesch, PM1
Szabo, G1
Wojdyga, R1
Grocott, HP1
Smith, PK1
Vetticaden, S1
Wheeler, A1
Levy, JH2
Xie, G1
Liu, M1
Greiff, G1
Stenseth, R2
Videm, V1
Lydersen, S1
Irgens, W1
Bjella, L2
Shimizu, K1
Toda, Y1
Iwasaki, T1
Takeuchi, M1
Morimatsu, H1
Egi, M1
Suemori, T1
Suzuki, S1
Morita, K1
Sano, S1
Graham, EM1
Atz, AM1
Gillis, J1
Desantis, SM1
Haney, AL1
Deardorff, RL1
Uber, WE1
Reeves, ST1
McGowan, FX1
Bradley, SM1
Spinale, FG1
Nargol, A1
Van Aelbrouck, C1
Cacheux, C1
Ipema, HJ1
Tanzi, MG1
Pasquali, SK1
Li, JS1
He, X1
Jacobs, ML1
O'Brien, SM1
Hall, M1
Jaquiss, RD1
Welke, KF1
Peterson, ED1
Shah, SS1
Jacobs, JP1
Perdigão, JP1
de Almeida, PC1
Rocha, TD1
Mota, MR1
Alves, AP1
Roy, SP1
Tanki, UF1
Dutta, A1
Jain, SK1
Nagi, ON1
Nayak, RM1
Maniar, PR1
Keijzer, R1
Wilschut, DE1
Houmes, RJ1
van de Ven, KP1
van den Hout, L1
Sluijter, I1
Rycus, P1
Bax, KM1
Tibboel, D1
Mansouri, M1
Attary, M1
Bagheri, K1
Massoumi, G1
Ghavami, B1
Clavé, A1
Fazilleau, F1
Dumser, D1
Lacroix, J1
Loomba, A1
Loomba, K1
Bains, R1
Bains, VK1
Domschke, C1
Strowitzki, T1
Huth-Kuehne, A1
Staritz, P1
Sohn, C1
Schuetz, F1
Hsu, CH1
Chen, WS1
Abrams, J1
Peña, JJ1
Mateo, E1
Martín, E1
Llagunes, J1
Carmona, P1
Blasco, L1
Giordano, R1
Palma, G1
Poli, V1
Palumbo, S1
Russolillo, V1
Cioffi, S1
Mucerino, M1
Mannacio, VA1
Vosa, C1
Martin, J1
Dell'Amore, A1
Caroli, G1
Nizar, A1
Cassanelli, N1
Luciano, G1
Greco, D1
Dolci, G1
Bini, A1
Stella, F1
Chan, CC1
Chan, YY1
Tanweer, F1
Mutsuzaki, H1
Ikeda, K1
de Jonge, T1
Cho, KY1
Khurana, S1
Gao, W1
Ju, Y1
Beckerman, Z1
Shopen, Y1
Alon, H1
Cohen, O1
Nir, RR1
Adler, Z1
Bolotin, G1
Sammartino, G1
Marenzi, G1
Miro, A1
Ungaro, F1
Nappi, A1
Sammartino, JC1
Quaglia, F1
Mortellaro, C1
Rhayem, Y1
Flaujac, C1
Fontenay, M1
Irisson, E1
Kerbaul, F1
Parratte, S1
Hémon, Y1
Argenson, JN1
Skovgaard, C1
Holm, B1
Lunn, TH1
Gaarn-Larsen, L1
Kehlet, H1
Sethna, NF1
Soriano, SG1
Zurakowski, D1
Samant, S1
Jiménez-Yuste, V1
Prim, MP1
De Diego, JI1
Villar, A1
Quintana, M2
Rabanal, I1
Sastre, N1
Hernández-Navarro, F1
Karevold, A1
Dale, O1
Good, L1
Peterson, E1
Lisander, B1
Piot, B1
Sigaud-Fiks, M1
Huet, P1
Fressinaud, E1
Trossaërt, M1
Mercier, J1
Keiani Motlagh, K1
Loeb, I1
Legrand, W1
Daelemans, P1
Van Reck, J1
Dodson, TB1
Durán de la Fuente, P1
García-Fernández, J1
Pérez-López, C1
Carceller, F1
Gilsanz Rodríguez, F1
Carter, G2
Goss, A2
Lloyd, J1
Tocchetti, R1
Gai, MY1
Wu, LF1
Su, QF1
Tatsumoto, K1
Armellin, G1
Vinciguerra, A1
Bonato, R1
Pittarello, D1
Giron, GP1
Chauhan, S1
Das, SN1
Bisoi, A1
Kale, S1
Kiran, U1
Benussi, S4
Sandrelli, L1
Grasso, MA2
Spagnolo, S2
Krohn, CD1
Sørensen, R1
Lange, JE1
Riise, R1
Bjørnsen, S1
Brosstad, F1
Della Valle, P1
Franco, A3
Gerli, C3
Baili, P1
Andreasen, JJ1
Nielsen, C1
Roberts, HR1
Escobar, M1
Monroe, DM1
Arora, RC1
Légaré, JF1
Buth, KJ1
Sullivan, JA1
Hirsch, GM1
Frachon, X1
Pommereuil, M1
Berthier, AM1
Lejeune, S1
Hourdin-Eude, S1
Quéro, J1
Mézière, X1
De Mello, G1
Garnier, J1
Lee, AP1
Boyle, CA1
Savidge, GF1
Fiske, J1
De Bels, D1
Demeere, JL1
Dugauquier, J1
Louis, P1
Van der Vorst, E1
Yasim, A1
Aşik, R1
Atahan, E1
Yamasaki, S1
Masuhara, K1
Fuji, T1
Huvers, F1
Slappendel, R1
Benraad, B1
van Hellemondt, G1
van Kraaij, M1
Morimoto, Y1
Yoshioka, A1
Sugimoto, M1
Imai, Y1
Kirita, T1
Jares, M1
Jirasek, K1
Kolesar, M1
Brucek, P1
Szekely, E1
Baralle, MM1
Raoul, G1
Marey, A1
Ferri, J1
Santos, AT1
Kalil, RA1
Bauemann, C1
Pereira, JB1
Nesralla, IA1
Arango, M1
Mangano, DT1
Tudor, IC1
Dietzel, C1
Abul-Azm, A1
Abdullah, KM1
Sacco, R2
Sacco, M1
Carpenedo, M2
Moia, M1
Niskanen, RO1
Korkala, OL1
Orpen, NM1
Little, C1
Walker, G1
Crawfurd, EJ1
Ickx, BE1
van der Linden, PJ1
Melot, C1
Wijns, W1
de Pauw, L1
Vandestadt, J1
Hut, F1
Pradier, O1
Jian, K1
Guo, Z1
Tarkka, M1
Barbato, L1
Rossi, E1
Panzeri, E1
Alberca, I1
Asuero, MS1
Bóveda, JL1
Carpio, N1
Contreras, E1
Fernández-Mondéjar, E1
Forteza, A1
García-Erce, JA1
García de Lorenzo, A1
Gomar, C1
Gómez, A1
Llau, JV1
López-Fernández, MF1
Moral, V1
Muñoz, M1
Páramo, JA1
Torrabadella, P1
Sánchez, C1
Weiskopf, RB1
Zufferey, P1
Merquiol, F1
Laporte, S1
Decousus, H1
Mismetti, P1
Auboyer, C1
Molliex, S1
Kuitunen, AH1
Suojaranta-Ylinen, RT1
Kukkonen, SI1
Niemi, TT1
Baric, D1
Biocina, B1
Unic, D1
Sutlic, Z1
Rudez, I1
Vrca, VB1
Brkic, K1
Ivkovic, M1
Bechstein, WO1
Strey, C1
Mehr-Aein, A2
Davoodi, S1
Madani-Civi, M2
Varela Crespo, CA1
Sanabria Carretero, P1
Palomero Rodríguez, MA1
Tormo las de Heras, C1
Rodríguez Pérez, E1
Goldman Tarlousky, L1
Boeken, U1
Litmathe, J1
Kurt, M1
Feindt, P1
Gams, E1
Caglar, GS1
Tasci, Y1
Kayikcioglu, F1
Haberal, A1
Maddali, MM1
Rajakumar, MC1
Ait Houssa, M1
Selkane, C1
Amahzoune, B1
El Bekkali, Y1
Wahid, FA1
Moutaki Allah, Y1
Boulahya, A1
Ibat, D1
Drissi, M1
Azendour, H1
Elkirat, A1
Jimenez, JJ2
Iribarren, JL2
Lorente, L2
Rodriguez, JM1
Hernandez, D2
Nassar, I2
Perez, R2
Brouard, M2
Milena, A1
Martinez, R2
Mora, ML2
Zhang, F1
Yu, J1
Castaman, G1
Ruggeri, M1
Rodeghiero, F1
Riverol, D1
de La Llana, R1
Dunning, J1
Versteegh, M1
Fabbri, A1
Pavie, A1
Kolh, P1
Lockowandt, U1
Nashef, SA1
Trudell, J1
McMurdy, N1
Fergusson, DA1
Hébert, PC1
Fremes, S1
MacAdams, C1
Murkin, JM1
Teoh, K1
Duke, PC1
Arellano, R1
Blajchman, MA1
Bussières, JS1
Côté, D1
Martineau, R1
Robblee, JA1
Rodger, M1
Wells, G1
Clinch, J1
Pretorius, R1
Chen, CC1
Wang, CP1
Lin, TH1
Lin, WD1
Liu, SA1
Penta de Peppo, A1
Pierri, MD1
Scafuri, A1
De Paulis, R1
Colantuono, G1
Caprara, E1
Tomai, F1
Chiariello, L1
Benoni, G2
Fredin, H2
Shore-Lesserson, L1
Reich, DL1
Vela-Cantos, F1
Ammar, T1
Ergin, MA1
Menichetti, A1
Tritapepe, L1
Ruvolo, G1
Speziale, G1
Cogliati, A1
Di Giovanni, C1
Pacilli, M1
Criniti, A1
Bandrowsky, T1
Vorono, AA1
Borris, TJ1
Marcantoni, HW1
Landymore, RW1
Murphy, JT1
Lummis, H1
Carter, C1
Dryden, PJ1
O'Connor, JP1
Jamieson, WR1
Reid, I1
Ansley, D1
Sadeghi, H1
Burr, LH1
Munro, AI1
Merrick, PM1
Gaspar, R1
Brenner, B1
Ardekian, L1
Peled, M1
Laufer, D1
Lambert, W1
Brisebois, FJ1
Wharton, TJ1
Carrier, RC1
Boyle, D1
Rowe, BH1
Mongan, PD1
Brown, RS1
Thwaites, BK1
Bernardoni-Socorro, C1
Arteaga-Vizcaino, M1
Villamizar, Y1
Diez-Ewald, M1
Vizcaíno-Salazar, G1
Torres-Guerra, E1
Quintero, J1
Okuyama, K1
Matsukawa, T1
Abe, F1
Kumazawa, T1
Davies, R1
Sindet-Pedersen, S1
Senghore, N1
Harris, M1
Blinder, D2
Manor, Y2
Taicher, S2
Hashomer, T1
Levi, M1
Cromheecke, ME1
de Jonge, E1
Prins, MH1
de Mol, BJ1
Briët, E1
Büller, HR1
Wong, BI1
McLean, RF1
Fremes, SE1
Deemar, KA1
Harrington, EM1
Christakis, GT1
Goldman, BS1
Federici, AB1
Stabile, F1
Zingaro, E1
Mannucci, PM1
Bertholini, DM1
Butler, CS1
Lethagen, S1
Nilsson, P1
Bublitz, R1
Sommer, S1
Weingart, D1
Bäuerle, K1
Both, A1
Maineri, P1
Covaia, G1
Realini, M1
Caccia, G1
Ucussich, E1
Luraschi, M1
Crosta, A1
Foresti, B1
Chiaranda, M1
Bellotti, F1
Oppizzi, M1
Cossolini, M1
Calori, G1
Torri, G2
Nitu-Whalley, IC1
Griffioen, A1
Harrington, C1
Lee, CA1
Santagostino, E1
Morfini, M1
Rocino, A1
Baudo, F1
Scaraggi, FA1
Gringeri, A1
Nielsen, RE1
Gortzak, RA1
Huijgens, PC1

Clinical Trials (125)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women: A Randomized Controlled Trial[NCT03820206]160 participants (Actual)Interventional2019-01-31Completed
Can the Prophylactic Administration of Tranexamic Acid Reduce Blood Loss After Robotic-assisted Radical Prostatectomy? The RARPEX (Robotic Assisted Radical Prostatectomy With TranEXamic Acid) Study.[NCT04319614]Phase 4200 participants (Actual)Interventional2020-02-24Completed
Comparative Use of Tranexamic Acid Intravenous and Topical Application in the Treatment of Intertrochanteric Fractures With Proximate Femoral Nail[NCT04696224]90 participants (Anticipated)Interventional2020-12-18Recruiting
Efficacy of Tranexamic Acid in Femoral Shaft Fractures Osteosynthesis; A Double Blind Randomized Controlled Trial[NCT04803591]Phase 40 participants (Actual)Interventional2021-08-01Withdrawn (stopped due to Not approved by Ethics Commettee)
Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss, Transfusion Index and Complications After Total Hip Replacement. A Prospective, Randomized, Double Blind Clinical Trial[NCT04187014]Phase 290 participants (Actual)Interventional2020-02-06Completed
Extended Postoperative Tranexamic Acid Use in Primary Total Knee Arthroplasty: A Prospective, Randomized Controlled Trial[NCT05099276]Phase 446 participants (Actual)Interventional2021-12-07Active, not recruiting
Efficacy of Local Hemostatic Management in Implant Surgery in Anticoagulated Patients on Warfarin: a Randomized Clinical Study[NCT04846114]71 participants (Actual)Interventional2016-03-31Completed
Efficacy of Tranexamic Acid (TXA) in Humerus ORIF[NCT05802238]Phase 2130 participants (Anticipated)Interventional2023-04-12Recruiting
Effects of the Application of a New Pharmacological Protocol for Shoulder Arthroscopy in Beach Chair Position[NCT05397652]Phase 4104 participants (Actual)Interventional2021-05-24Completed
Outcome Impact of Different Tranexamic Acid Regimen in Cardiac Surgery With Cardiopulmonary Bypass (the OPTIMAL Study)[NCT03782350]Phase 43,079 participants (Actual)Interventional2018-12-26Completed
The Effect of Topical Administration of Tranexamic Acid on Postoperative Bleeding and Seroma Formation in Patients Undergoing Mastectomy: A Prospective Placebo-controlled Double Blinded Randomized Study[NCT02627560]Phase 4202 participants (Actual)Interventional2016-01-31Completed
Randomized Study on the Topical Application of Tranexamic Acid to Wound Bed for Hemostasis in the Setting Granulating Wounds Following Mohs Micrographic Surgery[NCT04541303]Early Phase 162 participants (Anticipated)Interventional2020-10-08Recruiting
Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage[NCT05554211]Phase 230 participants (Anticipated)Interventional2022-07-12Recruiting
Hemostatic Effects of Ulinastatin and Tranexamic Acid in Cardiac Surgery With Cardiopulmonary Bypass: A Pilot Study[NCT01060189]426 participants (Actual)Interventional2008-04-30Completed
TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural Hematoma[NCT05713630]Phase 3130 participants (Anticipated)Interventional2024-03-31Not yet recruiting
Does Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Reduce Blood Loss and Transfusion Requirements? A Double-blinded Randomized Controlled Trial[NCT05024253]Phase 348 participants (Anticipated)Interventional2021-08-02Recruiting
Is Serum Gentamicin Concentration Modified With Autologous Cell-saved Blood Transfusion After Total Knee Arthroplasty Using Tranexamic Acid: A Randomized Control Trial[NCT04505748]40 participants (Actual)Interventional2020-01-01Completed
Comparison of Topical Tranexamic Acid and Floseal® on Blood Loss After Total Knee Arthroplasty in Patients With a Thromboembolic Risk[NCT02865174]Phase 490 participants (Anticipated)Interventional2016-09-30Not yet recruiting
Tranexamic Acid To Reduce Bleeding in Patients Treated With New Oral Anticoagulants Undergoing Dental Extraction[NCT03413891]Phase 4222 participants (Actual)Interventional2018-02-07Terminated (stopped due to Advice from DSMB)
Comparison Between the Effect of Topical Tranexamic Acid Versus Hydrogen Peroxide on Perioperative Blood Loss in Elective Spine Surgeries[NCT05152186]Phase 3120 participants (Actual)Interventional2021-06-01Active, not recruiting
Topical Tranexamic Acid (TXA) in Hip Fractures, A Double-Blind, Randomized Controlled Trial[NCT02993341]Phase 365 participants (Actual)Interventional2016-11-30Completed
The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery Based on Rotational Thromboelastometry (ROTEM®).[NCT03897621]50 participants (Actual)Interventional2019-05-20Completed
The Impact of Pre-emptive Large Doses of Methylprednisolone Combined With Gabapentin on Pain Treatment and Convalescence After Total Knee Arthroplasty in Elderly: A Double-blind Randomized Study[NCT04653415]Phase 4160 participants (Actual)Interventional2019-06-01Completed
The Effects of the Timing of Tranexamic Acid Administration on Blood Loss in Hip Fractures.[NCT04488367]Early Phase 1120 participants (Anticipated)Interventional2020-07-06Recruiting
Comparative Study of the Efficiency of Oral Tranexamic Tcid vs. Oral Tminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement. A Prospective, Randomized, Double Blinded Controlled Clinical Trial.[NCT03365999]Phase 292 participants (Actual)Interventional2017-10-15Completed
Effect of no Drainage Tube on Blood Loss and Recovery After High Tibial Osteotomy[NCT03954860]80 participants (Actual)Interventional2018-08-01Completed
Evaluation of the Use of Tranexamic Acid in Tibial Osteotomies: a Randomised Controlled Clinical Trial.[NCT04785651]84 participants (Anticipated)Interventional2021-02-22Recruiting
Efficacy of Tranexamic Acid in Reducing Requirement of Blood Transfusion in Lower Limb Trauma Surgery: A Prospective Randomized Controlled Study[NCT04986813]Phase 4100 participants (Actual)Interventional2017-04-01Completed
Study of the Noninferiority of an Oral vs Intravenous Administration of Tranexamic Acid in Total Hip Arthroplasty[NCT04691362]Phase 4230 participants (Actual)Interventional2021-01-01Completed
The Effect of Local Tranexamic Acid on Post-operative Edema and Ecchymosis in Eyelid Surgery[NCT04951128]Phase 450 participants (Anticipated)Interventional2021-08-01Not yet recruiting
Intravenous Administration of Tranexamic Acid Significantly Improved Clarity of Visual Field in Arthroscopic Shoulder Surgery. A Prospective, Double-blind and Randomized Controlled Trial[NCT04025736]72 participants (Actual)Interventional2017-06-07Completed
Local Injection of Tranexamic Acid May Reduce Bleeding, Injection Pain, and Other Post-op Complications During Mohs Micrographic Surgery[NCT04630886]Early Phase 1200 participants (Anticipated)Interventional2021-06-16Enrolling by invitation
Topical Application Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery[NCT05708690]Phase 4132 participants (Actual)Interventional2022-10-01Completed
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) Study[NCT03954314]Phase 33,242 participants (Actual)Interventional2019-09-17Terminated (stopped due to Upon the Data Safety Monitoring Board review of the interim analysis (75% of participants have finished their follow-up) on November 17, 2023, they made a recommendation to stop recruitment into the trial.)
Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis[NCT05774717]Phase 160 participants (Anticipated)Interventional2023-04-01Recruiting
Efficacy of Postoperative Pain Control Between Transarticular VS Periartiucular Multimodal Drug Infiltration in Total Hip Arthroplasty: Double-blinded Randomized Control Trial[NCT05325671]120 participants (Anticipated)Interventional2022-04-05Not yet recruiting
Postoperative Drainage in Total Knee Arthroplasty in the Presence of Tranexamic Acid: a Clinical Trial[NCT03915756]42 participants (Anticipated)Interventional2019-08-22Recruiting
The Impact of Topical Tranexamic Acid on Pre- and Post-operative Hemoglobin / Hematocrit in Isolated Operative Posterior Wall Acetabular Fractures: a Prospective, Randomized, Double-blinded, Multicenter Study[NCT05357079]Early Phase 198 participants (Anticipated)Interventional2017-08-25Recruiting
KINCISE™ Surgical Automated System in Total Hip Arthroplasty (THA)[NCT05223777]50 participants (Anticipated)Interventional2021-09-09Recruiting
Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty[NCT03825939]Phase 452 participants (Actual)Interventional2015-04-21Terminated (stopped due to Lack of patient enrollment due to only one surgeon that was enrolling.)
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study (TAPPAS): A Randomized, Placebo-controlled Double Blind Trial[NCT02806024]Phase 414 participants (Actual)Interventional2016-11-30Completed
Evaluation of a Transfusion Therapy Using Whole Blood Versus Fractionated Blood Products in the Management of Coagulopathy in Patients Admitted to Hospital for Acute Traumatic Hemorrhage[NCT04431999]Phase 3200 participants (Anticipated)Interventional2021-12-04Recruiting
Comparison of the Effect of Two Common Regimens of Administration of Tranexamic Acid on Hemostasis and Clinical Outcome of Patients Undergoing Total Knee Arthroplasty[NCT04443920]Phase 486 participants (Actual)Interventional2019-10-29Completed
Range of Motion and Function Following Primary Repair of Traumatic Zone 1 or Zone 2 Digit Flexor Tendon Injuries - Impact of Tranexamic Acid Use - A Prospective Study[NCT04178655]Early Phase 148 participants (Anticipated)Interventional2019-11-30Not yet recruiting
Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial[NCT03364491]Phase 311,000 participants (Actual)Interventional2018-03-15Completed
Single Centre Randomised Controlled Trial to Assess the Effect of the Addition of Twenty-four Hours of Oral Tranexamic Acid Post-operatively to a Single Intra-operative Intravenous Dose of Tranexamic Acid on Calculated Blood Loss Following Primary Hip and[NCT03690037]Phase 41,089 participants (Actual)Interventional2016-07-07Completed
The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty[NCT03795649]80 participants (Anticipated)Interventional2018-12-18Recruiting
Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.[NCT02579941]40 participants (Actual)Interventional2015-11-30Completed
Prophylactic Use of Topical Tranexamic Acid to Aid Surgical Haemostasis During Caesarean Sections in Parturients With Moderate to High Risk of Bleeding[NCT02492087]Phase 384 participants (Anticipated)Interventional2015-08-31Recruiting
Tranexamic Acid in Knee Joint Surgery - a Randomised Controlled Trial[NCT02278263]Phase 4150 participants (Actual)Interventional2014-12-31Completed
The Comparative Efficacy of Peri-articular and Intraarticular Tranexamic Acid in Total Knee Arthroplasty: A Prospective, Double-Blind Randomized, Controlled Trial[NCT03074994]Phase 2108 participants (Anticipated)Interventional2016-10-31Recruiting
Comparative Study For Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section: A Randomised Controlled Trial[NCT02739815]Phase 4200 participants (Actual)Interventional2016-04-30Completed
Tranexamic Acid Versus Novel Uterine Cooling Technique in Reducing Blood Loss and Incidence of Postpartum Hemorrhage at Caesarean Section[NCT02780245]Phase 4100 participants (Actual)Interventional2016-06-30Completed
Comparison of Combined Topical Tranexamic Acid With Floseal® With Intravenous Tranexamic Acid on Blood Loss in Total Knee Arthroplasty[NCT03328832]Phase 470 participants (Actual)Interventional2017-09-12Completed
Tranexamic Acid Comparison in Hip Replacement (TeACH-R) Trial: Comparative Efficacy of Intravenous Versus Topical Tranexamic Acid for Reducing Blood Loss in Elective Primary Total Hip Arthroplasty.[NCT02056444]149 participants (Actual)Interventional2014-02-28Completed
Blood-saving Effect of Kaolin-based Hemostatic Gauze Combined With Intravenous Tranexamic Acid in Total Knee Arthroplasty[NCT05504577]Phase 4120 participants (Anticipated)Interventional2022-03-16Recruiting
A Prospective, Randomized, Single-blinded, Non-inferiority Study to Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer Compared to the Unipolar Electrocautery in Primary Unilateral Total Knee Arthroplasty[NCT03952546]211 participants (Actual)Interventional2019-05-07Completed
Comparison of Topical and Infusion Tranexamic Acid on Blood Loss and Risk of Deep Vein Thrombosis After Total Knee Arthroplasty[NCT02453802]Phase 490 participants (Anticipated)Interventional2015-06-30Not yet recruiting
Efficacy of Low-dose Intra-articular Tranexamic Acid in Total Knee Replacement; A Prospective Triple-blinded Randomized Controlled Trial.[NCT01850394]152 participants (Actual)Interventional2010-01-31Completed
Blood Loss Reduction After Total Knee Arthroplasty. A Comparison Between Topical Tranexamic Acid and Platelet Rich Plasma: Controlled Clinical Trial[NCT02650856]Phase 340 participants (Actual)Interventional2015-09-30Completed
Blood-saving Effect of Combined Intravenous Tranexamic Acid With Topical Floseal® Application, a Comparison With Intravenous Tranexamic Acid Only in Total Hip Arthroplasty[NCT03623789]Phase 490 participants (Anticipated)Interventional2018-08-15Recruiting
[NCT02644473]Phase 40 participants (Actual)Interventional2016-02-29Withdrawn (stopped due to Study did not receive IRB approval, so did not start)
Minimization of Bleeding Complications Through Utilization of Perioperative Tranexamic Acid in Breast Surgery: A Randomized Double-blinded Placebo-controlled Trial[NCT02615366]Phase 4800 participants (Anticipated)Interventional2016-02-29Not yet recruiting
Serial Use of Intravenous and Oral Tranexamic Acid in Primary Total Knee Arthroplasty Patients: A Randomized Controlled Study[NCT03109652]Phase 4144 participants (Anticipated)Interventional2017-07-10Recruiting
Topical Application of Tranexamic Acid to Reduce Postoperative Blood Loss in Posterior Approach Spinal Surgery[NCT02063035]Phase 429 participants (Actual)Interventional2012-08-31Completed
Evaluation of Efficacy and Safety of Perioperative Tranexamic Acid During Primary Total Knee Arthroplasty: A Randomized, Clinical Trial[NCT05919615]100 participants (Actual)Interventional2021-07-15Completed
A Randomized Control Trial Evaluating the Use of Topical Tranexamic Acid in Bilateral Breast Reduction Surgery to Prevent Bleeding Complications[NCT04918576]Phase 3106 participants (Anticipated)Interventional2022-08-31Not yet recruiting
Effects of Tranexamic Acid for Alloplastic Breast Reconstruction: A Randomized Control Trial[NCT04918589]Phase 3106 participants (Anticipated)Interventional2022-08-31Not yet recruiting
Prospective Randomized Study Comparing Topical Versus Intravenous Tranexamic Acid in Anterior Total Hip Arthroplasty[NCT03359525]Phase 4114 participants (Anticipated)Interventional2017-07-01Recruiting
Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department[NCT02930941]Phase 435 participants (Actual)Interventional2016-02-29Terminated (stopped due to Terminate due to slow enrollment rate.)
The Effectiveness Of Intravenous Tranexamic Acid (TXA) on Reducing Perioperative Blood Loss For Patients Undergoing Periacetabular Osteotomy (PAO): A Randomized Double Blind Placebo Controlled Trial[NCT03823417]Phase 40 participants (Actual)Interventional2019-07-31Withdrawn (stopped due to Investigators decided not to begin the study.)
The Effect of Topical Administration of Tranexamic Acid, Adrenaline and Bupivacain on Postoperative Bleeding and Pain in Patients Undergoing Breast Surgery. A Four-armed Placebo-controlled Double Blinded Randomized Study[NCT01964781]Phase 430 participants (Actual)Interventional2013-08-31Completed
Use of TRanEXamic Acid in Reduction Mammoplasty (TREX-ARM): a Double-blinded Randomized Controlled Trial[NCT04947514]Phase 498 participants (Actual)Interventional2021-10-29Completed
Role of Tranexamic Acid (TXA) in the Reduction of Post-operative Hematoma and Seroma in Patients Undergoing Panniculectomy or Abdominoplasty, a Pilot Study.[NCT04902950]Phase 49 participants (Actual)Interventional2020-08-17Terminated (stopped due to Logistics)
Pilot RCT: Use of Tranexamic Acid (TXA) in Post Mastectomy Patients for Seroma and Hematoma Prevention[NCT03738527]Phase 4100 participants (Anticipated)Interventional2019-10-07Recruiting
Analgesic Efficacy of Adductor Canal Block (ACB) Before and After Primary Total Knee Arthroplasty (TKA): A Prospective Randomized Trial to Compare Postoperative Clinical Outcomes[NCT02908711]Phase 450 participants (Actual)Interventional2016-10-31Completed
Analgesic Efficacy of Quadaratus Lumborum Block (QLB) for Laparoscopic Colectomy Surgery: A Prospective Observational Case Control Trial to Evaluate Clinical Outcomes[NCT03017638]14 participants (Actual)Observational2017-02-27Completed
An Ideal End-tidal Carbon Dioxide Level to Control Intraoperative Bleeding and Improve the Quality of Surgical Field Vision in Septorhinoplasty Operations Under General Anesthesia: a Prospective Clinical Study[NCT05497375]70 participants (Actual)Interventional2022-08-20Completed
Prophylactic Use of Tranexamic Acid for Preventing Postpartum Hemorrhage: A Randomized, Double-blinded, Placebo-controlled Pilot Trial[NCT03069859]Phase 231 participants (Actual)Interventional2018-03-06Active, not recruiting
Prevention of Postpartum Hemorrhage With Tranexamic Acid (TXA)[NCT03326596]Phase 41,000 participants (Anticipated)Interventional2018-04-20Recruiting
Evaluation of Tranexamic Acid Prior to Surgery in the Geriatric Hip Fracture Population for the Reduction of Post-Operative Blood Transfusion[NCT03923959]Phase 3400 participants (Anticipated)Interventional2020-02-01Active, not recruiting
Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty: A Randomized Controlled Trial[NCT02829346]Phase 260 participants (Actual)Interventional2012-10-31Completed
The Use of Tranexamic Acid in Chinese Elderly Patients Undergoing Femoral Nailing for Intertrochanteric Fracture: A Randomized Controlled Trial[NCT04290884]Phase 4120 participants (Anticipated)Interventional2018-05-23Active, not recruiting
Does Tranexamic Acid Significantly Reduce Total Blood Loss During Proximal Femoral Nailing for the Intertrochanteric Femoral Fracture in the Elderly?[NCT05359172]100 participants (Actual)Observational2021-04-01Completed
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid in Patients at High Risk for Blood Transfusion After Spine Surgery[NCT03849443]Early Phase 1604 participants (Anticipated)Interventional2019-08-26Recruiting
The Effect of Using Tranexamic Acid Soaked Absorbable Gelatin Sponge in Reducing Rectus Sheath Hematoma Formation After Cesarean Section in Patients Using Warfarin Compounds[NCT05439694]Phase 463 participants (Actual)Interventional2022-07-03Completed
A Randomised, Prospective Evaluation on the Effectiveness of Tranexamic Acid in Reducing Postoperative Swelling and Haematoma Formation After the Latarjet Procedure.[NCT03458468]100 participants (Actual)Interventional2018-03-01Completed
Low Versus High Dose Tranexamic Acid in Adult Spinal Deformity Surgery: A Randomized, Blinded, Controlled Trial[NCT02053363]Phase 2/Phase 364 participants (Actual)Interventional2014-03-31Completed
Role of Topical Tranexamic Acid in Total Hip Arthroplasty[NCT01866943]Phase 241 participants (Actual)Interventional2011-11-30Terminated
The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery[NCT01728636]Phase 261 participants (Actual)Interventional2013-01-15Completed
Role of Tranexamic Acid for Reducing Blood Loss in Patients Undergoing Major Gastro-intestinal Surgery[NCT01655641]Phase 2/Phase 3118 participants (Anticipated)Interventional2012-07-31Active, not recruiting
Topical Application of Tranexamic Acid to Reduce Post-operative Bleeding in Coronary Artery Bypass Surgery[NCT01519245]Phase 344 participants (Actual)Interventional2011-12-31Completed
Determination of the Minimal Concentration of Antifibrinolytics Required to Inhibit t-PA-activated Fibrinolysis Using an in Vitro Experimental Model of Fibrinolysis.[NCT02352675]40 participants (Actual)Observational2015-04-30Completed
Intravenous Tranexamic Acid to Reduce Blood Loss in Reverse Total Shoulder Arthroplasty[NCT02043132]Phase 2/Phase 3116 participants (Actual)Interventional2013-09-30Completed
The Effect of Intravenous E-Aminocaproic Acid (EACA) on Blood Loss and Transfusion Requirements After Bilateral Varus Rotational Osteotomy (VRO)[NCT02257580]Phase 428 participants (Actual)Interventional2015-04-01Completed
A Novel Technique Of Uterine Cooling During Repeated Cesarean Section For Reducing Blood Loss[NCT03793153]99 participants (Actual)Interventional2018-12-19Completed
Peroperative Tranexamic Acid as Prophylaxis of Haemorrhage in Benign Hysterectomy - a Randomized, Placebo-controlled Trial[NCT01940419]Phase 4332 participants (Actual)Interventional2013-04-30Completed
The Use of Tranexamic Acid in Irrigation Fluid to Improve Arthroscopic Visualization in Shoulder Surgery: A Randomized Controlled Trial[NCT04594408]Phase 4128 participants (Actual)Interventional2020-09-01Active, not recruiting
The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery[NCT02684851]Phase 387 participants (Actual)Interventional2012-10-31Completed
Benefits on Post-operative Pain of Intravenous, Intraoperative, Tranexamic Acid Injection During Arthroscopic Shoulder Surgery.[NCT05302986]Phase 3220 participants (Anticipated)Interventional2023-02-24Recruiting
Evaluation of the Pharmacokinetic Profile of Tranexamic Acid, After Injection in a Knee Neo-articulation.[NCT02319915]Early Phase 114 participants (Actual)Interventional2015-02-18Completed
The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients: a Randomized Placebo-controlled Trial[NCT01895101]Phase 4750 participants (Actual)Interventional2013-10-31Completed
CONSERV - 2 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) - A Phase 2 Randomized Double-Blind Active-Controlled Study in Subjects Exposed to Cardio-pulmonary Bypass During Cardiac Surgery a[NCT00888940]Phase 2243 participants (Actual)Interventional2009-06-30Completed
Tranexamic Acid Reduces Blood Loss After Off-pump Coronary Artery Bypass Grafting[NCT01064167]231 participants (Actual)Interventional2009-02-28Completed
Phase 4 Study of Tranexamic Acid for Elderly Patients Undergoing Combined Aortic Valve Replacement and Coronary Artery Bypass Surgery.[NCT00375466]63 participants (Actual)Interventional2006-09-30Completed
Tranexamic Acid Reduces Blood Loss in Pediatric Cardiac Surgery[NCT00994994]160 participants (Actual)Interventional2006-01-31Completed
The Blood Saving Effect and Wound-related Complications of Tranexamic Acid in Mininally Invasive Total Knee Arthroplasty With Rivaroxaban as Thromboprophylaxis[NCT02458729]Phase 4294 participants (Actual)Interventional2012-08-31Completed
Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery: a Multicenter Randomized Double Blind Placebo Controlled Therapeutic and Pharmaco-biological Dose Ranging Study (TRACES) for Its Optimal Benefit/Risk[NCT02797119]Phase 4225 participants (Actual)Interventional2016-03-15Terminated (stopped due to Study will be stopped due to the impossibility of reaching the objective of inclusions within a reasonable time frame and taking into account the recommendations of the international WOMAN study)
The Efficacy of Intravenous Tranexamic Acid in Decreasing Blood Loss in Pediatric Idiopathic Scoliosis Surgery?[NCT01813058]Phase 1/Phase 2120 participants (Actual)Interventional2013-01-31Completed
DEPOSITION: Pilot Study Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery[NCT03376061]Phase 497 participants (Actual)Interventional2017-12-21Completed
Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty[NCT01370460]Phase 2101 participants (Actual)Interventional2011-06-30Completed
A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery[NCT03037515]Phase 4120 participants (Anticipated)Interventional2017-02-15Not yet recruiting
Tranexamic Acid in Surgery of Advanced Ovarian Cancer - a Prospective Randomized Double Blind Placebo Controlled Study[NCT00740116]Phase 4100 participants (Actual)Interventional2008-03-31Completed
The Effect of Tranexamic Acid (TXA) on Blood Loss and Transfusion Rates in Burn Wound Surgery - A Randomized, Double-Blinded Placebo-Controlled Trial[NCT02753816]25 participants (Actual)Interventional2016-04-30Terminated (stopped due to Study enrollment and goals unable to be reached.)
Influence of Elevated Baseline Serum Creatinine and Body Composition on Acute Kidney Injury in Cardiac Surgery - The InCreAS Trial[NCT02598271]200 participants (Actual)Observational2016-10-31Completed
Efficacy in Controlling Bleeding Post-coronary Bypass Surgery Using Combination of Local Application of Tranexamic Acid and Intravenous Tranexamic Compared to Intravenous Tranexamic Acid Alone. A Randomized Controlled Trial[NCT01600599]40 participants (Actual)Interventional2011-01-31Completed
The Effect of Tranexamic Acid (TXA) on Blood Loss in Burn Surgery - A Randomized, Double-Blinded Placebo-Controlled Trial[NCT03113253]Phase 4121 participants (Actual)Interventional2016-09-22Active, not recruiting
Early Versus Late Post Caesarean Section Oral Anticoagulation Initiation and Risk of Maternal Complications in Patients With Mechanical Heart Valve Prosthesis[NCT04855110]114 participants (Anticipated)Interventional2021-04-19Recruiting
PHASE IV Study of Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After Percutaneous Aortic Valve Implantation. Multicenter Randomized Clinical Trial[NCT01642134]Phase 4124 participants (Actual)Interventional2013-04-30Completed
Observatory of Anticoagulation After Bioprosthetic Aortic Valve Replacement[NCT01293188]434 participants (Actual)Observational2011-01-31Completed
Perioperative Interventions to Optimize Cerebral Oxygen Saturation (rSO2) in High-risk Patients Undergoing Cardiac Surgery Should Have a Beneficial Systemic Effect for Enhancing Global Tissue Perfusion and Improve Outcomes.[NCT01432184]200 participants (Actual)Interventional2010-07-31Completed
Prospective Randomised Trial Comparing Intraoperative Topical Quixil and Intravenous Tranexamic Acid, in Reduction of Blood Loss Following Primary Hip & Knee Joint Replacement Surgery.[NCT00378872]132 participants (Actual)Interventional2006-06-30Completed
The Effect of Low Dose Corticosteroids on Perioperative Markers of Thrombosis and Fibrinolysis in Total Knee Arthroplasty[NCT01815918]Phase 460 participants (Actual)Interventional2011-02-28Completed
Randomized Placebo Controlled Study Using Tranexamic Acid in Revision Total Hip Arthroplasty[NCT00375440]0 participants (Actual)Interventional2005-02-28Withdrawn (stopped due to Study halted prematurely as investigator left the institution.)
The Effect of Tranexamic Acid on Blood Loss and Transfusion Rates in Major Oncologic Surgery[NCT01980355]76 participants (Actual)Interventional2012-06-12Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Length of Hospital Stay

Measured in Days (NCT03825939)
Timeframe: At Hospital Discharge

InterventionDays (Mean)
Intravenous Tranexamic Acid3
Intravenous Placebo3
Intravenous Tranexamic Acid Followed by Intravenous Placebo3

Blood Transfusion (Number of Units Transfused) Intraoperatively

Total number of units of blood transfused (whole blood, platelets, cryoprecipitate, and fresh frozen plasma) intra-operatively is a secondary outcome. (NCT02806024)
Timeframe: Pulled from operative note, completed by the time of discharge.

Interventionunits (Mean)
Treatment Arm (Tranexamic Acid, or TXA)5.2
Placebo Arm17.6

Estimated Blood Loss (EBL)

EBL is estimated by the surgeon and anesthesia team at the completion of the surgery (cesarean delivery &/or cesarean hysterectomy). (NCT02806024)
Timeframe: 1-3 hours (will be determined at the completion of the surgery).

Interventioncc (Mean)
Treatment Arm (Tranexamic Acid, or TXA)3116
Placebo Arm9420

Change in Hemoglobin

[Key secondary outcome] Change in hemoglobin from the most recent measured before delivery to lowest measured in the 48 hours after delivery (NCT03364491)
Timeframe: from 4 weeks before delivery to 48 hours postpartum

Interventiongrams per deciliter (Mean)
Tranexamic Acid-1.8
Placebo-1.9

Length of Stay

Mother's length of stay from delivery to discharge (NCT03364491)
Timeframe: Until hospital discharge, an average of 3 days

Interventiondays (Median)
Tranexamic Acid3
Placebo3

Number of Mothers Who Died or Had Thromboembolic Events (Venous or Arterial), Ischemic Stroke, Myocardial Infarction, New-onset Seizure Activity, or Were Admitted to the Intensive Care Unit for More Than 24 Hours

(NCT03364491)
Timeframe: within 6 weeks postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid35
Placebo32

Number of Participants Who Received Open Label TXA or Other Antifibrinolytic

This is the number of mothers who were treated with any amount of open-label TXA (not blinded study drug) or another antifibrinolytic (eg., Amicar) (NCT03364491)
Timeframe: within 7 days postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid108
Placebo109

Number of Participants Who Received Surgical or Radiologic Interventions to Control Bleeding and Related Complications

This is the number of mothers who required any of the following types of surgical procedures to control bleeding: laparotomy, evacuation of hematoma, hysterectomy, uterine packing, intrauterine balloon tamponade, interventional radiology (NCT03364491)
Timeframe: within 7 days postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid233
Placebo231

Number of Participants Who Received Treatments and Interventions in Response to Bleeding and Related Complications

[Key secondary outcome] This is the number of mothers who received treatments and interventions to control bleeding such as: uterotonics such as prostaglandins or methergine, but excluding oxytocin; open label TXA or other antifibrinolytics; transfusion of 1 or more units of fresh frozen plasma, cryoprecipitate, or platelets or administration of any factor concentrates; laparotomy, evacuation of hematoma, hysterectomy, uterine packing, intrauterine balloon tamponade, interventional radiology (NCT03364491)
Timeframe: within 7 days postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid892
Placebo986

Number of Participants Who Were Transfused With 4 or More Units of Packed Red Blood Cells

Participants were categorized according to the amount of packed red blood cells or whole blood transfused, either as 0 to 3 units, or 4 or more units (NCT03364491)
Timeframe: within 7 days postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid20
Placebo19

Number of Participants Who Were Transfused With Other Blood Products

This is the number of mothers who received during the first 7 days after delivery a transfusion of 1 or more units of fresh frozen plasma, cryoprecipitate, or platelets, or received any factor concentrates (NCT03364491)
Timeframe: within 7 days postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid29
Placebo31

Number of Participants Who Were Treated With Uterotonics Other Than Oxytocin

This is the number of mothers who were treated with uterotonics such as prostaglandins or methergine, but excluding oxytocin, from delivery through 48 hours after delivery. (NCT03364491)
Timeframe: within 48 hours postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid649
Placebo732

Number of Participants With a Thromboembolic Event (Venous or Arterial), Ischemic Stroke, or Myocardial Infarction

[Key secondary outcome] This is the number of mothers who experienced a thromboembolic event, ischemic stroke, or myocardial infarction during the 6 weeks after delivery. (NCT03364491)
Timeframe: within 6 weeks postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid12
Placebo13

Number of Participants With Estimated Blood Loss Greater Than 1 Liter During Delivery

[Major secondary outcome] The surgeon or anesthesiologist estimated the blood loss during the delivery in milliliters, which was recorded in the anesthesia record and/or operative report (NCT03364491)
Timeframe: From skin incision to transfer from operating room, average of 1 hour

InterventionParticipants (Count of Participants)
Tranexamic Acid339
Placebo368

Number of Participants With Maternal Death or Transfusion of Packed Red Blood Cells

Participants were monitored from delivery until hospital discharge or 7 days after delivery (postpartum), whichever is sooner. This is the number of mothers who died for any reason, or had a blood transfusion of 1 or more units (of packed red blood cells, including whole blood or cell saver). (NCT03364491)
Timeframe: by hospital discharge or by 7 days postpartum, whichever is sooner

InterventionParticipants (Count of Participants)
Tranexamic Acid201
Placebo233

Number of Participants With Postpartum Infectious Complications

[Key Secondary Outcome] This is the number of mothers who experienced any of the following infectious complications in the 6 weeks after delivery: endometritis, surgical site infection, pelvic abscess (NCT03364491)
Timeframe: within 6 weeks postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid162
Placebo125

Number of Participants With Seizure Activity That Was Not Seen Prior to Study Enrollment

This is the number of mothers who experienced seizure activity, confirmed by central review, whose onset is after enrollment (NCT03364491)
Timeframe: within 6 weeks postpartum

InterventionParticipants (Count of Participants)
Tranexamic Acid2
Placebo0

Blood Loss

"The loss of haemoglobin (Hb) was then estimated according to the formula:~Hb(loss) = Blood volume (BV) x (Hbi-Hbe) x 0.001+Hbt~where Hb (loss) (g) is the amount of Hb lost, Hbi (g/L) the Hb concentration before surgery, Hbe (g/L) is the Hbe concentration on the third day after surgery, and Hbt (g) is the total amount of allogeneic Hb transfused. A unit of banked blood is considered to contain a minimum of 40g Hb (Blood component data sheet, New Zealand Blood Services [NZBS]). All units of blood are processed and stored in a nationally standardised manner. The blood loss (ml) was related to the patient's preoperative Hb value (g/L):~Blood loss =1000 x Hb(loss) /Hbi" (NCT02278263)
Timeframe: Post operative day 3

Interventionmls (Mean)
Control1090
Intraarticular716
Systemic746

Length of Stay (LOS)

Day of surgery is counted as Day 0. (NCT02278263)
Timeframe: Average length of stay is expected to be 3 to 5 days

Interventiondays (Median)
Control4
Topical4
Systemic4

Number of Participants Receiving Allogenic Blood Transfusion

"Those patients receiving blood products. Standardised protocol is as follows:~The criterion for transfusion of blood products will be a haemoglobin < 80g/L or a haemoglobin <100g/L in a patient with ischaemic heart disease or with significant symptomatology" (NCT02278263)
Timeframe: Participants will be followed for the duration of their hospital stay expected to be an average of 3-5 days

InterventionParticipants (Count of Participants)
Control2
Topical1
Systemic0

Perioperative Fluid Administration

Intravenous fluid (excluding blood transfusion) given during and first 24 hours after surgery (NCT02278263)
Timeframe: Day 1

Interventionmls (Mean)
Control1765
Topical1613
Systemic1807

Number of Participants Experiencing Symptomatic Venothromboembolic (VTE) Disease

Rates of deep vein thrombosis (DVT) and pulmonary embolus (PE) in each group recorded as a percentage (NCT02278263)
Timeframe: Postoperatively within 30 days after surgery

,,
InterventionParticipants (Count of Participants)
DVTPE
Control00
Systemic01
Topical02

Range of Active Flexion

Range of motion measured in degrees on postoperative days 1-3 (NCT02278263)
Timeframe: Days 1-3

,,
Interventiondegrees (Mean)
Day 1Day 2Day 3
Control577175
Systemic587278
Topical657582

Range of Passive Flexion

Range of motion measured in degrees for postoperative days 1 to 3 (NCT02278263)
Timeframe: Days 1-3

,,
Interventiondegrees (Mean)
Day 1Day 2Day 3
Control657682
Systemic688087
Topical748187

Blood Transfusion Rate

We will record the event of blood transfusion, and calculate the incidence of transfusion (NCT03328832)
Timeframe: From the operation to the postoperative day 3 or 4

InterventionParticipants (Count of Participants)
Combined Topical TXA and Floseal1
Topical TXA Alone0

Incidence of Thrombosis Events

The composite of any venous thromoembolism events, ischemic heart attacks, cerebrovascular accidents (NCT03328832)
Timeframe: within 30 days of the operation

InterventionParticipants (Count of Participants)
Combined Topical TXA and Floseal0
Topical TXA Alone0

Total Blood Loss After Operation

Total blood loss was calculated according to Nadler et al., which used maximum postoperative reduction of the Hb level adjust for weight and height of the patient. The formula is as follows, Total blood loss = (Total blood volume x [change in Hb level / preoperative Hb level])x1000+volume transfused (NCT03328832)
Timeframe: From the operation to the postoperative day 3 or 4

Interventionml (Mean)
Combined Topical TXA and Floseal678
Topical TXA Alone733

Functional Outcomes

"Functional outcomes measured by the 2011 Knee Society Score. The Functional Activities section consists of 4 sub-sections with a total score ranging from 0-100 points. The higher the numerical value the better the outcome. The sub-sections consist of: (1)Walking and Standing 0-30 points (2)Standard Activities 0-30 points (3)Advanced Activities 0-25 points (4)Discretionary Knee Activities 0-15 points." (NCT03952546)
Timeframe: 8 weeks

Interventionscore on a scale (Mean)
Treatment Arm56.45
Control Arm61.79

Hemostasis

Postoperative day 1 estimated blood loss as calculated by the Gross' Formula (NCT03952546)
Timeframe: Postoperative day 1

Interventionmilliliters (Mean)
Treatment Arm924
Control Arm1062

Wound Infection

Participants were assessed for any wound infection within 90 days of surgery. (NCT03952546)
Timeframe: 90 days postoperatively

InterventionNumber of events (Number)
Saline-Coupled Bipolar Sealer1
Unipolar Electrocautery3

Number of Patients Required Blood Transfusion

(NCT01850394)
Timeframe: postoperative period (5 days after surgery)

Interventionparticipants (Number)
Control Group10
TXA-250 Group6
TXA-500 Group0

Total Hemoglobin Loss

Total hemoglobin loos measured by difference between hemoglobin preoperatively and the fourth postoperative day (NCT01850394)
Timeframe: 5 days after surgery

Interventiong/dL (Mean)
Control Group2.9
TXA-250 Group2.2
TXA-500 Group2.2

Knee Function Scores

"Knee function score was measured with 2 methods, and were evaluated preoperatively and then postoperatively at 3-month, 6-month, and 1-year period.~Knee Society Knee Score using for rating knee function measurement and subdivided into two parts; knee score and function score 1.1. Knee score : calculated from pain, presence of deformity, total range of flexion, alignment, and stability. Total score is 100 (0-100), more score means better.~1.2. Function score : calculated from patient's ability to walk and climb stairs. The score ranges from 0-100, more score means better.~Western Ontario and McMaster Universities Arthritis Index or WOMAC score : a widely used, standardized questionnaires for evaluating the condition of patients with knee osteoarthritis, including pain (score = 0-20), stiffness (0-8), and functional limitation (0-68). Total score ranges from 0-68, lower score means better." (NCT01850394)
Timeframe: 1 year after surgery

,,
Interventionunits on a scale (Mean)
Knee Society Knee score at 1 yearWOMAC score at 1 year
Control Group148.915.5
TXA-250 Group151.215.1
TXA-500 Group150.914.5

Number of Patients Having Postoperative Complications

"Postoperative complications were measured as an incidence of the following complications;~wound hematoma~surgical site infection~systemic infection~deep vein thrombosis~pulmonary embolism~knee stiffness requiring manipulation~medical complication such as myocardial infarction, congestive hear failure" (NCT01850394)
Timeframe: postoperative 1-year period

,,
Interventionparticipants (Number)
Re-clamp incidenceRe-dressing incidenceVenous thromboembolic complicationCongestive heart failure
Control Group6340
TXA-250 Group1011
TXA-500 Group0020

Perioperative Blood Loss

"Drainage blood loss measured by accumulating total drainage volume postoperatively~Calculated total blood loss measured by using specific formula and difference between hematocrit preoperatively and the fourth postoperative day" (NCT01850394)
Timeframe: 5 days after surgery

,,
Interventionml (Median)
Drainage blood lossCalculated total blood loss
Control Group546.9329.2
TXA-250 Group475.0239.7
TXA-500 Group430.2217.2

Therapeutic Effect on Drainage Quantification

The blood quantification will be taken at 6am every day. (NCT02650856)
Timeframe: up to 2nd day post operative (24 and 48 hrs)

,
InterventionmL (Mean)
24 hours48 hours
Group 1 Tranexamic Acid246.4120.8
Group 2 Platelet Rich Plasma263.2140.2

Therapeutic Effect on Hematocrit Level

The blood test will be taken at 6am every day. Using the same laboratory parameters. (NCT02650856)
Timeframe: up to 3rd day post operative (Baseline, 24, 48 and 72hrs)

,
Interventionpercentage of Hematocrite (Mean)
Baseline24 hours48 hours72 hours
Group 1 Tranexamic Acid41.731.629.128.6
Group 2 Platelet Rich Plasma41.529.827.727.3

Therapeutic Effect on Hemoglobin Level

The blood test will be taken at 6am every day. Using the same laboratory parameters. (NCT02650856)
Timeframe: up to 3rd day post operative (Baseline, 24, 48 and 72hrs)

,
Interventiong/dL (Mean)
Baseline24 hours48 hours72 hours
Group 1 Tranexamic Acid13.610.39.59.3
Group 2 Platelet Rich Plasma13.69.99.29.1

Blood Loss Volume Following Surgery

Blood loss following surgery was defined as the total amount of fluid collected from the drain in the wound site during the hospital stay. (NCT02063035)
Timeframe: From end of surgery on Day 1 to end of hospital stay up to approximately 5 days

InterventionmL (Median)
Tranexamic Acid534
Placebo530

Change in Hemoglobin Level From Preoperative Appointment to Postoperative Hospital Discharge

Blood loss was calculated from the difference between the level of hemoglobin at the preoperative appointment and the lowest level during the postoperative hospitalization period. Reported here is the change in hemoglobin level after surgery. A negative number indicates a reduction in hemoglobin level. (NCT02063035)
Timeframe: From preoperative appointment approximately one week before surgery to end of hospital stay up to approximately 5 days after surgery

Interventiongrams per deciliter (g/dL) (Median)
Tranexamic Acid-3.2
Placebo-4.6

Hospital Length of Stay in Days

The number of days the participants stayed in the hospital after surgery was recorded. (NCT02063035)
Timeframe: From end of surgery on Day 1 to end of hospital stay up to approximately 2 weeks

Interventiondays (Median)
Tranexamic Acid5
Placebo6

Post-operative Blood Transfusions During Hospitalization

All units of blood transfused during the hospital stay after surgery were recorded. One red blood cell unit contains 300 to 360 mL of whole blood. (NCT02063035)
Timeframe: From end of surgery on Day 1 to end of hospital stay up to approximately 5 days

Interventionunits of blood (Median)
Tranexamic Acid0
Placebo0

Length of Stay in the Emergency Department (Minutes, Median, Inter-Quartile Range)

Length of stay was defined as time from enrollment in study to discharge from the emergency department (NCT02930941)
Timeframe: During emergency department (ED) visit

Interventionminutes (Median)
TXA Group268
NS Group346

Number of Participants With Re-bleeding at 24 Hours

The number of participants with re-bleeding at 24 Hours was evaluated during follow up phone call (NCT02930941)
Timeframe: 24 hours

InterventionParticipants (Count of Participants)
TXA Group3
NS Group9

Number of Participants With Re-bleeding at One Week

The number of participants with re-bleeding at one week was evaluated during the follow-up phone call (NCT02930941)
Timeframe: 7 days

InterventionParticipants (Count of Participants)
TXA Group2
NS Group6

Thromboembolism

Patient reported thromboembolic events during follow-up phone calls at 24 hours and at one week (NCT02930941)
Timeframe: 7 days

InterventionParticipants (Count of Participants)
TXA Group0
NS Group0

Time to Control of Bleeding (Minutes, Median, Interquartile Range)

Time to control of bleeding was defined as the time from the start of enrollment and direct pressure and administration of study drug to the resolution of bleeding (NCT02930941)
Timeframe: During emergency department (ED) visit

Interventionminutes (Median)
TXA Group64
NS Group42

Drug-Related Adverse Events

Patient-reported drug-related adverse events during ED visit (NCT02930941)
Timeframe: during emergency department (ED) visit

,
InterventionParticipants (Count of Participants)
Nasal burningNasal irritationUnpleasant taste
NS Group000
TXA Group201

Number of Breasts With Development of Hematoma

The number of breasts with clinically significant hematoma (collection of blood under the skin) requiring either conservative management or operative washout was determined. (NCT04947514)
Timeframe: Up to 30 days

Interventionbreasts (Number)
Treatment Side (Right or Left)2
Placebo Side (Right or Left)1

Number of Participants Requiring a Blood Transfusion

The number of participants requiring blood transfusion was based on the postoperative decline in hematocrit level (NCT04947514)
Timeframe: Up to 30 days

InterventionParticipants (Count of Participants)
Treatment Side (Right or Left)0
Placebo Side (Right or Left)0

Number of Participants With Deep Vein Thrombosis/Venous Thromboembolism

Incidence of clinically significant deep vein thrombosis or pulmonary embolism detected on imaging (ultrasound or CT scan) (NCT04947514)
Timeframe: Up to 30 days

InterventionParticipants (Count of Participants)
Treatment Side (Right or Left)0
Placebo Side (Right or Left)0

Number of Days Until Drain Removal

The number of days that the post surgical drains remain in place after the surgery. When less than 30 cc per drain in a 24-hour period, the participants are to call and schedule drain removal. (NCT04902950)
Timeframe: Up to 56 days post operatively.

InterventionDays (Mean)
Group 116
Group 222

Number of Participants That Returned to the Operating Room

Return to the operating room for evacuation post surgical operative hematoma or seroma assessed by clinical evaluation to include palpation for ballotable fluid collection and assessment of skin for a shiny/tight appearance suggestive of an underlying fluid collection. (NCT04902950)
Timeframe: Up to 8 weeks postoperatively

InterventionParticipants (Count of Participants)
Group 10
Group 20

Participants With Post Operative Hematoma

Patients will be monitored clinically at each post-operative visit for signs of post-operative hematoma or seroma. Each patient will be evaluated one week, three weeks, and eight weeks following their procedure to assess overall wound healing. (NCT04902950)
Timeframe: Up to 8 weeks postoperatively

InterventionParticipants (Count of Participants)
Group 10
Group 21

Blood Loss

"To compare the estimated blood loss in patients undergoing complex, reconstructive, spinal fusion surgeries receiving one of two dosing protocols for the anti-fibrinolytic, TXA.~Estimated blood loss was calculated by suction canister volume minus intraoperative irrigation fluid plus blood content in sponges as estimated by weight for all cases." (NCT02053363)
Timeframe: This outcome is measured during surgery, from exposure to wound closure, approximately 8 hours.

InterventionmL (Mean)
High Dose/Study Group2046
Standard of Care/Control1596

Number of Patients Sustaining Intraoperative or 90 Day Complications

To compare the rates of intraoperative complications and 90 day complications observed in the two groups. (NCT02053363)
Timeframe: Perioperative complications were defined as complications occurring within 90 days of surgery.

InterventionParticipants (Count of Participants)
High Dose/Study Group2
Standard of Care/Control3

Red Blood Cell Transfusions

To compare the mean volume (mL) of packed red blood cell (PRBC) transfusions given to the two groups. Volumes of RBC vary from bag to bag and real volumes will be recorded as provided by the blood bank. (NCT02053363)
Timeframe: Participants will be followed for the duration of their hospital stay measured from day of surgery to day of discharge from the hospital, approximately 7 days.

InterventionmL (Mean)
High Dose/Study Group1259
Standard of Care/Control935

Estimated Blood Loss

Estimated Blood Loss defined as Pre Op Hgb mins the Post Op Day two Hgb. (NCT01866943)
Timeframe: Pre Op, Post Op Day 2

InterventionHemoglobin (grams/deciliter) (Mean)
Baseline Population2.93

Harris Hip Scores

Standardized questionnaire that measures clinical function related to the hip. Total potential range is from 4.0 - 96.0. A higher score indicates a more favorable clinical outcome. (NCT01866943)
Timeframe: 2 week

Interventionunits on a scale (Mean)
All Study Participants65.76

Harris Hip Scores

Standardized questionnaire that measures clinical function related to the hip. Total potential range is from 4.0 - 96.0. A higher score indicates a more favorable clinical outcome. (NCT01866943)
Timeframe: 6 week

Interventionunits on a scale (Mean)
All Study Participants81.77

Harris Hip Scores

Standardized questionnaire that measures clinical function related to the hip. Total potential range is from 4.0 - 96.0. A higher score indicates a more favorable clinical outcome. (NCT01866943)
Timeframe: Preoperative

Interventionunits on a scale (Mean)
All Study Participants58.34

Mid Thigh Circumference

Measurement of the thigh at the half way point between the prominence of the greater trochanter and the lateral epicondyle of the femur. No data recorded at 2 weeks or 6 weeks for this study population. (NCT01866943)
Timeframe: Pre Op

Interventioncentimeters (Mean)
Baseline Population52.99

Additional Blood Products Transfused

Total additional blood products (fresh frozen plasma, cryoprecipitate, and platelets) transfused in the perioperative period measured in units. (NCT01728636)
Timeframe: 24 hours after skin incision

InterventionUnits (Mean)
Tranexamic Acid1
Placebo2

Estimated Intraoperative Blood Loss

Estimated Intraoperative blood loss in milliliters (mLs) (NCT01728636)
Timeframe: Incision to skin closure (approximately 10 hours)

InterventionMilliliters (Mean)
Tranexamic Acid1550
Placebo1600

Post Operative Major Morbidity

Number of participants who experienced arterial or venous thromboembolism, neurologic complications (including stroke, seizure,and delirium), infections, and pulmonary renal or cardiac adverse outcomes (demand ischemia, myocardial infarction or new arrhythmia) before another operative procedure or hospital discharge. (NCT01728636)
Timeframe: Time of surgery to date of discharge from hospital (average 7 days)

InterventionParticipants (Count of Participants)
Tranexamic Acid9
Placebo9

Total Operating Room Time

Total operating room time from incision to closure of incision in minutes. (NCT01728636)
Timeframe: Minutes

InterventionMinutes (Median)
Tranexamic Acid602
Placebo576

Total Red Blood Cells Transfused in the Intraoperative Period

Total red blood cells transfused in the intraoperative period in (mL). Total RBC equal packed red blood cells and cell saver infusion. (NCT01728636)
Timeframe: Intraoperative period (approximately 12 hours)

Interventionmilliliters (Median)
Tranexamic Acid1140
Placebo1460

Total Tranexamic Acid Dose (mg)

Total milligrams of intravenous tranexamic acid administered during the surgical procedure. (NCT01728636)
Timeframe: Intraoperative period

Interventionmilligrams (Median)
Tranexamic Acid1408
Placebo0

Number of Units of Packed Red Blood Cells (PRBC) Transfused Following Coronary Artery Bypass Graft Surgery

Research participants were to receive a blood transfusion in the Intensive Care Unit (ICU) post-operatively if hemoglobin reached a nadir of 80g/L, or at the discretion of the intensivist or cardiac surgeon according to patient clinical status. Transfusion was quantified based on the number of units of PRBC received. (1 unit = 1 bag of blood, as prepared by Canadian Blood Services). Clinical status of research participants was followed throughout their duration in the ICU only. Participation in this study ended upon transfer out of the ICU, to the Cardiology Ward. (NCT01519245)
Timeframe: From ICU admission to transfer to the Cardiology Ward (placebo group = 24.4 hours; trial group = 24.7 hours)

InterventionUnit(s) of PRBC (Number)
Trial Drug0
Placebo0

Total Volume of Blood Loss From Mediastinal Chest Tubes at Time of Removal (Assuming the Total Volume of Loss is Blood).

According to standard practice, research participants were be transferred to the intensive care unit (ICU) for post-operative monitoring. Measurement of chest tube output began immediately on arrival to the ICU. Hourly measurements were recorded. Data collection ended upon chest tube removal, or return to the operating room for exploratory surgery due to massive blood loss. As per ICU protocol, chest tubes were be removed when blood loss was recorded to be less than 200mL after six consecutive hours. (NCT01519245)
Timeframe: From ICU admission post-operatively to mediastinal chest tube removal (placebo group = 20.6 hours; trial group = 19.8 hours)

InterventionmL (Mean)
Trial Drug632
Placebo789

Volume of Blood Loss After 12 Hours

Volume of chest tube loss at 12 hours (assuming the total volume of loss is blood). (NCT01519245)
Timeframe: 12 hours following admission to the Intensive Care Unit

InterventionmL (Mean)
Trial Drug464
Placebo570

Volume of Blood Loss at 6 Hours

Volume of chest tube loss at 6 hours (assuming the total volume of loss is blood). (NCT01519245)
Timeframe: 6 hours following admission to the Intensive Care Unit

InterventionmL (Mean)
Trial Drug342
Placebo417

Number of Participants Experiencing Deep Vein Thrombosis

"The occurrence of the following systemic and surgical site complications within 6 weeks of surgery will be recorded. Data will be obtained from EMR and from patient at standard of care 2 week and 6 week follow-up appointment.~Deep venous thrombosis" (NCT02043132)
Timeframe: up to 6-weeks post-operatively

InterventionParticipants (Count of Participants)
Tranexamic Acid0
Normal Saline0

Number of Participants Experiencing Hematoma as a Surgical Site Complication

"The occurrence of the following systemic and surgical site complications within 6 weeks of surgery will be recorded. Data will be obtained from EMR and from patient at standard of care 2 week and 6 week follow-up appointment.~Hematoma" (NCT02043132)
Timeframe: up to 6-weeks post-operatively

InterventionParticipants (Count of Participants)
Tranexamic Acid0
Normal Saline0

Number of Participants Experiencing Infection as a Surgical Site Complication

"The occurrence of the following systemic and surgical site complications within 6 weeks of surgery will be recorded. Data will be obtained from EMR and from patient at standard of care 2 week and 6 week follow-up appointment.~Infection" (NCT02043132)
Timeframe: up to 6-weeks post-operatively

InterventionParticipants (Count of Participants)
Tranexamic Acid0
Normal Saline0

Number of Participants Experiencing Myocardial Infarction

"The occurrence of the following systemic and surgical site complications within 6 weeks of surgery will be recorded. Data will be obtained from EMR and from patient at standard of care 2 week and 6 week follow-up appointment.~Myocardial infarction" (NCT02043132)
Timeframe: up to 6-weeks post-operatively

InterventionParticipants (Count of Participants)
Tranexamic Acid0
Normal Saline1

Number of Participants Experiencing Pulmonary Embolism

"The occurrence of the following systemic and surgical site complications within 6 weeks of surgery will be recorded. Data will be obtained from EMR and from patient at standard of care 2 week and 6 week follow-up appointment.~Pulmonary Embolism" (NCT02043132)
Timeframe: up to 6-weeks post-operatively

InterventionParticipants (Count of Participants)
Tranexamic Acid0
Normal Saline0

Total Blood Loss

Total Blood Loss as calculated according to method as described by Good et al. Total Blood Loss (mL) = 1000 X Hb(loss)/Hb(initial) (NCT02043132)
Timeframe: Preoperative through Postoperative Days 1 and 2

InterventionTotal Blood Loss (mL) (Mean)
Tranexamic Acid1122.4
Normal Saline1472

Total Drain Output

Total Drain Output as measured postoperatively 0-48 hours (NCT02043132)
Timeframe: 0-48 hours postoperatively

InterventionmL (Mean)
Tranexamic Acid221
Normal Saline372

Total Hemoglobin Loss

Total hemoglobin loss estimated using the formula for total blood volume described by Nadler et al Hb(loss) = blood volume (L) x [Hb(initial)(g/L) - Hb(final)(g/L)] + Hb(transfused) (NCT02043132)
Timeframe: Preoperative through Postoperative Days 1 and 2

Interventiong (Mean)
Tranexamic Acid154.6
Normal Saline200.1

Complications [VTE (Symptomatic of DVT or PE), Infection (Superficial, Deep), Hematoma, Seroma, Reoperation, and Death]

Incidence of VTE (symptomatic of DVT or PE), infection (superficial, deep), hematoma, seroma, reoperation, and death, measured in person-years ( x cases per 100,000 person years) (NCT02257580)
Timeframe: an expected average of 1 week (post-surgery), Follow-up at 6 weeks

Interventioncases per 100,000 person years (Number)
E-Aminocaproic Acid (EACA)0
Placebo0

Intraoperative Calculated Total Blood Loss

Determined by estimated blood volume, calculated using difference in preoperative and postoperative hemoglobin and applied to the Nadler equation for estimating blood volume while adjusting for transfused hemoglobin to produce a single metric of calculated intraoperative blood loss. (NCT02257580)
Timeframe: Intraoperative (3-6 hours)

InterventionmL (Mean)
E-Aminocaproic Acid (EACA)535.7
Placebo628.0

Intraoperative Cell Saver Utilization

Number of participants requiring 1 unit of intraoperative cell saver transfusion. Patients either received or did not receive intraoperative cell saver transfusion. The maximum number of intraoperative units transfused in this study was 1 unit. The count of participants in the data table refers to the number of patients who received this transfusion. (NCT02257580)
Timeframe: Intraoperative, 1 day

InterventionParticipants (Count of Participants)
E-Aminocaproic Acid (EACA)7
Placebo7

Length of Hospital Stay

postoperative day of discharge after surgery- day of intake. (NCT02257580)
Timeframe: Post-Surgery, an expected average of 1 week

Interventiondays (Mean)
E-Aminocaproic Acid (EACA)5.5
Placebo5.1

Post Operative Blood Loss

24 hour drain output (mL) (NCT02257580)
Timeframe: Post-Surgery, 24 hours

InterventionmL (Mean)
E-Aminocaproic Acid (EACA)72.5
Placebo103.3

Postoperative Allogeneic Blood Transfusion

The number of participants that required 1 unit of blood transfused post-operatively. Patients received blood if necessary post operatively, and the maximum number of units a patient received was 1. The count of participants refers to the number of patients who received this transfusion unit. (NCT02257580)
Timeframe: Post-Surgery, an expected average of 1 week

InterventionParticipants (Count of Participants)
E-Aminocaproic Acid (EACA)4
Placebo3

Allogenic Blood Transfusion Rates

Number of participant received allogenic blood transfusions. (NCT02684851)
Timeframe: post-operative

InterventionParticipants (Count of Participants)
Tranexamic21
Placebo13

Estimate Blood Loss

To measure average estimate perioperative blood loss (NCT02684851)
Timeframe: perioperative

InterventionmL (Mean)
Tranexamic727.6
Placebo560.1

Number of Participants With a Thromboembolic Event

Do patients undergoing acetabular ORIF who receive tranexamic acid have a higher risk for thromboembolic events than patients who receive placebo? (NCT02684851)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Tranexamic1
Placebo0

Units of Packed Red Blood Cells Transfused

Average units packed red blood cells transfused among participants (NCT02684851)
Timeframe: perioperative

InterventionUnits of packed red blood cells (Mean)
Tranexamic2.65
Placebo2.36

Number of Participants Requiring Surgical Re-exploration

the secondary objective of this study is to determine whether pericardial lavage with saline gives an improvement in haemostasis, compared with no pericardial lavage, resulting in a reduction of surgical re-explorations and post-operative 12-hour blood loss. The choice for a surgical re-exploration will be decided according to the ICU protocol. (NCT01895101)
Timeframe: participants will be followed for the duration of ICU stay, an expected average of 2 days

Interventionparticipants (Number)
Pericardial Lavage With 200 ml Normothermic Saline Solution10
No Pericardial Lavage9
2 gr Tranexamic Acid Diluted in 200 ml Normothermic Saline12

Postoperative Blood Loss

The primary study parameter is 12 hours postoperative blood loss and is assessed by postoperative chest tube production. Postoperative chest tube production 12 hours after surgical procedure (NCT01895101)
Timeframe: 12 hours postoperative

Interventionml (Median)
Pericardial Lavage With 200 ml Normothermic Saline Solution290
No Pericardial Lavage300
2 gr Tranexamic Acid Diluted in 200 ml Normothermic Saline290

Total Red Blood Cell Transfusions (Cumulative of Pre, Peri and Postoperative Period)

The amount of red blood cell transfusions the patient receive pre, peri and postoperatively during their stay in the hospital. (NCT01895101)
Timeframe: participants will be followed for the duration of ICU stay, an expected average of 2 days/ And participants will be followed for the duration of hospital stay, an expected average of 3 weeks

InterventionIU (Mean)
Pericardial Lavage With 200 ml Normothermic Saline Solution0.7
No Pericardial Lavage1.1
2 gr Tranexamic Acid Diluted in 200 ml Normothermic Saline0.7

Cumulative Volume of Packed Red Blood Cells Transfused

(NCT00888940)
Timeframe: 12 hours after the end of surgery

InterventionmL (Mean)
Ecallantide1223.2
Cyklokapron(R)623.5

Treatment-emergent Adverse Events.

(NCT00888940)
Timeframe: Over the duration of the study.

,
Interventionevents (Number)
At Least 1 TEAEAt Least 1 Related TEAEAt Least 1 Severe TEAEAt Least 1 Serious TEAEAt Least 1 Related & Serious TEAEPremature Study Drug Discontinuations Due to TEAERelated TEAE Resulting in Discontinuation of DrugTEAE Resulting in DeathRelated TEAE Resulting in Death
Cyklokapron(R)945172812040
Ecallantide10053845420130

Number of Patients Required Allogenic Red Blood Cells Transfusion

(NCT01064167)
Timeframe: 1month postoperative

Interventionparticipants (Number)
Tranexamic Acid Group37
Control Group54

Postoperative Chest Tube Drainage

(NCT01064167)
Timeframe: 24h postoperative

Interventionml (Mean)
Tranexamic Acid Group654
Control Group891

Perioperative Blood Loss

Perioperative blood loss (during operation and for entire hospital admission) (NCT01813058)
Timeframe: perioperarively - during entire hospital admission

InterventionmL (Mean)
Placebo1031
Tranexamic Acid836

Mean Concentration of TxA in Plasma Collected From Participants

Plasma TxA concentrations measured from blood samples taken upon arrival in the ICU (NCT03376061)
Timeframe: on arrival in ICU within 3 hours

Interventionmicrogram per milliliter per kilogram (Mean)
Topical TxA (Intervention)0.58
Intravenous TxA (Control)1.10

Median Number of Hours Participants Spent in ICU

Number of hours participants spent in the intensive care unit (ICU) (NCT03376061)
Timeframe: Number of hours spent in ICU from arrival to exit (collected at the Post-Operative Visit).

Interventionhours (Median)
Topical TxA (Intervention)23
Intravenous TxA (Control)26

Median Volume of Mediastinal Fluid Collected From Participants

Cumulative volume (mL) of fluid collected from mediastinal drainage tubes 24 hours after the surgical procedure (NCT03376061)
Timeframe: Fluid collected in the first 24 hours after the surgical procedure

InterventionmL (Median)
Topical TxA (Intervention)500
Intravenous TxA (Control)540

Number of Participants With Mortality

The occurrence of death due to any cause (NCT03376061)
Timeframe: Patients will be followed post-operatively until hospital discharge

InterventionParticipants (Count of Participants)
Topical TxA (Intervention)1
Intravenous TxA (Control)1

Number of Participants With RBC Transfusion

Patients requiring a red blood cell transfusion (NCT03376061)
Timeframe: Intra-operative and post-operative RBC transfusions

InterventionParticipants (Count of Participants)
Topical TxA (Intervention)19
Intravenous TxA (Control)23

Number of Participants With Re-operation for Bleeding or Tamponade

Occurrence of re-operation for the purpose of bleeding or cardiac tamponade (NCT03376061)
Timeframe: Patients will be followed post-operatively until hospital discharge

InterventionParticipants (Count of Participants)
Topical TxA (Intervention)0
Intravenous TxA (Control)1

Number of Participants With Seizures

Patients experiencing a post-operative seizure (NCT03376061)
Timeframe: Patients will be followed post-operatively until hospital discharge

InterventionParticipants (Count of Participants)
Topical TxA (Intervention)0
Intravenous TxA (Control)1

Blood Loss

Preoperative and lowest postoperative hemoglobin. Blood loss was calculated taking change in hemoglobin as described (units g/dL) and converting to blood loss (mL) according to the formulas included in the papers cited in this entry (Good 2003 Br J Anesthesia; Nadler 1962 Surgery, http://www.ncbi.nlm.nih.gov/pubmed/21936146). (NCT01370460)
Timeframe: participants will be followed for the duration of hospital stay, an expected average of 3 days

InterventionmL (Mean)
Placebo1293.1
Tranexamic Acid940.2

Postoperative Transfusion Rate

Number of patients with symptomatic (tachycardia, hypotension, presyncope) anemia of < 8.0g/dL hemoglobin, or any hemoglobin <7.0 g/dL, precipitated transfusion. (NCT01370460)
Timeframe: participants will be followed for the duration of hospital stay, an expected average of 3 days

Interventionparticipants (Number)
Tranexamic Acid0
Placebo4

Median Number of Transfused Units of Red Blood Cells (RBC)

Median number of red blood cells transfused among those who received RBC transfusions (NCT00740116)
Timeframe: From start of operation to discharge from hospital, up to 5 weeks

Interventionunits (Median)
The Placebo Group2
The Tranexamic Acid Group2

Number of Patients Receiving Blood Transfusions

Total number of RBC-transfused women in each group (NCT00740116)
Timeframe: From start of operation to discharge from hospital, up to 5 weeks

Interventionparticipants (Number)
Tranexamic Group15
Placebo Group22

Number of Patients With Clinically or Radiologically Verified Thromboembolic Events Within 5 Weeks Postoperatively

Thromboembolic events including arterial thrombosis, muscle vein thrombosis, superficial and deep venous thrombosis. (NCT00740116)
Timeframe: From time of operation to 5 weeks postoperatively.

InterventionParticipants (Count of Participants)
Tranexamic Group2
Placebo Group5

Number of Units of Red Blood Cells (RBC) Transfused

Total number of red blood cells (RBC) transfused across all participants (NCT00740116)
Timeframe: From start of operation to discharge from hospital, up to 5 weeks

Interventionunits (Number)
Tranexamic Group38
Placebo Group53

Perioperative Bleeding Volume

Estimation of total blood loss was based on the estimation of the Hb balance method (Brecher, et al.1997) with the assumption that the body blood volume was normalised on the fifth postoperative day. The haemoglobin level was assessed preoperatively and on the fifth postoperative day. The predicted blood volume (PBV, l) was calculated according to the method described by Nadler et al. (1962), using body weight and height. The extravasation of haemoglobin was calculated taking into account allogenic transfused haemoglobin. Total blood loss perioperatively was related to the patient's preoperative haemoglobin value. Blood loss due to haematomas or a reoperation within the first five days after surgery was also considered. (NCT00740116)
Timeframe: From start of operation to discharge from hospital, up to 5 weeks

Interventionmilliliter (Median)
Tranexamic Group520
Placebo Group730

Blood Transfusion Rates, Defined Nominally (Binary) as Having at Least One Transfusion

To determine the impact of perioperative administration of Tranexamic Acid on transfusion rates in major burn surgeries. (NCT02753816)
Timeframe: First burn surgery to hospital discharge

InterventionPatients with 1 or more transfusions (Number)
Tranexamic Acid2
Placebo3

Effect of Tranexamic Acid on the Total Length of Hospital Admission for a Large (350 cm2) Burn Injury

To determine the impact of Tranexamic Acid on total hospital length of stay by comparing the hospital admission date and the hospital discharge date. This determination will take into account current burn size and location, procedures performed and their effect on wound healing and skin graft survival. (NCT02753816)
Timeframe: Hospital admission to hospital discharge

InterventionDays (Median)
Tranexamic Acid23
Placebo9

Intraoperative Blood Loss in mL

To determine the impact of perioperative administration of Tranexamic Acid on blood loss in major burn surgeries. (NCT02753816)
Timeframe: Intraoperative, average 122 minutes

InterventionmL (Median)
Tranexamic Acid100
Placebo325

Plasmin-alpha-2-antiplasmin Complex (PAP), a Marker of Fibrinolysis

Study patients received 100 mg of intravenous hydrocortisone 2 h prior to surgery, and controls received normal saline. Blood samples, drawn pre-incision and at 4 h post tourniquet release, were assayed for PF1.2 and PAP (NCT01815918)
Timeframe: Baseline and up to 4 hours following surgery

,
Interventionug/L (Mean)
Baseline4 hs
Placebo623.31086.8
Treatment808.41638.6

Prothrombin Fragment (PF1.2), a Marker of Thrombin Generation

Study patients received 100 mg of intravenous hydrocortisone 2 h prior to surgery, and controls received normal saline. Blood samples, drawn pre-incision and at 4 h post tourniquet release, were assayed for PF1.2 and PAP (NCT01815918)
Timeframe: Baseline and up to 4 hours following surgery

,
InterventionpMol/L (Mean)
Baseline4s
Placebo263.6935.8
Treatment266.5615.9

Estimated Blood Loss

Surgical blood loss estimation (NCT01980355)
Timeframe: From time of surgery to 90 days post hospital discharge

InterventionmL (Median)
Tranexamic Acid450
Placebo365

Number of Participants Who Required Transfusion

To determine the impact of perioperative administration of tranexamic acid on blood loss and transfusion rates in major oncologic surgery (NCT01980355)
Timeframe: From time of surgery to 90 days post hospital discharge

InterventionParticipants (Count of Participants)
Tranexamic Acid8
Placebo5

Reviews

92 reviews available for tranexamic acid and Blood Loss, Postoperative

ArticleYear
The efficacy of Tranexamic Acid Administration in Patients Undergoing Tonsillectomy: An Updated Meta-Analysis.
    The Annals of otology, rhinology, and laryngology, 2022, Volume: 131, Issue:8

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorrhage; Tonsillectomy; Tran

2022
The Efficacy and Safety of Tranexamic Acid in the Management of Perioperative Bleeding After Percutaneous Nephrolithotomy: A Systematic Review and Meta-Analysis of Comparative Studies.
    Journal of endourology, 2022, Volume: 36, Issue:3

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Nephrolithotomy, Percutaneous; Postoperative

2022
Antifibrinolytic Drugs for the Prevention of Bleeding in Pediatric Cardiac Surgery on Cardiopulmonary Bypass: A Systematic Review and Meta-analysis.
    Anesthesia and analgesia, 2022, 05-01, Volume: 134, Issue:5

    Topics: Aminocaproic Acid; Anaphylaxis; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Su

2022
Tranexamic acid in head and neck procedures: a systematic review and meta-analysis of randomized controlled trials.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2022, Volume: 279, Issue:5

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemoglobins; Humans; Postoperative Hemorrhage; Random

2022
Tranexamic acid reduces postoperative blood loss in Chinese pediatric patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis.
    Medicine, 2022, Mar-04, Volume: 101, Issue:9

    Topics: Antifibrinolytic Agents; Blood Component Transfusion; Blood Loss, Surgical; Cardiac Surgical Procedu

2022
The use of tranexamic acid reduces blood loss in osteotomy at knee level: a systematic review.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2022, Volume: 30, Issue:12

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemoglobins; Humans; Osteotomy; Postoperative Hemorrh

2022
Prophylactic Use of Antifibrinolytics During Pediatric Cardiac Surgery With Cardiopulmonary Bypass on Postoperative Bleeding and Transfusion: A Systematic Review and Meta-Analysis.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2022, 11-01, Volume: 23, Issue:11

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Component Transfusion; Cardiac Surgical

2022
Impact of direct oral anticoagulants on bleeding tendency and postoperative complications in oral surgery: a systematic review of controlled studies.
    Oral surgery, oral medicine, oral pathology and oral radiology, 2023, Volume: 135, Issue:3

    Topics: Administration, Oral; Anticoagulants; Humans; Oral Surgical Procedures; Postoperative Hemorrhage; Tr

2023
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
    Asian journal of surgery, 2023, Volume: 46, Issue:8

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ

2023
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
    Asian journal of surgery, 2023, Volume: 46, Issue:8

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ

2023
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
    Asian journal of surgery, 2023, Volume: 46, Issue:8

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ

2023
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
    Asian journal of surgery, 2023, Volume: 46, Issue:8

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ

2023
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
    Asian journal of surgery, 2023, Volume: 46, Issue:8

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ

2023
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
    Asian journal of surgery, 2023, Volume: 46, Issue:8

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ

2023
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
    Asian journal of surgery, 2023, Volume: 46, Issue:8

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ

2023
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
    Asian journal of surgery, 2023, Volume: 46, Issue:8

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ

2023
Efficacy and safety of tranexamic acid in unicompartmental knee arthroplasty: A systematic review and meta-analysis.
    Asian journal of surgery, 2023, Volume: 46, Issue:8

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ

2023
Role of Tranexamic Acid (TXA) in Preventing Bleeding Following Sleeve Gastrectomy: a Systematic Review and Meta-analysis.
    Obesity surgery, 2023, Volume: 33, Issue:5

    Topics: Adolescent; Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Gastrectomy; Humans;

2023
The Effects of Tranexamic Acid in Breast Surgery: A Systematic Review and Meta-Analysis.
    Plastic and reconstructive surgery, 2023, 12-01, Volume: 152, Issue:6

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Breast Neoplasms; Female; Hematoma; Humans; Postopera

2023
A systematic review on the efficacy of tranexamic acid in head and neck surgery.
    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2023, Volume: 48, Issue:4

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorrhage; Tonsillectom

2023
The effect of different hemostatic agents following dental extraction in patients under oral antithrombotic therapy: a network meta-analysis.
    Scientific reports, 2023, 08-02, Volume: 13, Issue:1

    Topics: Chitosan; Collagen; Cyanoacrylates; Fibrinolytic Agents; Hemostatics; Humans; Network Meta-Analysis;

2023
Systematic review and meta-analysis of topical tranexamic acid in spine surgery.
    Neurosurgical focus, 2023, Volume: 55, Issue:4

    Topics: Blood Loss, Surgical; Case-Control Studies; Cross-Sectional Studies; Hemoglobins; Humans; Postoperat

2023
Does tranexamic acid diminish hemorrhage and pain in open elbow arthrolysis? a systematic review and meta-analysis.
    BMC musculoskeletal disorders, 2023, Oct-06, Volume: 24, Issue:1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Elbow; Humans; Pain; Postoperative Hemorrhage; Tranex

2023
Efficacy and Safety of Tranexamic Acid in Reducing Blood Loss of Lower Extremity Osteotomy in Peri-acetabulum and High Tibia: A Systematic Review and Meta-analysis.
    Orthopaedic surgery, 2019, Volume: 11, Issue:4

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Humans; Lower Extremity; Osteotomy

2019
Efficacy and safety of tranexamic acid usage in patients undergoing posterior lumbar fusion: a meta-analysis.
    BMC musculoskeletal disorders, 2019, Aug-31, Volume: 20, Issue:1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hemoglobins; Humans; Intervertebra

2019
Tranexamic Acid in the Perioperative Period: Yes, No, Maybe?
    Advances in anesthesia, 2019, Volume: 37

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Dose-Response Relationship, Drug; Humans; Postoperati

2019
The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials.
    Journal of thrombosis and thrombolysis, 2020, Volume: 50, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Fracture Fixation; Hip Fractures; Human

2020
[Fast-track arthroplasty-intra- and post-operative management].
    Der Orthopade, 2020, Volume: 49, Issue:4

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; I

2020
Tranexamic acid is effective in decreasing postoperative intraarticular bleeding in arthroscopic knee surgery.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2020, Volume: 31, Issue:3

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Humans; Male; Postoperative Hemorr

2020
Intravenous Tranexamic Acid Decreases Blood Transfusion in Off-Pump Coronary Artery Bypass Surgery: A Meta-analysis.
    The heart surgery forum, 2020, 02-25, Volume: 23, Issue:1

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Component Transfusion; Coronary Artery B

2020
Prophylactic Topical Tranexamic Acid Versus Placebo in Surgical Patients: A Systematic Review and Meta-analysis∗.
    Annals of surgery, 2021, 04-01, Volume: 273, Issue:4

    Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorr

2021
Effectiveness and safety of the use of antifibrinolytic agents in total-knee arthroplasty: A meta-analysis.
    Medicine, 2020, Volume: 99, Issue:20

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ

2020
The effect of tranexamic acid on the values of activated clotting time in patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis.
    Journal of clinical anesthesia, 2020, Volume: 67

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgical Procedures; Humans; Postoperative He

2020
Exposure-Response Relationship of Tranexamic Acid in Cardiac Surgery.
    Anesthesiology, 2021, 02-01, Volume: 134, Issue:2

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgical Procedures; Dose-Response Relationsh

2021
Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2021, Sep-01, Volume: 32, Issue:6

    Topics: Antifibrinolytic Agents; Blood Component Transfusion; Deamino Arginine Vasopressin; Disease Manageme

2021
Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysis.
    Journal of orthopaedic surgery and research, 2021, Jun-22, Volume: 16, Issue:1

    Topics: Administration, Topical; Blood Loss, Surgical; Clinical Trials as Topic; Drainage; Humans; Length of

2021
Efficacy and Safety of Antifibrinolytic Drugs in Pediatric Surgery: A Systematic Review.
    Seminars in thrombosis and hemostasis, 2021, Volume: 47, Issue:5

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Child; Humans; Pharmaceutical Prep

2021
Preventing perioperative bleeding in patients with inherited bleeding disorders.
    Evidence-based dentistry, 2017, Volume: 18, Issue:1

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Hemophilia A; Humans; Postoperativ

2017
Intra-articular Tranexamic Acid in Primary Total Knee Arthroplasty: Meta-analysis.
    The journal of knee surgery, 2018, Volume: 31, Issue:1

    Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi

2018
Oral tranexamic acid can reduce blood loss after total knee and hip arthroplasty: A meta-analysis.
    International journal of surgery (London, England), 2017, Volume: 46

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl

2017
Most Effective Regimen of Tranexamic Acid for Reducing Bleeding and Transfusions in Primary Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials.
    The journal of knee surgery, 2018, Volume: 31, Issue:7

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2018
The effect of tranexamic acid to reduce blood loss and transfusion on off-pump coronary artery bypass surgery: A systematic review and cumulative meta-analysis.
    Journal of clinical anesthesia, 2018, Volume: 44

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass, Off-Pump;

2018
[Research progress on tranexamic acid application strategy in total knee arthroplasty].
    Zhongguo gu shang = China journal of orthopaedics and traumatology, 2016, Oct-25, Volume: 29, Issue:10

    Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi

2016
The efficacy of oral versus intravenous tranexamic acid in reducing blood loss after primary total knee and hip arthroplasty: A meta-analysis.
    Medicine, 2018, Volume: 97, Issue:36

    Topics: Administration, Intravenous; Administration, Oral; Antifibrinolytic Agents; Arthritis; Arthroplasty,

2018
A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery.
    Clinical interventions in aging, 2018, Volume: 13

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical;

2018
The Efficacy and Safety of Intravenous Tranexamic Acid in Reducing Surgical Blood Loss in Posterior Lumbar Interbody Fusion for the Adult: A Systematic Review and a Meta-Analysis.
    World neurosurgery, 2019, Volume: 122

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Human

2019
Tranexamic Acid Plus Low-dose Epinephrine Reduces Blood Loss in Total Knee Arthroplasty: A Systematic Review and Meta-analysis.
    Orthopaedic surgery, 2018, Volume: 10, Issue:4

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; D

2018
Oral tranexamic acid reduces blood loss in total-knee arthroplasty: A meta-analysis.
    Medicine, 2018, Volume: 97, Issue:45

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Su

2018
Tranexamic acid and perioperative bleeding in children: what do we still need to know?
    Current opinion in anaesthesiology, 2019, Volume: 32, Issue:3

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Child; Dose-Response Relationship,

2019
Topical Use of Tranexamic Acid in Cardiac Surgery: A Meta-Analysis.
    The Thoracic and cardiovascular surgeon, 2020, Volume: 68, Issue:3

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Cardiac Surgical Procedures; Female;

2020
Epsilon-aminocaproic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study.
    Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology, 2019, Jul-18, Volume: 20, Issue:1

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; B

2019
Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials.
    Chinese journal of traumatology = Zhonghua chuang shang za zhi, 2013, Volume: 16, Issue:2

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; H

2013
Antifibrinolytic agents in current anaesthetic practice.
    British journal of anaesthesia, 2013, Volume: 111, Issue:4

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Proced

2013
Antifibrinolytic agents in current anaesthetic practice.
    British journal of anaesthesia, 2013, Volume: 111, Issue:4

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Proced

2013
Antifibrinolytic agents in current anaesthetic practice.
    British journal of anaesthesia, 2013, Volume: 111, Issue:4

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Proced

2013
Antifibrinolytic agents in current anaesthetic practice.
    British journal of anaesthesia, 2013, Volume: 111, Issue:4

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Proced

2013
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Knee, 2013, Volume: 20, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2013
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Knee, 2013, Volume: 20, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2013
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Knee, 2013, Volume: 20, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2013
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Knee, 2013, Volume: 20, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2013
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Knee, 2013, Volume: 20, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2013
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Knee, 2013, Volume: 20, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2013
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Knee, 2013, Volume: 20, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2013
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Knee, 2013, Volume: 20, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2013
Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Knee, 2013, Volume: 20, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2013
[Perioperative management of type 2B Von Willebrand's disease in a patient undergoing urgent abdominal surgery].
    Revista espanola de anestesiologia y reanimacion, 2014, Volume: 61, Issue:4

    Topics: Abdomen, Acute; Blood Loss, Surgical; Emergencies; Factor VIII; Female; Heparin, Low-Molecular-Weigh

2014
Post-operative blood management strategies for total hip arthroplasty.
    Surgical technology international, 2014, Volume: 24

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion, Autologous; Drainage; Hu

2014
Reduced blood loss after intra-articular tranexamic acid injection during total knee arthroplasty: a meta-analysis of the literature.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2014, Volume: 22, Issue:12

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; H

2014
Tranexamic acid - a useful drug in ENT surgery?
    The Journal of laryngology and otology, 2014, Volume: 128, Issue:7

    Topics: Antifibrinolytic Agents; Humans; Otorhinolaryngologic Diseases; Otorhinolaryngologic Surgical Proced

2014
A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement.
    The bone & joint journal, 2014, Volume: 96-B, Issue:8

    Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Repl

2014
Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2015, Volume: 25, Issue:3

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S

2015
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials.
    The Knee, 2014, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2014
Efficiency of tranexamic acid in perioperative blood loss in hip arthroplasty: a systematic literature review and meta-analysis.
    Revista espanola de anestesiologia y reanimacion, 2015, Volume: 62, Issue:5

    Topics: Adolescent; Adult; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Blood Transfusion; Female;

2015
Topical application of tranexamic acid in primary total hip arthroplasty: a systemic review and meta-analysis.
    International journal of surgery (London, England), 2015, Volume: 15

    Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion;

2015
What dose of tranexamic acid is most effective and safe for adult patients undergoing cardiac surgery?
    Interactive cardiovascular and thoracic surgery, 2015, Volume: 21, Issue:3

    Topics: Adult; Angina, Unstable; Antifibrinolytic Agents; Blood Loss, Surgical; Coronary Artery Bypass; Dose

2015
[The possibility of using tranexamic acid for the treatment of bleeding in otorhinolaryngology].
    Vestnik otorinolaringologii, 2015, Volume: 80, Issue:2

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Otorhinolaryngologic Surgical Procedures; Pos

2015
Predicting Blood Loss in Total Knee and Hip Arthroplasty.
    The Orthopedic clinics of North America, 2015, Volume: 46, Issue:4

    Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bl

2015
[PERIOPERATIVE BLOOD MANAGEMENT STRATEGIES FOR JOINT ARTHROPLASTY].
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2015, Volume: 29, Issue:6

    Topics: Antifibrinolytic Agents; Arthroplasty; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, A

2015
Tranexamic Acid in Hip and Knee Arthroplasty.
    The Journal of the American Academy of Orthopaedic Surgeons, 2015, Volume: 23, Issue:12

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss

2015
Tranexamic Acid in Hip and Knee Arthroplasty.
    The Journal of the American Academy of Orthopaedic Surgeons, 2015, Volume: 23, Issue:12

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss

2015
Tranexamic Acid in Hip and Knee Arthroplasty.
    The Journal of the American Academy of Orthopaedic Surgeons, 2015, Volume: 23, Issue:12

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss

2015
Tranexamic Acid in Hip and Knee Arthroplasty.
    The Journal of the American Academy of Orthopaedic Surgeons, 2015, Volume: 23, Issue:12

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss

2015
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Acta obstetricia et gynecologica Scandinavica, 2016, Volume: 95, Issue:1

    Topics: Antifibrinolytic Agents; Blood Transfusion; Female; Hemoglobins; Humans; Oxytocics; Postoperative He

2016
Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    The Cochrane database of systematic reviews, 2015, Dec-24, Issue:12

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Factor IX; Factor VIII; Hemophilia

2015
Surgical treatment of craniosynostosis in infants: open vs closed repair.
    Current opinion in anaesthesiology, 2016, Volume: 29, Issue:3

    Topics: Anesthesia; Antifibrinolytic Agents; Craniosynostoses; Craniotomy; Hemodynamic Monitoring; Humans; I

2016
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis
    Annals of hematology, 2016, Volume: 95, Issue:5

    Topics: Anticoagulants; Antineoplastic Agents; Blood Coagulation Factors; Blood Loss, Surgical; Blood Transf

2016
Manifestation of tranexamic acid toxicity in chronic kidney disease and kidney transplant patients: A report of four cases and review of literature.
    Nephrology (Carlton, Vic.), 2017, Volume: 22, Issue:4

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Blood Loss, Surgic

2017
Topical fibrin sealant versus intravenous tranexamic acid for reducing blood loss following total knee arthroplasty: A systematic review and meta-analysis.
    International journal of surgery (London, England), 2016, Volume: 32

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2016
The effectiveness and safety of tranexamic acid in bilateral total knee arthroplasty: A meta-analysis.
    Medicine, 2016, Volume: 95, Issue:39

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Humans; M

2016
An Evaluation of the Efficacy of Local Hemostatic Measures in Dental Patients Taking Oral Anticoagulants: A Critical Review of the Literature Over the Past Two Decades.
    Current clinical pharmacology, 2016, Volume: 11, Issue:4

    Topics: Administration, Oral; Anticoagulants; Antifibrinolytic Agents; Hemostatic Techniques; Humans; Oral S

2016
Topical versus systemic tranexamic acid after total knee and hip arthroplasty: A meta-analysis of randomized controlled trials.
    Medicine, 2016, Volume: 95, Issue:41

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Drug Admin

2016
Topical application of tranexamic acid in anticoagulated patients undergoing minor oral surgery: A systematic review and meta-analysis of randomized clinical trials.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2017, Volume: 45, Issue:1

    Topics: Administration, Topical; Anticoagulants; Antifibrinolytic Agents; Humans; Oral Surgical Procedures;

2017
Efficacy and safety of tranexamic acid in reducing blood loss in scoliosis surgery: a systematic review and meta-analysis.
    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2017, Volume: 26, Issue:1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemoglobins; Humans; Postoperative Hemorrhage; Scolio

2017
[Blood conservation approaches in orthopedic surgery].
    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2008, Volume: 15, Issue:5

    Topics: Anemia; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Drug Admi

2008
The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2009, Jan-20, Volume: 180, Issue:2

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Coronary Artery

2009
What influence do anticoagulants have on oral implant therapy? A systematic review.
    Clinical oral implants research, 2009, Volume: 20 Suppl 4

    Topics: Administration, Oral; Administration, Topical; Anticoagulants; Atrial Fibrillation; Contraindication

2009
Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2010, Volume: 37, Issue:6

    Topics: Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Drug Administrat

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Antifibrinolytics in major orthopaedic surgery.
    The Journal of the American Academy of Orthopaedic Surgeons, 2010, Volume: 18, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Huma

2010
Tranexamic acid in cardiac surgery: is there a cause for concern?
    Critical care (London, England), 2010, Volume: 14, Issue:5

    Topics: Animals; Aprotinin; Cardiac Surgical Procedures; Humans; Postoperative Hemorrhage; Tranexamic Acid

2010
Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era.
    Current opinion in anaesthesiology, 2011, Volume: 24, Issue:1

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Hum

2011
Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: a systematic review and meta-analysis.
    Journal of cardiothoracic and vascular anesthesia, 2011, Volume: 25, Issue:1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass, Off-Pump;

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Hemostasis, Surgical; Hu

2011
[Transfusion for post-partum haemorrhage: what's new in 2011?].
    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2011, Volume: 18, Issue:2

    Topics: Antifibrinolytic Agents; Blood Transfusion; Cesarean Section; Clinical Trials as Topic; Combined Mod

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Tranexamic acid in total knee replacement: a systematic review and meta-analysis.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfu

2011
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:1

    Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini

2012
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:1

    Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini

2012
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:1

    Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini

2012
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:1

    Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini

2012
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:1

    Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini

2012
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:1

    Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini

2012
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:1

    Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini

2012
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:1

    Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini

2012
Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:1

    Topics: Administration, Topical; Aminocaproates; Antifibrinolytic Agents; Cardiac Surgical Procedures; Clini

2012
Systematic review and meta-analysis of the use of tranexamic acid in tonsillectomy.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2013, Volume: 270, Issue:2

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorrhage; Tonsillectomy; Tran

2013
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Erythrocyte Transfu

2006
[Local and systemic hemostasis in surgery].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2007, Volume: 78, Issue:2

    Topics: Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Factor VIIa; Fibrin Tissue Adhesive; Hemos

2007
Pharmacologic methods to reduce perioperative bleeding.
    Transfusion, 2008, Volume: 48, Issue:1 Suppl

    Topics: Aminocaproic Acid; Aprotinin; Deamino Arginine Vasopressin; Hemorrhage; Hemostatics; Humans; Meta-An

2008
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2008, Volume: 34, Issue:1

    Topics: Anticoagulants; Aprotinin; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Evi

2008
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2008, Volume: 34, Issue:1

    Topics: Anticoagulants; Aprotinin; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Evi

2008
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2008, Volume: 34, Issue:1

    Topics: Anticoagulants; Aprotinin; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Evi

2008
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2008, Volume: 34, Issue:1

    Topics: Anticoagulants; Aprotinin; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Evi

2008
Current antifibrinolytic therapy for coronary artery revascularization.
    AANA journal, 2008, Volume: 76, Issue:2

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Coro

2008
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
    Lancet (London, England), 1999, Dec-04, Volume: 354, Issue:9194

    Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiac

1999
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
    Lancet (London, England), 1999, Dec-04, Volume: 354, Issue:9194

    Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiac

1999
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
    Lancet (London, England), 1999, Dec-04, Volume: 354, Issue:9194

    Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiac

1999
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
    Lancet (London, England), 1999, Dec-04, Volume: 354, Issue:9194

    Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiac

1999
Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease.
    American journal of hematology, 2001, Volume: 66, Issue:4

    Topics: Anesthesia, Obstetrical; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Deamino Ar

2001
[Tranexamic acid reduces blood loss and the need of blood transfusion after knee arthroplasty].
    Ugeskrift for laeger, 2002, Jan-14, Volume: 164, Issue:3

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; H

2002

Trials

279 trials available for tranexamic acid and Blood Loss, Postoperative

ArticleYear
Multimodal Peri-articular Injection with Tranexamic Acid can reduce postoperative blood loss versus Intravenous Tranexamic Acid in Total Knee Arthroplasty: A Randomized Controlled Trial.
    Journal of orthopaedic surgery and research, 2021, Sep-03, Volume: 16, Issue:1

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S

2021
Use of a Multifunctional Cocktail for Postoperative Bleeding and Pain Control in Spinal Fusion: A Randomized, Double-blind, Controlled Trial.
    Spine, 2022, 09-15, Volume: 47, Issue:18

    Topics: Analgesics, Opioid; Blood Loss, Surgical; Double-Blind Method; Hemoglobins; Humans; Pain; Pain Manag

2022
Efficacy and Safety of Postoperative Intravenous Tranexamic Acid in Total Knee Arthroplasty: A Prospective Randomized Controlled Study.
    Orthopaedic surgery, 2021, Volume: 13, Issue:8

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth

2021
Synergistic Effect of a Prolonged Combination Course of Tranexamic Acid and Dexamethasone Involving High Initial Doses in Total Knee Arthroplasty: A Randomized Controlled Trial.
    The journal of knee surgery, 2023, Volume: 36, Issue:5

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S

2023
Adjunctive Topical Tranexamic Acid for Blood Salvage Does Not Reduce Postoperative Blood Loss Compared with Placebo in Patients Who Undergo Palliative Decompressive Spinal Metastasis Surgery: A Randomized Controlled Trial.
    Spine, 2022, Feb-01, Volume: 47, Issue:3

    Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorr

2022
Topical administration of tranexamic acid in elderly patients undergoing short femoral nailing for intertrochanteric fracture: A randomised controlled trial.
    Injury, 2022, Volume: 53, Issue:2

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Fracture Fixation, Int

2022
Pre-Emptive Antifibrinolysis: Its Role and Efficacy in Hip Fracture Patients Undergoing Total Hip Arthroplasty.
    The Journal of arthroplasty, 2022, Volume: 37, Issue:4

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hip Fractures;

2022
Invited Discussion on: Re-evaluating the Effect of Preoperative Tranexamic Acid on Blood Loss and Field Quality During Rhinoplasty: A Randomized double-blinded controlled Trial.
    Aesthetic plastic surgery, 2022, Volume: 46, Issue:3

    Topics: Blood Loss, Surgical; Double-Blind Method; Humans; Postoperative Hemorrhage; Rhinoplasty; Tranexamic

2022
Tranexamic acid combined with compression dressing reduces blood loss in gluteal muscle contracture surgery.
    BMC surgery, 2022, Feb-11, Volume: 22, Issue:1

    Topics: Antifibrinolytic Agents; Bandages; Blood Loss, Surgical; Contracture; Humans; Muscles; Postoperative

2022
Safety and efficacy of preoperative tranexamic acid in reducing intraoperative and postoperative blood loss in high-risk women undergoing cesarean delivery: a randomized controlled trial.
    BMC pregnancy and childbirth, 2022, Mar-14, Volume: 22, Issue:1

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Electiv

2022
Can the prophylactic administration of tranexamic acid reduce the blood loss after robotic-assisted radical prostatectomy? Robotic Assisted Radical Prostatectomy with tranEXamic acid (RARPEX): study protocol for a randomized controlled trial.
    Trials, 2022, Jun-18, Volume: 23, Issue:1

    Topics: Antifibrinolytic Agents; Double-Blind Method; Humans; Male; Pilot Projects; Postoperative Hemorrhage

2022
Use of Tranexamic Acid in Liposculpture: A Double-Blind, Multicenter, Randomized Clinical Trial.
    Plastic and reconstructive surgery, 2022, 09-01, Volume: 150, Issue:3

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; Female; Hemoglobins; Humans; Lys

2022
The effect of tranexamic acid injection during anterior cruciate ligament reconstruction surgery on postoperative bleeding, pain and swelling.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2023, Volume: 33, Issue:3

    Topics: Anterior Cruciate Ligament Injuries; Anterior Cruciate Ligament Reconstruction; Humans; Knee Joint;

2023
Tranexamic acid effects in postoperative bleeding outcomes in laparoscopic sleeve gastrectomy: a controlled study.
    Acta cirurgica brasileira, 2022, Volume: 37, Issue:7

    Topics: Adolescent; Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Blood Loss, Surgical; Gastrectomy;

2022
Clinical trial to determine whether the timing of tranexamic acid administration influences perioperative bleeding in total knee arthroplasty.
    Revista espanola de anestesiologia y reanimacion, 2022, Volume: 69, Issue:9

    Topics: Arthroplasty, Replacement, Knee; Double-Blind Method; Hemoglobins; Humans; Postoperative Hemorrhage;

2022
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2022, Dec-15, Volume: 36, Issue:12

    Topics: Aged; Antifibrinolytic Agents; Arthrodesis; Blood Loss, Surgical; Bone Screws; Fracture Fixation, In

2022
Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study.
    BMC musculoskeletal disorders, 2023, Jan-04, Volume: 24, Issue:1

    Topics: Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Dalt

2023
Efficacy of intravenous tranexamic acid administration in medial opening-wedge distal tibial tuberosity osteotomy (MOWDTO) for varus knee osteoarthritis: a randomized control trial.
    Journal of orthopaedic surgery and research, 2023, Mar-08, Volume: 18, Issue:1

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Osteoarthritis,

2023
The effect of intravenous unit-dose tranexamic acid on visible and hidden blood loss in posterior lumbar interbody fusion: a randomized clinical trial.
    Scientific reports, 2023, 03-22, Volume: 13, Issue:1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; C-Reactive Protein; Hemostatics; Humans; Postoperativ

2023
Medullary cavity application of tranexamic acid to reduce blood loss in tibial intramedullary nailing procedures-a randomized controlled trial.
    International orthopaedics, 2023, Volume: 47, Issue:8

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Exsanguination; Fracture Fixation, Intramedullary; Hu

2023
Comparative study of carbazochrome sodium sulfonate and tranexamic acid in reducing blood loss and inflammatory response following direct anterior total hip arthroplasty: a prospective randomized controlled trial.
    International orthopaedics, 2023, Volume: 47, Issue:10

    Topics: Anti-Inflammatory Agents; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgi

2023
[Effects of Tranexamic Acid on Perioperative Blood Loss and Wound Hematoma Development in Lumbar Spine Surgery: a Prospective Randomized Study].
    Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca, 2023, Volume: 90, Issue:3

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hematoma; Humans; Postoperative Hemorrhage; Prospecti

2023
Peroperative administration of tranexamic acid in sleeve gastrectomy to reduce hemorrhage: a double-blind randomized controlled trial.
    Surgical endoscopy, 2023, Volume: 37, Issue:10

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; Hum

2023
Risk of bleeding in anticoagulated patients undergoing dental extraction treated with topical tranexamic acid compared to collagen-gelatin sponge: Randomized clinical trial.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2023, Volume: 51, Issue:6

    Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Collagen; Gelatin; Humans; P

2023
Efficacy of perioperative cryotherapy combined with intra-articular injection of tranexamic acid in total knee arthroplasty.
    Medicine, 2023, Jul-21, Volume: 102, Issue:29

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Injections,

2023
Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial.
    BMC pregnancy and childbirth, 2023, Aug-25, Volume: 23, Issue:1

    Topics: Blood Loss, Surgical; Cesarean Section; Female; Humans; Misoprostol; Oxytocin; Postoperative Hemorrh

2023
Effect of Tranexamic Acid on Postoperative Bleeding in Sleeve Gastrectomy: a Randomized Trial.
    Obesity surgery, 2023, Volume: 33, Issue:12

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Obesity, Morbid; Postoperative Hemorrhage; Tr

2023
The efficacy of temperature intervention combined with tranexamic acid in reducing blood loss and accelerating recovery during spinal fusion.
    Medicine, 2023, Nov-24, Volume: 102, Issue:47

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemoglobins; Humans; Postoperative Hemorrhage; Pulmon

2023
Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial.
    Orthopaedic surgery, 2019, Volume: 11, Issue:4

    Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical;

2019
Hemostatic and Anti-Inflammatory Effects of Carbazochrome Sodium Sulfonate in Patients Undergoing Total Knee Arthroplasty: A Randomized Controlled Trial.
    The Journal of arthroplasty, 2020, Volume: 35, Issue:1

    Topics: Administration, Intravenous; Administration, Topical; Adrenochrome; Anti-Inflammatory Agents; Antifi

2020
Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
    The bone & joint journal, 2019, Volume: 101-B, Issue:9

    Topics: Administration, Intravenous; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Arthroplasty, Replace

2019
First Comparative Study of the Effectiveness of the Use of Tranexamic Acid against ε-Aminocapróic Acid via the Oral Route for the Reduction of Postoperative Bleeding in TKA: A Clinical Trial.
    The journal of knee surgery, 2021, Volume: 34, Issue:4

    Topics: Administration, Oral; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Arthroplasty, Replacement, K

2021
[Effect of tranexamic acid combined flexion position of hip and knee on perioperative bleeding following unilateral total knee arthroplasty].
    Zhongguo gu shang = China journal of orthopaedics and traumatology, 2019, Aug-25, Volume: 32, Issue:8

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi

2019
Monitoring of fibrinolytic system activity with plasminogen, D-dimers and FDP in primary total knee arthroplasty (TKA) after topical, intravenous or combined administration of tranexamic acid.
    Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2020, Volume: 164, Issue:2

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2020
Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial.
    BMC musculoskeletal disorders, 2019, Oct-25, Volume: 20, Issue:1

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L

2019
Tranexamic acid to reduce bleeding after dental extraction in patients treated with non-vitamin K oral anticoagulants: design and rationale of the EXTRACT-NOAC trial.
    The British journal of oral & maxillofacial surgery, 2019, Volume: 57, Issue:10

    Topics: Administration, Oral; Anticoagulants; Double-Blind Method; Humans; Postoperative Hemorrhage; Thrombo

2019
Prospective Study on the Efficacy of Orally Administered Tranexamic Acid and Goreisan for the Prevention of Recurrence After Chronic Subdural Hematoma Burr Hole Surgery.
    World neurosurgery, 2020, Volume: 134

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Drugs, Chinese Herbal; Female; Follow-Up Studie

2020
Tranexamic acid has no advantage in head and neck surgical procedures: a randomised, double-blind, controlled clinical trial.
    The Journal of laryngology and otology, 2019, Volume: 133, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; Female; Humans; Male; Mid

2019
Safety and efficacy of tranexamic acid in paediatric cardiac surgery: study protocol for a double-blind randomised controlled trial.
    BMJ open, 2019, 11-25, Volume: 9, Issue:11

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedures; Cardi

2019
Tranexamic acid in ENT.
    The Journal of laryngology and otology, 2019, Volume: 133, Issue:12

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Brain Injuries, Traumatic; Humans; Otolaryngology; Pl

2019
The antifibrinolytic and anti-inflammatory effects of a high initial-dose tranexamic acid in total knee arthroplasty: a randomized controlled trial.
    International orthopaedics, 2020, Volume: 44, Issue:3

    Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Antifibrinolytic Agents; Arthroplasty,

2020
Trial protocol: preoperative administration of tranexamic acid in sleeve gastrectomy (PATAS) to reduce haemorrhage rates. A randomised controlled trial.
    BMJ open, 2020, 02-05, Volume: 10, Issue:2

    Topics: Adult; Antifibrinolytic Agents; Double-Blind Method; Gastrectomy; Humans; Postoperative Hemorrhage;

2020
Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): Rationale, design, and study protocol of a multicenter randomized controlled trial.
    American heart journal, 2020, Volume: 222

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical;

2020
Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2021, Volume: 29, Issue:2

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2021
Effects of Intravenous Tranexamic Acid During Rhytidectomy: A Randomized, Controlled, Double-Blind Pilot Study.
    Aesthetic surgery journal, 2021, 01-25, Volume: 41, Issue:2

    Topics: Blood Loss, Surgical; Double-Blind Method; Humans; Pilot Projects; Postoperative Hemorrhage; Prospec

2021
Topical tranexamic acid in cemented primary total knee arthroplasty without tourniquet: a prospective randomized study.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2020, Volume: 30, Issue:6

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2020
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
    BJS open, 2020, Volume: 4, Issue:2

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal

2020
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
    BJS open, 2020, Volume: 4, Issue:2

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal

2020
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
    BJS open, 2020, Volume: 4, Issue:2

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal

2020
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
    BJS open, 2020, Volume: 4, Issue:2

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal

2020
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
    BJS open, 2020, Volume: 4, Issue:2

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal

2020
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
    BJS open, 2020, Volume: 4, Issue:2

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal

2020
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
    BJS open, 2020, Volume: 4, Issue:2

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal

2020
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
    BJS open, 2020, Volume: 4, Issue:2

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal

2020
Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.
    BJS open, 2020, Volume: 4, Issue:2

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Breast Neoplasms; Double-Blind Method; Femal

2020
Tranexamic acid for the Latarjet procedure: a randomized controlled trial.
    Journal of shoulder and elbow surgery, 2020, Volume: 29, Issue:5

    Topics: Administration, Intravenous; Adult; Analgesics, Opioid; Antifibrinolytic Agents; Blood Loss, Surgica

2020
Results after the application of tranexamic acid intravenous or intra-articular in the control of postsurgical bleeding after total hip arthroplasty: a randomized controlled trial.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2020, Volume: 30, Issue:7

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Su

2020
Effect of ulinastatin on post-operative blood loss and allogeneic transfusion in patients receiving cardiac surgery with cardiopulmonary bypass: a prospective randomized controlled study with 10-year follow-up.
    Journal of cardiothoracic surgery, 2020, May-14, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Antifibrinolytic Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypas

2020
Effect of topical tranexamic acid on post-traumatic elbow stiffness in patients treated with open arthrolysis: a prospective comparative study.
    Journal of shoulder and elbow surgery, 2020, Volume: 29, Issue:7

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Drainage; Elbow; Elbow Joint; Female; Humans;

2020
Topical Tranexamic Acid in Total Knee Arthroplasty: Does It Augment the Effect of the Intravenous Administration in Patients with Moderate-to-High Risk of Bleeding? A Randomized Clinical Trial.
    The journal of knee surgery, 2021, Volume: 34, Issue:14

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2021
Effectiveness of preemptive antifibrinolysis with tranexamic acid in rheumatoid arthritis patients undergoing total knee arthroplasty: a study protocol for a randomized controlled trial.
    BMC musculoskeletal disorders, 2020, Jul-15, Volume: 21, Issue:1

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthritis, Rheumatoid; Arthroplasty, Replaceme

2020
Tranexamic acid is beneficial for blood management of high tibial osteotomy: a randomized controlled study.
    Archives of orthopaedic and trauma surgery, 2021, Volume: 141, Issue:9

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Middle Aged; Osteotomy; Postoperative Hemorrh

2021
Better Treatment Values in Local Application of Tranexamic Acid (TXA) than Intravenous Application with the Same Dose in Total Hip Arthroplasty.
    Advances in therapy, 2020, Volume: 37, Issue:10

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Humans; Postoperative

2020
Tranexamic Acid for Blood Loss after Transforaminal Posterior Lumbar Interbody Fusion Surgery: A Double-Blind, Placebo-Controlled, Randomized Study.
    BioMed research international, 2020, Volume: 2020

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Double-Blind Method; Female; Humans; Len

2020
Intravenous tranexamic acid reduces blood loss and transfusion requirements after periacetabular osteotomy.
    The bone & joint journal, 2020, Volume: 102-B, Issue:9

    Topics: Acetabulum; Administration, Intravenous; Adolescent; Adult; Antifibrinolytic Agents; Blood Loss, Sur

2020
Optimal dose of topical tranexamic acid considering efficacy and safety in total knee arthroplasty: a randomized controlled study.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2021, Volume: 29, Issue:10

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2021
Tranexamic acid reduces blood cost in long-segment spinal fusion surgery: A randomized controlled study protocol.
    Medicine, 2020, 09-11, Volume: 99, Issue:37

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Double-Blind Method; Female; Human

2020
Is Preoperative Administration of Tranexamic Acid Effective on Blood Loss Reduction in Mandibular Fracture Surgeries? A Triple-Blind Randomized Clinical Trial.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2021, Volume: 79, Issue:2

    Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Chicago; Female;

2021
The effect of multiple-dose oral versus intravenous tranexamic acid in reducing postoperative blood loss and transfusion rate after adolescent scoliosis surgery: a randomized controlled trial.
    The spine journal : official journal of the North American Spine Society, 2021, Volume: 21, Issue:2

    Topics: Administration, Intravenous; Adolescent; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Post

2021
Reduction of Blood Loss by Intra-articular Injection of Tranexamic Acid Combined with Knee and Hip Flexion at 45° During Primary Total Knee Arthroplasty: A Randomized Controlled Trial.
    Orthopaedic surgery, 2020, Volume: 12, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Hematocri

2020
The influence of topical use of tranexamic acid in reducing blood loss on early operation for thoracolumbar burst fracture: a randomized double-blinded controlled study.
    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2021, Volume: 30, Issue:10

    Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorr

2021
Is serum gentamicin concentration modified with autologous cell-saved blood transfusion after total knee arthroplasty using tranexamic acid? A randomised control trial.
    Orthopaedics & traumatology, surgery & research : OTSR, 2021, Volume: 107, Issue:3

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; B

2021
Effects of Different Applications of Tranexamic Acid on Perioperative Blood Transfusion Rate and Postoperative Pain in Unilateral Total Knee Arthroplasty.
    Advances in therapy, 2021, Volume: 38, Issue:2

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; H

2021
Tranexamic acid versus aminocapróic acid in multiple doses via the oral route for the reduction of postoperative bleeding in total primary hip arthroplasty: a prospective, randomized, double-blind, controlled study.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2021, 03-01, Volume: 32, Issue:2

    Topics: Administration, Oral; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Arthroplasty, Replacement, H

2021
Comparison of Effects of a Thrombin-Based Hemostatic Agent and Topical Tranexamic Acid on Blood Loss in Patients with Preexisting Thromboembolic Risk Undergoing a Minimally Invasive Total Knee Arthroplasty. A Prospective Randomized Controlled Trial.
    BioMed research international, 2021, Volume: 2021

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement

2021
Effects of tourniquet use on clinical outcomes and cement penetration in TKA when tranexamic acid administrated: a randomized controlled trial.
    BMC musculoskeletal disorders, 2021, Jan-31, Volume: 22, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Bone Cements; Humans

2021
Tranexamic acid in joint replacement : a randomized trial comparing intravenous oral and topical routes.
    Acta orthopaedica Belgica, 2020, Volume: 86, Issue:3

    Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Aged; Aged, 80 and over;

2020
Are The Applications of Tranexamic Acid in Reverse Hybrid Total Knee Arthroplasty (TKA) The Same as Those in Fully Cemented TKA?: A Randomized Controlled Trial.
    Advances in therapy, 2021, Volume: 38, Issue:5

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; H

2021
Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial.
    PLoS medicine, 2021, Volume: 18, Issue:5

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Belgium; Dou

2021
Intravenous tranexamic acid reduce postoperative drainage and pain after open elbow arthrolysis: a randomized controlled trial.
    Journal of shoulder and elbow surgery, 2021, Volume: 30, Issue:8

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Drainage; Elbow; Humans;

2021
A randomized comparative evaluation of local infiltration analgesia, extended nerve blocks, and conventional analgesia in pain management after total knee arthroplasty.
    Joint diseases and related surgery, 2021, Volume: 32, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Analgesia; Anesthesia, Local; Anesthesia, Spinal; Anesthetics, Local

2021
Evaluation of efficacy and safety of systemic and topical intra-articular administration of tranexamic acid in primary unilateral total hip arthroplasty.
    Medicine, 2021, Jul-02, Volume: 100, Issue:26

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Tr

2021
Combined topical and intravenous administration of tranexamic acid further reduces postoperative blood loss in adolescent idiopathic scoliosis patients undergoing spinal fusion surgery: a randomized controlled trial.
    BMC musculoskeletal disorders, 2021, Aug-09, Volume: 22, Issue:1

    Topics: Administration, Intravenous; Administration, Topical; Adolescent; Antifibrinolytic Agents; Blood Los

2021
Topical tranexamic acid in hip fractures: a randomized, placebo-controlled double-blinded study.
    Canadian journal of surgery. Journal canadien de chirurgie, 2021, 08-10, Volume: 64, Issue:4

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou

2021
Determination of Perioperative Blood Loss: Accuracy or Approximation?
    Anesthesia and analgesia, 2017, Volume: 125, Issue:1

    Topics: Algorithms; Anthropometry; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surg

2017
Tranexamic Acid Reduces Occult Blood Loss, Blood Transfusion, and Improves Recovery of Knee Function after Total Knee Arthroplasty: A Comparative Study.
    The journal of knee surgery, 2018, Volume: 31, Issue:3

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; F

2018
The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial.
    International orthopaedics, 2017, Volume: 41, Issue:10

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomark

2017
Tranexamic Acid Safely Reduced Blood Loss in Hemi- and Total Hip Arthroplasty for Acute Femoral Neck Fracture: A Randomized Clinical Trial.
    Journal of orthopaedic trauma, 2017, Volume: 31, Issue:7

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgic

2017
Effectiveness and Safety of Batroxobin, Tranexamic Acid and a Combination in Reduction of Blood Loss in Lumbar Spinal Fusion Surgery.
    Spine, 2018, 03-01, Volume: 43, Issue:5

    Topics: Adult; Aged; Antifibrinolytic Agents; Batroxobin; Blood Loss, Surgical; Blood Transfusion; Double-Bl

2018
The effectiveness of low-dose and high-dose tranexamic acid in posterior lumbar interbody fusion: a double-blinded, placebo-controlled randomized study.
    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2017, Volume: 26, Issue:11

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Middle Aged; Postoperative Hemorrhage;

2017
Comparison of intravenous and intra-articular tranexamic acid in reducing blood loss in primary total knee replacement.
    Eklem hastaliklari ve cerrahisi = Joint diseases & related surgery, 2017, Volume: 28, Issue:2

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi

2017
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.
    Journal of orthopaedic surgery and research, 2017, Aug-15, Volume: 12, Issue:1

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Fracture Fixation, Internal; Hip Fractures

2017
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.
    Journal of orthopaedic surgery and research, 2017, Aug-15, Volume: 12, Issue:1

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Fracture Fixation, Internal; Hip Fractures

2017
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.
    Journal of orthopaedic surgery and research, 2017, Aug-15, Volume: 12, Issue:1

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Fracture Fixation, Internal; Hip Fractures

2017
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.
    Journal of orthopaedic surgery and research, 2017, Aug-15, Volume: 12, Issue:1

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Fracture Fixation, Internal; Hip Fractures

2017
Blood Conservation Using Tranexamic Acid Is Not Superior to Epsilon-Aminocaproic Acid After Total Knee Arthroplasty.
    The Journal of bone and joint surgery. American volume, 2017, Oct-04, Volume: 99, Issue:19

    Topics: Adult; Aged; Aged, 80 and over; Aminocaproic Acid; Antifibrinolytic Agents; Arthroplasty, Replacemen

2017
Effects of low-dose epinephrine on perioperative hemostasis and inflammatory reaction in major surgical operations: a randomized clinical trial.
    Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:1

    Topics: Adrenergic Agonists; Adult; Aged; Anti-Inflammatory Agents; Antifibrinolytic Agents; Arthroplasty, R

2018
[Comparison of different modes of using tranexamic acid administration on reducing hidden blood loss in total hip arthroplasty].
    Zhongguo gu shang = China journal of orthopaedics and traumatology, 2016, Aug-25, Volume: 29, Issue:8

    Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Repl

2016
Effect of knee flexion position and combined application of tranexamic acid on blood loss following primary total knee arthroplasty: a prospective randomized controlled trial.
    International orthopaedics, 2018, Volume: 42, Issue:3

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2018
The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA.
    Injury, 2018, Volume: 49, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Fracture Fixation, Intramedullary; Hip

2018
Low-Dose Epinephrine Plus Tranexamic Acid Reduces Early Postoperative Blood Loss and Inflammatory Response: A Randomized Controlled Trial.
    The Journal of bone and joint surgery. American volume, 2018, Feb-21, Volume: 100, Issue:4

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Drug Therapy, Com

2018
Comparison between Intravenous Boluses versus Infusion of Tranexamic Acid (TXA) to Reduce Bleeding in Paediatric Cyanotic Congenital Heart Disease (CHD) Surgeries.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:3

    Topics: Administration, Intravenous; Adolescent; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cardi

2018
Comparing the efficacy of intravenous or intra-articular tranexamic acid in reducing blood loss in simultaneous bilateral knee replacement surgery without the use of tourniquet.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2018, Volume: 28, Issue:7

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2018
Use of Tranexamic Acid to Reduce Blood Loss in Liposuction.
    Plastic and reconstructive surgery, 2018, Volume: 141, Issue:5

    Topics: Adult; Blood Loss, Surgical; Double-Blind Method; Female; Hematocrit; Humans; Injections, Intravenou

2018
The Effect of Tranexamic Acid on Preventing Post-partum Hemorrhage Due to Uterine Atony: A Triple-blind Randomized Clinical Trial.
    Current clinical pharmacology, 2018, Volume: 13, Issue:2

    Topics: Adult; Antifibrinolytic Agents; Double-Blind Method; Female; Humans; Injections, Intravenous; Postop

2018
Topical use of tranexamic acid in open heart surgery.
    JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:4

    Topics: Administration, Topical; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical Procedures; Do

2018
Blood-conserving efficacy of multiple doses of oral tranexamic acid associated with an enhanced-recovery programme in primary total knee arthroplasty: a randomized controlled trial.
    The bone & joint journal, 2018, Volume: 100-B, Issue:8

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Su

2018
Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a
    Trials, 2018, Jul-31, Volume: 19, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthropla

2018
Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration.
    Scientific reports, 2018, 09-11, Volume: 8, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthritis, Rheumat

2018
Similar thromboprophylaxis with rivaroxaban and low molecular weight heparin but fewer hemorrhagic complications with combined intra-articular and intravenous tranexamic acid in total knee arthroplasty.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2019, Volume: 29, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Blood Loss, Surgica

2019
Efficacy and safety of multiple boluses of oral versus intravenous tranexamic acid at reducing blood loss after primary total knee arthroplasty without a tourniquet: A prospective randomized clinical trial.
    Thrombosis research, 2018, Volume: 171

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl

2018
Using intra-articular tranexamic acid in total knee replacement surgery with and without bleeding control: a prospective randomized double blind study.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:18

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi

2018
Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: A randomized clinical trial.
    Thrombosis research, 2018, Volume: 171

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl

2018
Blood loss after intraarticular and intravenous tranexamic acid in total knee arthroplasty.
    JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Dose-Response Relationship, Drug; F

2018
Effects of tranexamic acid on short-term and long-term outcomes of on-pump coronary artery bypass grafting: Randomized trial and 7-year follow-up.
    Cardiovascular therapeutics, 2018, Volume: 36, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Cardiopulmonary Bypass; China; Coronary Artery Bypass; Coronary Arter

2018
The antifibrinolytic and anti-inflammatory effects of multiple doses of oral tranexamic acid in total knee arthroplasty patients: a randomized controlled trial.
    Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:12

    Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Antifibrinolytic Agents; Arthroplasty, Replace

2018
Subcutaneous tranexamic acid in upper eyelid blepharoplasty: a prospective randomized pilot study.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2018, Volume: 53, Issue:6

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Blepharoplasty; Blood Loss, Surgical; Chalazion; D

2018
Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study).
    Archives of orthopaedic and trauma surgery, 2019, Volume: 139, Issue:5

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement

2019
Single Intravenous Administration of Tranexamic Acid in Anterior Cruciate Ligament Reconstruction to Reduce Postoperative Hemarthrosis and Increase Functional Outcomes in the Early Phase of Postoperative Rehabilitation: A Randomized Controlled Trial.
    Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association, 2019, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Anterior Cruciate Ligament Injuries; Anterior Cruciate Ligament Reconstruction; A

2019
Subcutaneous Injection of Tranexamic Acid to Reduce Bleeding During Dermatologic Surgery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2019, Volume: 45, Issue:6

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dermatologic Surgical Proced

2019
Intra-Articular Tranexamic Acid Mitigates Blood Loss and Morphine Use After Total Knee Arthroplasty. A Randomized Controlled Trial.
    The Journal of arthroplasty, 2019, Volume: 34, Issue:5

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L

2019
Finding the Optimal Regimen for Oral Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial.
    The Journal of bone and joint surgery. American volume, 2019, Mar-06, Volume: 101, Issue:5

    Topics: Administration, Oral; Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement

2019
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) study: Results of a pilot study.
    Journal of cardiac surgery, 2019, Volume: 34, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Aortic Valve; Blood Loss, Surgical; Cardiac

2019
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) study: Results of a pilot study.
    Journal of cardiac surgery, 2019, Volume: 34, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Aortic Valve; Blood Loss, Surgical; Cardiac

2019
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) study: Results of a pilot study.
    Journal of cardiac surgery, 2019, Volume: 34, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Aortic Valve; Blood Loss, Surgical; Cardiac

2019
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) study: Results of a pilot study.
    Journal of cardiac surgery, 2019, Volume: 34, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Aortic Valve; Blood Loss, Surgical; Cardiac

2019
Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2019, Volume: 25, Issue:2

    Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical;

2019
Reduced perioperative blood loss in children undergoing craniosynostosis surgery using prolonged tranexamic acid infusion: a randomised trial.
    British journal of anaesthesia, 2019, Volume: 122, Issue:6

    Topics: Anesthesia, General; Antifibrinolytic Agents; Blood Loss, Surgical; Child, Preschool; Craniosynostos

2019
Effect of single-dose intravenous tranexamic acid on postoperative nasal bleed in septoplasty.
    European annals of otorhinolaryngology, head and neck diseases, 2019, Volume: 136, Issue:6

    Topics: Adolescent; Adult; Double-Blind Method; Epistaxis; Humans; Infusions, Intravenous; Middle Aged; Nasa

2019
2019 Mark Coventry Award: A multicentre randomized clinical trial of tranexamic acid in revision total knee arthroplasty: does the dosing regimen matter?.
    The bone & joint journal, 2019, Volume: 101-B, Issue:7_Supple_C

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Drug Administration

2019
Intra-Articular Injection of Tranexamic Acid on Perioperative Blood Loss During Unicompartmental Knee Arthroplasty.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, Jul-09, Volume: 25

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2019
High-dose (3 g) topical tranexamic acid has higher potency in reducing blood loss after total knee arthroplasty compared with low dose (500 mg): a double-blind randomized controlled trial.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2019, Volume: 29, Issue:8

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Trans

2019
Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2013, Volume: 26, Issue:17

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Elective Surgical Procedures

2013
Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2014, Volume: 22, Issue:8

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Clinical Protocol

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2014
[Influence of different tranexamic acid administration methods during and after cardiac surgery on coagulation function and postoperative blood loss].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2013, Volume: 35, Issue:2

    Topics: Adolescent; Adult; Aged; Antifibrinolytic Agents; Blood Coagulation; Cardiac Surgical Procedures; Ca

2013
Topical application of tranexamic acid after adenoidectomy: a double-blind, prospective, randomized, controlled study.
    International journal of pediatric otorhinolaryngology, 2013, Volume: 77, Issue:7

    Topics: Adenoidectomy; Adolescent; Antifibrinolytic Agents; Child; Child, Preschool; Double-Blind Method; Fe

2013
Tranexamic acid reduces postoperative blood loss of degenerative lumbar instability with stenosis in posterior approach lumbar surgery: a randomized controlled trial.
    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2013, Volume: 22, Issue:9

    Topics: Aged; Antifibrinolytic Agents; Blood Coagulation Tests; Decompression, Surgical; Female; Humans; Int

2013
Tranexamic acid in decreasing blood loss during and after caesarean section.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:7

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female;

2013
Tranexamic acid in decreasing blood loss during and after caesarean section.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:7

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female;

2013
Tranexamic acid in decreasing blood loss during and after caesarean section.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:7

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female;

2013
Tranexamic acid in decreasing blood loss during and after caesarean section.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:7

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female;

2013
Tranexamic acid in decreasing blood loss during and after caesarean section.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:7

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female;

2013
Tranexamic acid in decreasing blood loss during and after caesarean section.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:7

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female;

2013
Tranexamic acid in decreasing blood loss during and after caesarean section.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:7

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female;

2013
Tranexamic acid in decreasing blood loss during and after caesarean section.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:7

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female;

2013
Tranexamic acid in decreasing blood loss during and after caesarean section.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:7

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female;

2013
[Diagnosis and correction of hemostasis disorder during surgeries for bile duct diseases].
    Klinichna khirurhiia, 2013, Issue:4

    Topics: Antifibrinolytic Agents; Choledocholithiasis; Drug Administration Schedule; Hemostasis; Humans; Post

2013
Effect of tranexamic acid on reducing postoperative blood loss in combined hypotensive epidural anesthesia and general anesthesia for total hip replacement.
    Journal of clinical anesthesia, 2013, Volume: 25, Issue:5

    Topics: Adult; Anesthesia, Epidural; Anesthesia, General; Antifibrinolytic Agents; Arthroplasty, Replacement

2013
Post-operative blood loss in total knee arthroplasty: knee flexion versus pharmacological techniques.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2014, Volume: 22, Issue:11

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Humans; K

2014
[Effectiveness and safety of tranexamic acid in patients receiving on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2013, Jun-01, Volume: 51, Issue:6

    Topics: Aged; Aged, 80 and over; Aspirin; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Female; Hu

2013
Topical administration of tranexamic acid in primary total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2014
Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial.
    The Journal of bone and joint surgery. American volume, 2013, Nov-20, Volume: 95, Issue:22

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Fibrin Tissue Adhesive; Hemo

2013
[Tranexamic acid gel in patients treated with oral anticoagulants].
    Medicina clinica, 2014, Dec-09, Volume: 143, Issue:11

    Topics: Acenocoumarol; Anticoagulants; Antifibrinolytic Agents; Gels; Humans; Postoperative Hemorrhage; Toot

2014
Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial.
    BMC musculoskeletal disorders, 2013, Dec-05, Volume: 14

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Constriction; Dra

2013
Comparison of two tranexamic acid dose regimens in patients undergoing cardiac valve surgery.
    Journal of cardiothoracic and vascular anesthesia, 2014, Volume: 28, Issue:5

    Topics: Adult; Antifibrinolytic Agents; Cardiopulmonary Bypass; Double-Blind Method; Female; Follow-Up Studi

2014
Low dose tranexamic acid effect on post-coronary artery bypass grafting bleeding.
    Asian cardiovascular & thoracic annals, 2013, Volume: 21, Issue:6

    Topics: Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiopulmonary Bypass; Chest Tubes; Corona

2013
Knee flexion after total knee arthroplasty reduces blood loss.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2014, Volume: 22, Issue:8

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Humans; K

2014
Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement

2014
Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement

2014
Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement

2014
Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement

2014
Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:12

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transf

2014
Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:12

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transf

2014
Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:12

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transf

2014
Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:12

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transf

2014
Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:8

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2014
The reduction in blood loss with intra-articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized controlled trial.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2015, Volume: 25, Issue:1

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Coagulation

2015
[Topical application of tranexamic acid to prevent post-tonsillectomy haemorrhage].
    Laryngo- rhino- otologie, 2015, Volume: 94, Issue:2

    Topics: Administration, Topical; Adolescent; Adult; Age Factors; Child; Child, Preschool; Female; Hemostasis

2015
Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:12

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2014
[Effect of priming solution and ultrafiltration on post-operative bleeding and blood transfusion in cardiac surgery. Randomized controlled trial].
    Revista espanola de anestesiologia y reanimacion, 2015, Volume: 62, Issue:2

    Topics: Aged; Aged, 80 and over; Albumins; Blood Coagulation Tests; Blood Loss, Surgical; Blood Transfusion;

2015
Postoperative hemostatic efficacy of gauze soaked in tranexamic acid, fibrin sponge, and dry gauze compression following dental extractions in anticoagulated patients with cardiovascular disease: a prospective, randomized study.
    Oral and maxillofacial surgery, 2015, Volume: 19, Issue:2

    Topics: Administration, Topical; Adult; Aged; Anticoagulants; Brazil; Cardiovascular Diseases; Female; Fibri

2015
Evaluation of the Efficacy of Tranexamic Acid on the Surgical Field in Primary Cleft Palate Surgery on Children-A Prospective, Randomized Clinical Study.
    The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, 2015, Volume: 52, Issue:5

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Child, Preschool; Cleft Palate; Double-Blind Method;

2015
The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty.
    The Journal of arthroplasty, 2015, Volume: 30, Issue:5

    Topics: Administration, Intravenous; Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agen

2015
Bleeding reduction after topical application of tranexamic acid together with Betadine solution in total knee arthroplasty. A randomised controlled study.
    Orthopaedics & traumatology, surgery & research : OTSR, 2015, Volume: 101, Issue:1

    Topics: Administration, Topical; Aged; Anti-Infective Agents, Local; Antifibrinolytic Agents; Arthroplasty,

2015
Topical application of tranexamic acid reduces postoperative bleeding in open-heart surgery: myth or fact?
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2015, Volume: 25, Issue:3

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgica

2015
Topical Administration of Tranexamic Acid Plus Diluted-Epinephrine in Primary Total Knee Arthroplasty: A Randomized Double-Blinded Controlled Trial.
    The Journal of arthroplasty, 2015, Volume: 30, Issue:8

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blin

2015
Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial.
    Archives of orthopaedic and trauma surgery, 2015, Volume: 135, Issue:7

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replaceme

2015
Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial.
    Archives of orthopaedic and trauma surgery, 2015, Volume: 135, Issue:7

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replaceme

2015
Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial.
    Archives of orthopaedic and trauma surgery, 2015, Volume: 135, Issue:7

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replaceme

2015
Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial.
    Archives of orthopaedic and trauma surgery, 2015, Volume: 135, Issue:7

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replaceme

2015
Safety and efficacy of intra-articular tranexamic acid injection without drainage on blood loss in total knee arthroplasty: A randomized clinical trial.
    International journal of surgery (London, England), 2015, Volume: 20

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2015
Topical Application of Tranexamic Acid Plus Diluted Epinephrine Reduces Postoperative Hidden Blood Loss in Total Hip Arthroplasty.
    The Journal of arthroplasty, 2015, Volume: 30, Issue:12

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transf

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.
    The British journal of surgery, 2015, Volume: 102, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifibrinolytic Agents; Double-Blind Method; Fema

2015
[A PROSPECTIVE RANDOMIZED SELF-CONTROLLED STUDY ON EFFECT OF TRANEXAMIC ACID IN REDUCING BLOOD LOSS IN TOTAL KNEE ARTHROPLASTY].
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2015, Volume: 29, Issue:3

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; H

2015
Combined Administration of Systemic and Topical Tranexamic Acid for Total Knee Arthroplasty: Can It Be a Better Regimen and Yet Safe? A Randomized Controlled Trial.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:2

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2016
Intraoperative Use of Epsilon Amino Caproic Acid and Tranexamic Acid in Surgeries Performed Under Cardiopulmonary Bypass: a Comparative Study To Assess Their Impact On Reopening Due To Postoperative Bleeding.
    Ethiopian journal of health sciences, 2015, Volume: 25, Issue:3

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Cardiopulmonary Bypass; Female; Humans; Male; Mid

2015
The Efficacy of Preoperative Oral Tranexamic Acid on Intraoperative Bleeding During Rhinoplasty.
    The Journal of craniofacial surgery, 2016, Volume: 27, Issue:1

    Topics: Adolescent; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Double-Blind Me

2016
Staple Line Bleeding in Sleeve Gastrectomy-a Simple and Cost-Effective Solution.
    Obesity surgery, 2016, Volume: 26, Issue:7

    Topics: Adult; Antifibrinolytic Agents; Female; Gastrectomy; Humans; Laparoscopy; Male; Obesity, Morbid; Pos

2016
Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:5

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2016
Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:5

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2016
Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:5

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2016
Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:5

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2016
[The Effect of Tranexamic Acid on Blood Loss after Primary Unilateral Total Knee Arthroplasty. Prospective Single-Centre Study].
    Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca, 2015, Volume: 82, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2015
The effect of local and systemic application of tranexamic acid on the amount of blood loss and allogeneic blood transfusion after total knee replacement.
    Acta orthopaedica Belgica, 2015, Volume: 81, Issue:4

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Dose-Response Rel

2015
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
    American journal of obstetrics and gynecology, 2016, Volume: 215, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method;

2016
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
    American journal of obstetrics and gynecology, 2016, Volume: 215, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method;

2016
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
    American journal of obstetrics and gynecology, 2016, Volume: 215, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method;

2016
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
    American journal of obstetrics and gynecology, 2016, Volume: 215, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method;

2016
Topical vs Intravenous Tranexamic Acid in Reducing Blood Loss After Bilateral Total Knee Arthroplasty: A Prospective Study.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:7

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2016
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
    Journal of orthopaedic trauma, 2016, Volume: 30, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou

2016
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
    Journal of orthopaedic trauma, 2016, Volume: 30, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou

2016
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
    Journal of orthopaedic trauma, 2016, Volume: 30, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou

2016
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
    Journal of orthopaedic trauma, 2016, Volume: 30, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou

2016
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
    Journal of orthopaedic trauma, 2016, Volume: 30, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou

2016
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
    Journal of orthopaedic trauma, 2016, Volume: 30, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou

2016
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
    Journal of orthopaedic trauma, 2016, Volume: 30, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou

2016
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
    Journal of orthopaedic trauma, 2016, Volume: 30, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou

2016
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
    Journal of orthopaedic trauma, 2016, Volume: 30, Issue:8

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou

2016
Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: A double-blind, randomized controlled trial of different doses.
    Thrombosis research, 2016, Volume: 141

    Topics: Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Blood

2016
The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost?
    The Journal of arthroplasty, 2016, Volume: 31, Issue:9 Suppl

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl

2016
The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost?
    The Journal of arthroplasty, 2016, Volume: 31, Issue:9 Suppl

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl

2016
The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost?
    The Journal of arthroplasty, 2016, Volume: 31, Issue:9 Suppl

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl

2016
The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost?
    The Journal of arthroplasty, 2016, Volume: 31, Issue:9 Suppl

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl

2016
Effect of Topical and Intravenously Applied Tranexamic Acid Compared to Control Group on Bleeding in Primary Unilateral Total Knee Arthroplasty.
    The journal of knee surgery, 2017, Volume: 30, Issue:2

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2017
What is the optimal approach for tranexamic acid application in patients with unilateral total hip arthroplasty?
    Der Orthopade, 2016, Volume: 45, Issue:7

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Dose-Response

2016
Effectiveness and Safety of Fixed-Dose Tranexamic Acid in Simultaneous Bilateral Total Knee Arthroplasty: A Randomized Double-Blind Controlled Trial.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:11

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2016
Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
    The Journal of bone and joint surgery. American volume, 2016, May-18, Volume: 98, Issue:10

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2016
Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
    The Journal of bone and joint surgery. American volume, 2016, May-18, Volume: 98, Issue:10

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2016
Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
    The Journal of bone and joint surgery. American volume, 2016, May-18, Volume: 98, Issue:10

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2016
Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
    The Journal of bone and joint surgery. American volume, 2016, May-18, Volume: 98, Issue:10

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2016
The Assessment of Blood Loss During Total Knee Arthroplasty When Comparing Intravenous vs Intracapsular Administration of Tranexamic Acid.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:11

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L

2016
Multiple Boluses of Intravenous Tranexamic Acid to Reduce Hidden Blood Loss After Primary Total Knee Arthroplasty Without Tourniquet: A Randomized Clinical Trial.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:11

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomark

2016
Intravenous vs Topical Tranexamic Acid in Total Knee Arthroplasty Without Tourniquet Application: A Randomized Controlled Study.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:11

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2016
Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration.
    The Journal of bone and joint surgery. American volume, 2016, Jun-15, Volume: 98, Issue:12

    Topics: Administration, Intravenous; Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Arthropl

2016
Using tranexamic acid soaked absorbable gelatin sponge following complex posterior lumbar spine surgery: A randomized control trial.
    Clinical neurology and neurosurgery, 2016, Volume: 147

    Topics: Adult; Aged; Antifibrinolytic Agents; Female; Gelatin Sponge, Absorbable; Humans; Lumbar Vertebrae;

2016
Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: A prospective clinical study.
    Acta orthopaedica et traumatologica turcica, 2016, Volume: 50, Issue:4

    Topics: Administration, Intravenous; Aged; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Tran

2016
Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial.
    BMC musculoskeletal disorders, 2016, 07-26, Volume: 17

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood T

2016
Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial.
    BMC musculoskeletal disorders, 2016, 07-26, Volume: 17

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood T

2016
Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial.
    BMC musculoskeletal disorders, 2016, 07-26, Volume: 17

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood T

2016
Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial.
    BMC musculoskeletal disorders, 2016, 07-26, Volume: 17

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood T

2016
Topical tranexamic acid versus autotransfusion after total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2016, Volume: 24, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion, Autologous; Cost-

2016
Combined Administration of IV and Topical Tranexamic Acid is Not Superior to Either Individually in Primary Navigated TKA.
    The Journal of arthroplasty, 2017, Volume: 32, Issue:1

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2017
The Efficacy of Combined Use of Rivaroxaban and Tranexamic Acid on Blood Conservation in Minimally Invasive Total Knee Arthroplasty a Double-Blind Randomized, Controlled Trial.
    The Journal of arthroplasty, 2017, Volume: 32, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2017
Efficacy of a Single Dose and an Additional Dose of Tranexamic Acid in Reduction of Blood Loss in Total Knee Arthroplasty.
    The Journal of arthroplasty, 2017, Volume: 32, Issue:7

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L

2017
Optimizing effectivity of tranexamic acid in bilateral knee arthroplasty - A prospective randomized controlled study.
    The Knee, 2017, Volume: 24, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2017
Additional effects of topical tranexamic acid in on-pump cardiac surgery.
    Asian cardiovascular & thoracic annals, 2017, Volume: 25, Issue:1

    Topics: Administration, Intravenous; Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Tr

2017
Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures.
    Journal of orthopaedic surgery (Hong Kong), 2016, Volume: 24, Issue:3

    Topics: Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Bone Plates; Bone Scr

2016
Additional intraarticular tranexamic acid further reduced postoperative blood loss compared to intravenous and topical bathed tranexamic acid in total hip arthroplasty: a retrospective sequential series study.
    Transfusion, 2017, Volume: 57, Issue:4

    Topics: Administration, Intravenous; Administration, Topical; Aged; Arthroplasty, Replacement, Hip; Female;

2017
Topical and low-dose intravenous tranexamic acid in cyanotic cardiac surgery.
    Asian cardiovascular & thoracic annals, 2017, Volume: 25, Issue:2

    Topics: Administration, Intravenous; Administration, Topical; Adolescent; Antifibrinolytic Agents; Blood Coa

2017
Tranexamic acid reduces perioperative blood loss of posterior lumbar surgery for stenosis or spondylolisthesis: A randomized trial.
    Medicine, 2017, Volume: 96, Issue:1

    Topics: Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Decompression, Surgical; Double-Blind Me

2017
Effects of five treatment regimens on blood loss and blood transfusion in total knee arthroplasty: a preliminary study in China
.
    International journal of clinical pharmacology and therapeutics, 2017, Volume: 55, Issue:5

    Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Blood Lo

2017
Intravenous tranexamic acid reduces total blood loss in reverse total shoulder arthroplasty: a prospective, double-blinded, randomized, controlled trial.
    Journal of shoulder and elbow surgery, 2017, Volume: 26, Issue:8

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Shoulder; Blood Loss, Surgical; Blood Tran

2017
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2017, Volume: 25, Issue:1

    Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem

2017
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2017, Volume: 25, Issue:1

    Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem

2017
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2017, Volume: 25, Issue:1

    Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem

2017
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2017, Volume: 25, Issue:1

    Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem

2017
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2017, Volume: 25, Issue:1

    Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem

2017
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2017, Volume: 25, Issue:1

    Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem

2017
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2017, Volume: 25, Issue:1

    Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem

2017
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2017, Volume: 25, Issue:1

    Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem

2017
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2017, Volume: 25, Issue:1

    Topics: Administration, Oral; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem

2017
A randomized control trial to evaluate the effectiveness of intravenous, intra-articular and topical wash regimes of tranexamic acid in primary total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2017, Volume: 25, Issue:1

    Topics: Accidental Falls; Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacem

2017
Oral and Intravenous Tranexamic Acid Are Equivalent at Reducing Blood Loss Following Total Hip Arthroplasty: A Randomized Controlled Trial.
    The Journal of bone and joint surgery. American volume, 2017, Mar-01, Volume: 99, Issue:5

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl

2017
Oral and Intravenous Tranexamic Acid Are Equivalent at Reducing Blood Loss Following Total Hip Arthroplasty: A Randomized Controlled Trial.
    The Journal of bone and joint surgery. American volume, 2017, Mar-01, Volume: 99, Issue:5

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl

2017
Oral and Intravenous Tranexamic Acid Are Equivalent at Reducing Blood Loss Following Total Hip Arthroplasty: A Randomized Controlled Trial.
    The Journal of bone and joint surgery. American volume, 2017, Mar-01, Volume: 99, Issue:5

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl

2017
Oral and Intravenous Tranexamic Acid Are Equivalent at Reducing Blood Loss Following Total Hip Arthroplasty: A Randomized Controlled Trial.
    The Journal of bone and joint surgery. American volume, 2017, Mar-01, Volume: 99, Issue:5

    Topics: Administration, Intravenous; Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Repl

2017
What is the Ideal Route of Administration of Tranexamic Acid in TKA? A Randomized Controlled Trial.
    Clinical orthopaedics and related research, 2017, Volume: 475, Issue:8

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood T

2017
The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
    Anesthesia and analgesia, 2008, Volume: 107, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Aprotinin; Blood Coagulation; Blood Transfusion; Cardiopulmonary Bypa

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Spine, 2008, Nov-15, Volume: 33, Issue:24

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Tra

2008
The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2009, Volume: 35, Issue:1

    Topics: Antifibrinolytic Agents; Aprotinin; Blood Component Transfusion; Blood Loss, Surgical; Drug Administ

2009
Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery.
    Journal of cardiothoracic and vascular anesthesia, 2009, Volume: 23, Issue:3

    Topics: Adult; Aged; Blood Volume; Coronary Artery Bypass, Off-Pump; Double-Blind Method; Female; Humans; Ma

2009
Efficacy of tranexamic acid in reducing blood loss after cesarean section.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2009, Volume: 22, Issue:1

    Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Monitoring, Physiologic; Placebos;

2009
Efficacy of tranexamic acid in reducing blood loss after cesarean section.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2009, Volume: 22, Issue:1

    Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Monitoring, Physiologic; Placebos;

2009
Efficacy of tranexamic acid in reducing blood loss after cesarean section.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2009, Volume: 22, Issue:1

    Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Monitoring, Physiologic; Placebos;

2009
Efficacy of tranexamic acid in reducing blood loss after cesarean section.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2009, Volume: 22, Issue:1

    Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Monitoring, Physiologic; Placebos;

2009
Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2009, Volume: 36, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Double-Bli

2009
PAI-1 gene: pharmacogenetic association of 4G/4G genotype with bleeding after cardiac surgery--pilot study.
    European journal of anaesthesiology, 2009, Volume: 26, Issue:5

    Topics: Aged; Antifibrinolytic Agents; Aprotinin; Cardiac Surgical Procedures; Case-Control Studies; Female;

2009
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
    Journal of cardiothoracic surgery, 2009, Jun-18, Volume: 4

    Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal

2009
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
    Journal of cardiothoracic surgery, 2009, Jun-18, Volume: 4

    Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal

2009
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
    Journal of cardiothoracic surgery, 2009, Jun-18, Volume: 4

    Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal

2009
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
    Journal of cardiothoracic surgery, 2009, Jun-18, Volume: 4

    Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal

2009
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
    Journal of cardiothoracic surgery, 2009, Jun-18, Volume: 4

    Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal

2009
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
    Journal of cardiothoracic surgery, 2009, Jun-18, Volume: 4

    Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal

2009
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
    Journal of cardiothoracic surgery, 2009, Jun-18, Volume: 4

    Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal

2009
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
    Journal of cardiothoracic surgery, 2009, Jun-18, Volume: 4

    Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal

2009
Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.
    Journal of cardiothoracic surgery, 2009, Jun-18, Volume: 4

    Topics: Administration, Topical; Antifibrinolytic Agents; Coronary Artery Bypass; Double-Blind Method; Femal

2009
Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
    Clinical hemorheology and microcirculation, 2009, Volume: 42, Issue:4

    Topics: Aged; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Elective Su

2009
The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia.
    Orthopedics, 2010, Volume: 33, Issue:1

    Topics: Anesthesia, Epidural; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Double-Blind Method;

2010
Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study.
    The Journal of arthroplasty, 2011, Volume: 26, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion, Autologous; Dose-

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    American journal of perinatology, 2011, Volume: 28, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Apgar Score; Birth Weight; Blood Loss, Surgical; Blood Transfusion;

2011
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Bone Cement

2010
[Tranexamic acid reduces haematomas but not pain after total knee arthroplasty].
    Annales francaises d'anesthesie et de reanimation, 2011, Volume: 30, Issue:1

    Topics: Aged; Anesthesia, General; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Hematom

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Local and systemic application of tranexamic acid in heart valve surgery: a prospective, randomized, double blind LOST study.
    Journal of thrombosis and thrombolysis, 2011, Volume: 32, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Component Transfusion; Cardiac Surgical Procedures; Double-Blin

2011
A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
    The Journal of thoracic and cardiovascular surgery, 2012, Volume: 143, Issue:5

    Topics: Aged; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Double-Blind Method

2012
Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Anesthesia and analgesia, 2012, Volume: 115, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Chest Tubes; Chi-Square Distribution; China; Coronary Artery Bypass,

2012
Tranexamic acid reduces blood transfusions in elderly patients undergoing combined aortic valve and coronary artery bypass graft surgery: a randomized controlled trial.
    Journal of cardiothoracic and vascular anesthesia, 2012, Volume: 26, Issue:2

    Topics: Age Factors; Aged; Aged, 80 and over; Antifibrinolytic Agents; Aortic Valve; Blood Transfusion; Coro

2012
Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.
    Journal of anesthesia, 2011, Volume: 25, Issue:6

    Topics: Adolescent; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child,

2011
Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.
    Journal of anesthesia, 2011, Volume: 25, Issue:6

    Topics: Adolescent; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child,

2011
Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.
    Journal of anesthesia, 2011, Volume: 25, Issue:6

    Topics: Adolescent; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child,

2011
Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.
    Journal of anesthesia, 2011, Volume: 25, Issue:6

    Topics: Adolescent; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Child,

2011
Postoperative bleeding after dental extraction in liver pretransplant patients.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2012, Volume: 70, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Cross-Sectional Studies; Dental Care for Chronically Ill; Female; He

2012
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2012, Volume: 20, Issue:12

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth

2012
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2012, Volume: 20, Issue:12

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth

2012
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2012, Volume: 20, Issue:12

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth

2012
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2012, Volume: 20, Issue:12

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth

2012
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2012, Volume: 20, Issue:12

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth

2012
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2012, Volume: 20, Issue:12

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth

2012
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2012, Volume: 20, Issue:12

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth

2012
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2012, Volume: 20, Issue:12

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth

2012
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2012, Volume: 20, Issue:12

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Double-Blind Meth

2012
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
    Clinical orthopaedics and related research, 2012, Volume: 470, Issue:9

    Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2012
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
    Clinical orthopaedics and related research, 2012, Volume: 470, Issue:9

    Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2012
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
    Clinical orthopaedics and related research, 2012, Volume: 470, Issue:9

    Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2012
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
    Clinical orthopaedics and related research, 2012, Volume: 470, Issue:9

    Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2012
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
    Clinical orthopaedics and related research, 2012, Volume: 470, Issue:9

    Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2012
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
    Clinical orthopaedics and related research, 2012, Volume: 470, Issue:9

    Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2012
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
    Clinical orthopaedics and related research, 2012, Volume: 470, Issue:9

    Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2012
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
    Clinical orthopaedics and related research, 2012, Volume: 470, Issue:9

    Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2012
Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
    Clinical orthopaedics and related research, 2012, Volume: 470, Issue:9

    Topics: Aged; Analysis of Variance; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2012
Comparative evaluation of the effects of tranexamic acid and low-dose aprotinin on post-valvular heart surgery bleeding and allogenic transfusion.
    Interactive cardiovascular and thoracic surgery, 2012, Volume: 15, Issue:1

    Topics: Adult; Analysis of Variance; Aprotinin; Blood Transfusion; Chest Tubes; Double-Blind Method; Drainag

2012
Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients.
    Orthopaedics & traumatology, surgery & research : OTSR, 2012, Volume: 98, Issue:5

    Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Bone Cements; Case-Co

2012
The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective?
    The Journal of bone and joint surgery. British volume, 2012, Volume: 94, Issue:7

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion

2012
The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective?
    The Journal of bone and joint surgery. British volume, 2012, Volume: 94, Issue:7

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion

2012
The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective?
    The Journal of bone and joint surgery. British volume, 2012, Volume: 94, Issue:7

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion

2012
The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective?
    The Journal of bone and joint surgery. British volume, 2012, Volume: 94, Issue:7

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion

2012
Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation.
    Heart, lung & circulation, 2012, Volume: 21, Issue:11

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Dou

2012
Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2013, Volume: 21, Issue:11

    Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical

2013
Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial.
    Archives of gynecology and obstetrics, 2013, Volume: 287, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Double-Blind Method; Female; Humans; Postoperative

2013
Local delivery of the hemostatic agent tranexamic acid in chronically anticoagulated patients.
    The Journal of craniofacial surgery, 2012, Volume: 23, Issue:6

    Topics: Administration, Oral; Adult; Aged; Anticoagulants; Female; Hemostatics; Humans; Male; Middle Aged; O

2012
No effect of fibrin sealant on drain output or functional recovery following simultaneous bilateral total knee arthroplasty: a randomized, double-blind, placebo-controlled study.
    Acta orthopaedica, 2013, Volume: 84, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Bli

2013
Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.
    Clinical pharmacokinetics, 2013, Volume: 52, Issue:4

    Topics: Antifibrinolytic Agents; Child, Preschool; Craniosynostoses; Dose-Response Relationship, Drug; Doubl

2013
Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.
    Clinical pharmacokinetics, 2013, Volume: 52, Issue:4

    Topics: Antifibrinolytic Agents; Child, Preschool; Craniosynostoses; Dose-Response Relationship, Drug; Doubl

2013
Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.
    Clinical pharmacokinetics, 2013, Volume: 52, Issue:4

    Topics: Antifibrinolytic Agents; Child, Preschool; Craniosynostoses; Dose-Response Relationship, Drug; Doubl

2013
Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.
    Clinical pharmacokinetics, 2013, Volume: 52, Issue:4

    Topics: Antifibrinolytic Agents; Child, Preschool; Craniosynostoses; Dose-Response Relationship, Drug; Doubl

2013
Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery.
    Anesthesia and analgesia, 2003, Volume: 96, Issue:4

    Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Coagulation Tests; Blood Transfusion;

2003
Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery.
    Anesthesia and analgesia, 2003, Volume: 96, Issue:4

    Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Coagulation Tests; Blood Transfusion;

2003
Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery.
    Anesthesia and analgesia, 2003, Volume: 96, Issue:4

    Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Coagulation Tests; Blood Transfusion;

2003
Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery.
    Anesthesia and analgesia, 2003, Volume: 96, Issue:4

    Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Coagulation Tests; Blood Transfusion;

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement.
    British journal of anaesthesia, 2003, Volume: 90, Issue:5

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blind Meth

2003
[Dental extraction in patients with bleeding disorders. Proposal of a protocol based on the type of anesthesia used].
    Revue de stomatologie et de chirurgie maxillo-faciale, 2003, Volume: 104, Issue:2

    Topics: Adolescent; Adult; Aged; Anesthesia, Dental; Anesthesia, General; Anesthesia, Local; Anticoagulants;

2003
[Prevention of postoperative bleeding in patients taking oral anticoagulants. Effects of tranexamic acid].
    Revue de stomatologie et de chirurgie maxillo-faciale, 2003, Volume: 104, Issue:2

    Topics: Acenocoumarol; Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolyti

2003
[Usefulness of tranexamic acid in cranial remodeling surgery].
    Revista espanola de anestesiologia y reanimacion, 2003, Volume: 50, Issue:8

    Topics: Anesthesia Recovery Period; Blood Component Transfusion; Blood Loss, Surgical; Craniosynostoses; Fem

2003
Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2003, Volume: 61, Issue:12

    Topics: Adult; Aged; Anticoagulants; Blood Loss, Surgical; Dental Care for Chronically Ill; Drug Interaction

2003
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Feb-10, Volume: 112, Issue:2

    Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration

2004
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Feb-10, Volume: 112, Issue:2

    Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration

2004
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Feb-10, Volume: 112, Issue:2

    Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration

2004
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Feb-10, Volume: 112, Issue:2

    Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration

2004
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Feb-10, Volume: 112, Issue:2

    Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration

2004
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Feb-10, Volume: 112, Issue:2

    Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration

2004
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Feb-10, Volume: 112, Issue:2

    Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration

2004
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Feb-10, Volume: 112, Issue:2

    Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration

2004
Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Feb-10, Volume: 112, Issue:2

    Topics: Adult; Blood Loss, Surgical; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration

2004
Tranexamic acid mouthwash--a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions.
    International journal of oral and maxillofacial surgery, 2003, Volume: 32, Issue:5

    Topics: Administration, Topical; Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Dental Care for Chron

2003
Tranexamic acid in primary CABG surgery: high vs low dose.
    Minerva anestesiologica, 2004, Volume: 70, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Postoperat

2004
Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery.
    Journal of cardiothoracic and vascular anesthesia, 2004, Volume: 18, Issue:2

    Topics: Adolescent; Aminocaproic Acid; Antifibrinolytic Agents; Blood Coagulation Tests; Blood Transfusion;

2004
Intraoperative moderate acute normovolemic hemodilution associated with a comprehensive blood-sparing protocol in off-pump coronary surgery.
    Anesthesia and analgesia, 2004, Volume: 98, Issue:5

    Topics: Aged; Anesthesia; Antifibrinolytic Agents; Blood Cell Count; Blood Transfusion; Blood Volume; Cardia

2004
Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedic surgery.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 2003, Issue:588

    Topics: Administration, Topical; Adult; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Female; Fibrin F

2003
Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.
    The Journal of thoracic and cardiovascular surgery, 2004, Volume: 128, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Biomarkers; Blood Coagulation; Blood Coagulation Tests; Blood Loss, S

2004
Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2004, Volume: 26, Issue:2

    Topics: Antifibrinolytic Agents; Blood Transfusion, Autologous; Cardiopulmonary Bypass; Coronary Artery Bypa

2004
Effectiveness in controlling haemorrhage after dental scaling in people with haemophilia by using tranexamic acid mouthwash.
    British dental journal, 2005, Jan-08, Volume: 198, Issue:1

    Topics: Adolescent; Adult; Aged; Cross-Over Studies; Dental Care for Chronically Ill; Dental Scaling; Double

2005
[Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2005, Volume: 5, Issue:1

    Topics: Administration, Cutaneous; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgica

2005
Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty.
    The Journal of bone and joint surgery. American volume, 2005, Volume: 87, Issue:4

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemostatic Tech

2005
Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2005, Volume: 28, Issue:4

    Topics: Aged; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Coronary Artery Bypass, Off-Pump; Cr

2005
A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2006, Volume: 39, Issue:1

    Topics: Antifibrinolytic Agents; Cardiopulmonary Bypass; Coronary Artery Bypass; Double-Blind Method; Female

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Effect of topical tranexamic acid in open heart surgery.
    European journal of anaesthesiology, 2006, Volume: 23, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical P

2006
Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different INR targets.
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:3

    Topics: Administration, Oral; Aged; Anticoagulants; Blood Coagulation; Cardiovascular Diseases; Cellulose, O

2006
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
    Acta orthopaedica, 2005, Volume: 76, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Me

2005
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients.
    The Knee, 2006, Volume: 13, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Double-Blind Method; Fema

2006
Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
    Transfusion, 2006, Volume: 46, Issue:4

    Topics: Adult; Aprotinin; Blood Loss, Surgical; Erythrocyte Transfusion; Female; Fibrinolysis; Hemostatics;

2006
Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass grafting.
    Scandinavian cardiovascular journal : SCJ, 2006, Volume: 40, Issue:2

    Topics: Aged; Angina Pectoris; Antifibrinolytic Agents; Chemoprevention; Coronary Artery Bypass, Off-Pump; F

2006
Tranexamic acid does not correct the haemostatic impairment caused by hydroxyethyl starch (200 kDa/0.5) after cardiac surgery.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2006, Volume: 17, Issue:8

    Topics: Antifibrinolytic Agents; Cardiopulmonary Bypass; Female; Humans; Hydroxyethyl Starch Derivatives; Ma

2006
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2007, Volume: 31, Issue:3

    Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion

2007
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2007, Volume: 31, Issue:3

    Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion

2007
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2007, Volume: 31, Issue:3

    Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion

2007
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2007, Volume: 31, Issue:3

    Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion

2007
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2007, Volume: 31, Issue:3

    Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion

2007
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2007, Volume: 31, Issue:3

    Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion

2007
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2007, Volume: 31, Issue:3

    Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion

2007
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2007, Volume: 31, Issue:3

    Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion

2007
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2007, Volume: 31, Issue:3

    Topics: Administration, Topical; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Transfusion

2007
Effects of tranexamic acid and autotransfusion in coronary artery bypass.
    Asian cardiovascular & thoracic annals, 2007, Volume: 15, Issue:1

    Topics: Adult; Blood Transfusion; Blood Transfusion, Autologous; Coronary Artery Bypass; Female; Hemostatics

2007
[Effect of tranexamic acid on postoperative bleeding in pediatric heart surgery].
    Revista espanola de anestesiologia y reanimacion, 2007, Volume: 54, Issue:3

    Topics: Antifibrinolytic Agents; Biomarkers; Blood Loss, Surgical; Blood Proteins; Cardiac Surgical Procedur

2007
Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study.
    European journal of obstetrics, gynecology, and reproductive biology, 2008, Volume: 137, Issue:2

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Double-Blind Method; Female

2008
Does tranexamic acid reduce blood loss in off-pump coronary artery bypass?
    Asian cardiovascular & thoracic annals, 2007, Volume: 15, Issue:4

    Topics: Adult; Antifibrinolytic Agents; Blood Coagulation; Blood Transfusion; Coronary Artery Bypass, Off-Pu

2007
Tranexamic acid and primary coronary artery bypass surgery: a prospective study.
    Asian cardiovascular & thoracic annals, 2007, Volume: 15, Issue:4

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass; Coro

2007
Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial.
    Critical care (London, England), 2007, Volume: 11, Issue:6

    Topics: Aged; Antifibrinolytic Agents; Cardiopulmonary Bypass; Case-Control Studies; Double-Blind Method; Fe

2007
[Clinical comparative studies on effect of tranexamic acid on blood loss associated with total knee arthroplasty].
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2007, Volume: 21, Issue:12

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Bl

2007
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Card

2008
Prospective, randomized, controlled trial of tranexamic acid in patients who undergo head and neck procedures.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2008, Volume: 138, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Double-Blind Method; Drainage; Female; Huma

2008
Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Texas Heart Institute journal, 1995, Volume: 22, Issue:3

    Topics: Adult; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Coagulation Tests; Blood L

1995
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.
    The Journal of bone and joint surgery. British volume, 1996, Volume: 78, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Volume; Double-Blind Method; Female; Hemo

1996
Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery.
    Anesthesia and analgesia, 1996, Volume: 83, Issue:1

    Topics: Adult; Aged; Antifibrinolytic Agents; Blood Coagulation; Blood Transfusion; Cardiopulmonary Bypass;

1996
Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid.
    The Journal of cardiovascular surgery, 1996, Volume: 37, Issue:4

    Topics: Aminocaproic Acid; Aprotinin; Blood Coagulation; Blood Loss, Surgical; Blood Transfusion; Cardiopulm

1996
The use of low-dose aprotinin, epsilon-aminocaproic acid or tranexamic acid for prevention of mediastinal bleeding in patients receiving aspirin before coronary artery bypass operations.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 1997, Volume: 11, Issue:4

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Aspirin; Coronary Artery Bypass; Dose-Respons

1997
Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1997, Volume: 44, Issue:9

    Topics: Antifibrinolytic Agents; Blood Coagulation; Blood Loss, Surgical; Blood Transfusion; Blood Volume; C

1997
The effectiveness of low dose tranexamic acid in primary cardiac surgery.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1998, Volume: 45, Issue:6

    Topics: Analysis of Variance; Antifibrinolytic Agents; Blood Coagulation; Blood Loss, Surgical; Blood Transf

1998
Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization.
    Anesthesia and analgesia, 1998, Volume: 87, Issue:2

    Topics: Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Cardiopulmonary Bypass; Chest Tubes; Coronary

1998
[Comparative effect of tranexamic acid on the reduction of bleeding during and after cardiac surgery].
    Masui. The Japanese journal of anesthesiology, 1998, Volume: 47, Issue:7

    Topics: Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmo

1998
The effect of tranexamic acid (cyclokapron) on blood loss after third molar extraction under a day case general anaesthetic.
    British dental journal, 1999, Jun-26, Volume: 186, Issue:12

    Topics: Adolescent; Adult; Ambulatory Surgical Procedures; Anesthesia, Dental; Anesthesia, General; Antifibr

1999
Aprotinin and tranexamic acid for high transfusion risk cardiac surgery.
    The Annals of thoracic surgery, 2000, Volume: 69, Issue:3

    Topics: Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Double-Blind Met

2000
Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2000, Volume: 6, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Deamino Arginine Vasopressin; D

2000
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
    Acta orthopaedica Scandinavica, 2000, Volume: 71, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho

2000
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
    Acta orthopaedica Scandinavica, 2000, Volume: 71, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho

2000
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
    Acta orthopaedica Scandinavica, 2000, Volume: 71, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho

2000
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
    Acta orthopaedica Scandinavica, 2000, Volume: 71, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho

2000
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
    Acta orthopaedica Scandinavica, 2000, Volume: 71, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho

2000
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
    Acta orthopaedica Scandinavica, 2000, Volume: 71, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho

2000
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
    Acta orthopaedica Scandinavica, 2000, Volume: 71, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho

2000
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
    Acta orthopaedica Scandinavica, 2000, Volume: 71, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho

2000
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.
    Acta orthopaedica Scandinavica, 2000, Volume: 71, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Double-Blind Metho

2000
[Hemostatic wound management in marcumar patients. Collagen fleece vs. tranexamic acid].
    Mund-, Kiefer- und Gesichtschirurgie : MKG, 2000, Volume: 4, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Alveolar Process; Anticoagulants; Collagen; Hemostasis, Surgical; He

2000
Postoperative bleeding after coronary revascularization. Comparison between tranexamic acid and epsilon-aminocaproic acid.
    Minerva cardioangiologica, 2000, Volume: 48, Issue:6

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Cardiopulmonary Bypass; Humans; Middle Aged; Postoperati

2000
Tranexamic acid administration after cardiac surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Anesthesiology, 2001, Volume: 94, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Cardiopulmonary Bypass; Comorbidity; Double

2001
Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study.
    The Annals of thoracic surgery, 2001, Volume: 72, Issue:2

    Topics: Aged; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Drug Ad

2001
Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Thrombosis and haemostasis, 2001, Volume: 86, Issue:4

    Topics: Adult; Antigens; Blood Loss, Surgical; Child; Child, Preschool; Drug Administration Schedule; Electi

2001

Other Studies

262 other studies available for tranexamic acid and Blood Loss, Postoperative

ArticleYear
Dose tranexamic acid reduce blood loss associated with simultaneous bilateral distal tibial tubercle-high tibial osteotomy?
    BMC musculoskeletal disorders, 2021, Nov-10, Volume: 22, Issue:1

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Case-Control Studies; Hu

2021
The Efficiency of Simultaneous Systemic and Topical Use of Tranexamic Acid in Spinal Fusion Surgery.
    Journal of neurological surgery. Part A, Central European neurosurgery, 2022, Volume: 83, Issue:1

    Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Postoperative Hemorrhage; Spinal Fusio

2022
Tranexamic acid in cardiac surgery: Are low doses enough?
    Revista espanola de anestesiologia y reanimacion, 2021, Volume: 68, Issue:10

    Topics: Antifibrinolytic Agents; Cardiac Surgical Procedures; Humans; Postoperative Hemorrhage; Prospective

2021
Comparison of intra-articular administration of adenosine, lidocaine and magnesium solution and tranexamic acid for alleviating postoperative inflammation and joint fibrosis in an experimental model of knee arthroplasty.
    Journal of orthopaedic surgery and research, 2021, Dec-20, Volume: 16, Issue:1

    Topics: Adenosine; Administration, Intravenous; Animals; Antifibrinolytic Agents; Arthroplasty, Replacement,

2021
Not all patients benefit from the postoperative antifibrinolytic treatment: clinical evidence against the universal use of tranexamic acid following total knee arthroplasty.
    Journal of orthopaedic surgery and research, 2022, Jan-29, Volume: 17, Issue:1

    Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replace

2022
Acute normovolemic hemodilution in combination with tranexamic acid is an effective strategy for blood management in lumbar spinal fusion surgery.
    Journal of orthopaedic surgery and research, 2022, Feb-05, Volume: 17, Issue:1

    Topics: Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Hemodilution; Humans; Intraopera

2022
Tranexamic acid improves early postoperative mobilization in cancer patients undergoing endoprosthetic reconstruction.
    Journal of surgical oncology, 2022, Volume: 125, Issue:8

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Bone Neoplasms; Humans; Postoperative Hemorrhage; Ret

2022
Efficacy and safety of intravenous combined with topical administration of tranexamic acid in reducing blood loss in opening wedge high tibial osteotomy procedure: A retrospective case-control study.
    Acta orthopaedica et traumatologica turcica, 2022, Volume: 56, Issue:2

    Topics: Activities of Daily Living; Administration, Intravenous; Administration, Topical; Antifibrinolytic A

2022
Comparison of weight-based versus standard dosing of tranexamic acid for blood loss and transfusion amount in knee arthroplasty without tourniquet.
    Acta orthopaedica Belgica, 2022, Volume: 88, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Female; Hemoglobins;

2022
Hidden blood loss of total knee arthroplasty in hemophilia arthritis: an analysis of influencing factors.
    BMC musculoskeletal disorders, 2022, Jun-17, Volume: 23, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthritis; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blo

2022
Comparison of blood loss between tranexamic acid-soaked absorbable Gelfoam and topical retrograde injection via drainage catheter plus clamping in cervical laminoplasty surgery.
    BMC musculoskeletal disorders, 2022, Jul-14, Volume: 23, Issue:1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Catheters; Constriction; Drainage; Gelatin Sponge, Ab

2022
The Effect of Tranexamic Acid on Operative and Postoperative Blood Loss in Transforaminal Lumbar Interbody Fusions.
    World neurosurgery, 2022, Volume: 166

    Topics: Adult; Blood Loss, Surgical; Child; Humans; Lumbar Vertebrae; Postoperative Hemorrhage; Retrospectiv

2022
Effectiveness of prophylactic doses of tranexamic acid in reducing hemorrhagic events in sleeve gastrectomy.
    Langenbeck's archives of surgery, 2022, Volume: 407, Issue:7

    Topics: Gastrectomy; Humans; Laparoscopy; Obesity, Morbid; Postoperative Complications; Postoperative Hemorr

2022
[Effects of oral and intravenous tranexamic acid on perioperative blood loss after lumbar spinal canal decompression and fusion].
    Zhongguo gu shang = China journal of orthopaedics and traumatology, 2022, Aug-25, Volume: 35, Issue:8

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Decompression; Humans; Postoperative Hemorrhage; Spin

2022
Effect of Topical Administration of Tranexamic Acid on Intraoperative and Postoperative Blood Loss during Posterior Cervical Laminectomy and Fusion Surgery: A Retrospective Study.
    Turkish neurosurgery, 2023, Volume: 33, Issue:1

    Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Hemostatics; Humans;

2023
    Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V..., 2022, Volume: 54, Issue:6

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Breast Neoplasms; Female; Humans; Male; Mastectomy; M

2022
Optimal Release Timing of Drain Clamping to Reduce Postoperative Bleeding after Total Knee Arthroplasty with Intraarticular Injection of Tranexamic Acid.
    Medicina (Kaunas, Lithuania), 2022, Sep-05, Volume: 58, Issue:9

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Constriction; Draina

2022
Does the clamping method in local and systemic TXA applications in total knee arthroplasty change the game?: A retrospective comparative cohort study.
    Medicine, 2022, Sep-23, Volume: 101, Issue:38

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Cohort Studie

2022
Does living at high altitude increase the risk of bleeding events after total knee arthroplasty? A retrospective cohort study.
    International orthopaedics, 2023, Volume: 47, Issue:1

    Topics: Altitude; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Fibrin Fib

2023
Tranexamic acid in pertrochanteric fractures: a retrospective analysis of perioperative outcomes after fixation with a proximal femoral nail.
    BMC musculoskeletal disorders, 2022, Nov-03, Volume: 23, Issue:1

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Femoral Fractures; Humans; Postoperative Hemorrhage;

2022
Use of tranexamic acid may reduce the need for routine tourniquet use in total knee arthroplasty.
    Joint diseases and related surgery, 2022, Volume: 33, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Humans; Male; Middle Aged; P

2022
Intravenous Tranexamic Acid Reduces Blood Loss in Multilevel Spine Surgeries.
    The Journal of the American Academy of Orthopaedic Surgeons, 2023, Feb-15, Volume: 31, Issue:4

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Lumbar Vertebrae

2023
Intravenous Tranexamic Acid Reduces Blood Loss in Multilevel Spine Surgeries.
    The Journal of the American Academy of Orthopaedic Surgeons, 2023, Feb-15, Volume: 31, Issue:4

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Lumbar Vertebrae

2023
Intravenous Tranexamic Acid Reduces Blood Loss in Multilevel Spine Surgeries.
    The Journal of the American Academy of Orthopaedic Surgeons, 2023, Feb-15, Volume: 31, Issue:4

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Lumbar Vertebrae

2023
Intravenous Tranexamic Acid Reduces Blood Loss in Multilevel Spine Surgeries.
    The Journal of the American Academy of Orthopaedic Surgeons, 2023, Feb-15, Volume: 31, Issue:4

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Lumbar Vertebrae

2023
Tranexamic acid in total knee arthroplasty.
    Anaesthesia, 2023, Volume: 78, Issue:3

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ

2023
Preliminary outcome of use of parenterally administered tranexamic acid during primary total knee replacement.
    Nigerian journal of clinical practice, 2023, Volume: 26, Issue:1

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S

2023
Topical administration of tranexamic acid reduces postoperative blood loss and inflammatory response in knee arthroscopic arthrolysis: a retrospective comparative study.
    BMC musculoskeletal disorders, 2023, Apr-05, Volume: 24, Issue:1

    Topics: Administration, Topical; Antifibrinolytic Agents; Arthroscopy; Blood Loss, Surgical; Hemarthrosis; H

2023
Topical tranexamic acid reduces postoperative hematomas in reduction mammaplasties.
    Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2023, Volume: 83

    Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Breast Neoplasms; Cohort Stu

2023
The efficacy and safety of intravenous administration of tranexamic acid in patients undergoing cardiac surgery: Evidence from a single cardiovascular center.
    Medicine, 2023, May-19, Volume: 102, Issue:20

    Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgical

2023
Efficacy and safety of using aminocaproic acid and tranexamic acid during the perioperative period for treating trochanteric fractures in elderly femurs.
    BMC musculoskeletal disorders, 2023, Jul-03, Volume: 24, Issue:1

    Topics: Aged; Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Humans; Posto

2023
Treatment of post-tonsillectomy hemorrhage with nebulized tranexamic acid: A retrospective study.
    International journal of pediatric otorhinolaryngology, 2023, Volume: 171

    Topics: Adult; Antifibrinolytic Agents; Child; Hemorrhage; Humans; Postoperative Hemorrhage; Retrospective S

2023
Postoperative clinical outcomes with and without short-term intravenous tranexamic acid after posterior lumbar interbody fusion: A prospective cohort study.
    Medicine, 2023, Nov-17, Volume: 102, Issue:46

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Lumbar Vertebrae

2023
Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia.
    BMC musculoskeletal disorders, 2019, Sep-04, Volume: 20, Issue:1

    Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Arthralgia; Arthroplasty, Replacement,

2019
Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial.
    Clinical orthopaedics and related research, 2020, Volume: 478, Issue:1

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Human

2020
Prothrombin Complex Concentrate before Urgent Surgery in Patients Treated with Rivaroxaban and Apixaban.
    Acta haematologica, 2020, Volume: 143, Issue:3

    Topics: Academic Medical Centers; Aged; Aged, 80 and over; Atrial Fibrillation; Blood Coagulation Factors; B

2020
Factor XIII deficiency leading to preseptal haematoma post-strabismus surgery.
    BMJ case reports, 2019, Nov-13, Volume: 12, Issue:11

    Topics: Antifibrinolytic Agents; Child; Exotropia; Eyelid Diseases; Factor XIII Deficiency; Female; Hematoma

2019
Topical Injection of Tranexamic Acid via a Drain Plus Drain-Clamping to Reduce Blood Loss in Degenerative Lumbar Scoliosis Surgery.
    Orthopaedic surgery, 2020, Volume: 12, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Decompression, Surgical; Drainage; Female; Humans; Injections, Intra-

2020
Tranexamic Acid Reduces Total Blood Loss and Inflammatory Response in Computer-Assisted Navigation Total Knee Arthroplasty.
    BioMed research international, 2019, Volume: 2019

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2019
Nebulized tranexamic acid for post-tonsillectomy hemorrhage in children: a promising game changer.
    The American journal of emergency medicine, 2020, Volume: 38, Issue:9

    Topics: Antifibrinolytic Agents; Child; Humans; Nebulizers and Vaporizers; Postoperative Hemorrhage; Tonsill

2020
Tranexamic Acid in Patients With Cancer Undergoing Endoprosthetic Reconstruction: A Retrospective Review.
    The Journal of the American Academy of Orthopaedic Surgeons, 2020, Mar-15, Volume: 28, Issue:6

    Topics: Antifibrinolytic Agents; Bone Neoplasms; Femur; Humans; Plastic Surgery Procedures; Postoperative He

2020
Intravenous Combined with Topical Tranexamic Acid Administration Has No Additional Benefits Compared with Intravenous Administration Alone in High Tibial Osteotomy: A Retrospective Case-Control Study.
    Orthopaedic surgery, 2020, Volume: 12, Issue:2

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Case-Control St

2020
Safety and efficacy of tranexamic acid with epinephrine for prevention of blood loss following surgery for trochanteric femoral fractures.
    Acta orthopaedica et traumatologica turcica, 2020, Volume: 54, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Epinephrine; Female; Fractur

2020
[A comparative study of Taylor spatial frame and unilateral external fixator in treatment of tibiofibular open fractures].
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2020, Apr-15, Volume: 34, Issue:4

    Topics: Blood Loss, Surgical; External Fixators; Fracture Fixation, Internal; Fracture Healing; Fractures, O

2020
Postoperative administration of tranexamic acid as approach to reduce blood loss after open-heart surgery.
    Clinical hemorheology and microcirculation, 2020, Volume: 76, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Cardiopulmonary Bypass; Female; Humans; Male; Postoperative Hemorrhag

2020
Postoperative Intravenous Iron Supplementation Does Not Improve Hemoglobin Level and Transfusion Rate Following Staged Bilateral Total Knee Arthroplasty.
    The Journal of arthroplasty, 2020, Volume: 35, Issue:9

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Cohort Studies; Diet

2020
[Analysis of hemostatic effect and safety of tranexamic acid in primary simultaneous bilateral total hip arthroplasty].
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2020, Jul-15, Volume: 34, Issue:7

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemostatics; Humans;

2020
Efficacy of intravenous tranexamic acid administration in revision hip arthroplasty.
    Der Orthopade, 2021, Volume: 50, Issue:6

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Su

2021
Tranexamic acid in hip hemiarthroplasty.
    Injury, 2020, Volume: 51, Issue:11

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Female; Hemiarthropla

2020
Tranexamic Acid Reduces the Rate of Periprosthetic Joint Infection After Aseptic Revision Arthroplasty.
    The Journal of bone and joint surgery. American volume, 2020, Aug-05, Volume: 102, Issue:15

    Topics: Aged; Antifibrinolytic Agents; Arthritis, Infectious; Arthroplasty, Replacement; Blood Transfusion;

2020
Letter on the article "Effect of single-dose intravenous tranexamic acid on postoperative nasal bleed in septoplasty".
    European annals of otorhinolaryngology, head and neck diseases, 2021, Volume: 138, Issue:2

    Topics: Epistaxis; Humans; Postoperative Hemorrhage; Rhinoplasty; Tranexamic Acid

2021
Higher doses of topical tranexamic acid safely improves immediate functional outcomes and reduces transfusion requirement in total knee arthroplasty.
    Archives of orthopaedic and trauma surgery, 2020, Volume: 140, Issue:12

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2020
Efficacy of topical versus intravenous tranexamic acid in spinal deformity.
    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2020, Volume: 29, Issue:12

    Topics: Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Child; Hu

2020
Is tranexamic acid effective on hidden blood loss in patients during total knee arthroplasty?
    Joint diseases and related surgery, 2020, Volume: 31, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Component Transfusion; Blood L

2020
Is continuation of anti-platelet treatment safe for elective total hip arthroplasty patients?
    Archives of orthopaedic and trauma surgery, 2020, Volume: 140, Issue:12

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Aspirin; Blood Los

2020
Improved platelet counts during prolonged tranexamic therapy for Quebec platelet disorder implicate the underlying fibrinolytic defect as the cause of lower platelet counts.
    International journal of laboratory hematology, 2020, Volume: 42, Issue:6

    Topics: Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Platelets; Factor V Deficiency; Fibrinol

2020
[Analysis of hemostatic effect of intra-articular injection of tranexamic acid after minimally invasive unicompartmental knee arthroplasty].
    Zhongguo gu shang = China journal of orthopaedics and traumatology, 2020, Nov-25, Volume: 33, Issue:11

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Female; Hemost

2020
Use of tranexamic acid is not associated with complications following bipolar hemiarthroplasty for metastatic disease.
    Journal of surgical oncology, 2021, Volume: 123, Issue:4

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Female; Femoral Neoplasms; Femur Neck; Follow-Up Stud

2021
Local Infiltration of Tranexamic Acid (TXA) in Liposuction: A Single-Surgeon Outcomes Analysis and Considerations for Minimizing Postoperative Donor Site Ecchymosis.
    Aesthetic surgery journal, 2021, 06-14, Volume: 41, Issue:7

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Ecchymosis; Humans; Lipectomy; Postoperative Hemorrha

2021
Does Not Use of Closed Suction Drainage in Total Knee Arthroplasty with Tranexamic Acid Reduce Blood Loss?
    Ortopedia, traumatologia, rehabilitacja, 2020, Oct-31, Volume: 22, Issue:5

    Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Drainage; Female; Hu

2020
Hockey: a pain in the butt! Isolated superior gluteal artery rupture following blunt pelvic trauma - an unusual case.
    Annals of the Royal College of Surgeons of England, 2021, Volume: 103, Issue:3

    Topics: Aneurysm, False; Antifibrinolytic Agents; Buttocks; Computed Tomography Angiography; Embolization, T

2021
Effects of disusing closed suction drainage in simultaneous bilateral total hip arthroplasty: A retrospective cohort study.
    PloS one, 2021, Volume: 16, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; Humans; M

2021
Comparing the effect of tourniquet and tranexamic acid on the tibial cement mantle thickness in total knee arthroplasty.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2022, Volume: 32, Issue:2

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoperativ

2022
Safety and Efficacy of Topical Administration of Tranexamic Acid in High-Risk Patients Undergoing Posterior Lumbar Interbody Fusion Surgery.
    World neurosurgery, 2021, Volume: 151

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Cardiovascular Disease

2021
Post-tonsillectomy hemorrhage control with nebulized tranexamic acid: A retrospective cohort study.
    International journal of pediatric otorhinolaryngology, 2021, Volume: 147

    Topics: Antifibrinolytic Agents; Child; Hemorrhage; Humans; Postoperative Hemorrhage; Retrospective Studies;

2021
Benefits of Tranexamic Acid in Total Knee Arthroplasty: A Classification and Regression Tree Analysis in Function of Instrumentation, BMI, and Gender.
    The journal of knee surgery, 2023, Volume: 36, Issue:2

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S

2023
[Study on the safety and effectiveness of low-dose tranexamic acid in operation of multi-level continuous thoracic ossification of ligament flavum].
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2021, Jul-15, Volume: 35, Issue:7

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Ligaments; Osteogenesis; Postoperative Hemorr

2021
[Application of tranexamic acid in the treatment of intertrochanteric fracture of femur].
    Zhongguo gu shang = China journal of orthopaedics and traumatology, 2021, Jul-25, Volume: 34, Issue:7

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Femur; Hip Fractures; Humans; Postoperative Hemorrhag

2021
Comparison of topical and intravenous Tranexamic acid for high tibial osteotomy: A retrospective study.
    Medicine, 2021, Aug-13, Volume: 100, Issue:32

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Follow-

2021
Significantly reducing blood loss via a peri-articular injection of tranexamic acid during total knee arthroplasty: a retrospective study.
    BMC musculoskeletal disorders, 2021, Aug-17, Volume: 22, Issue:1

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S

2021
[Can venous iron and tranexamic acid reduce the transfusion need? Report on a non randomized, case control study].
    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2017, Volume: 24, Issue:2

    Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Blood Transfusion; Case-Control Studies

2017
Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
    The Journal of arthroplasty, 2017, Volume: 32, Issue:8

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bloo

2017
Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists. A cohort study.
    Thrombosis and haemostasis, 2017, 06-27, Volume: 117, Issue:7

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Blood Coagul

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 05-11, Volume: 376, Issue:19

    Topics: Antifibrinolytic Agents; Arteries; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass;

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 05-11, Volume: 376, Issue:19

    Topics: Antifibrinolytic Agents; Arteries; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass;

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 05-11, Volume: 376, Issue:19

    Topics: Antifibrinolytic Agents; Arteries; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass;

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 05-11, Volume: 376, Issue:19

    Topics: Antifibrinolytic Agents; Arteries; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass;

2017
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    The New England journal of medicine, 2017, 05-11, Volume: 376, Issue:19

    Topics: Antifibrinolytic Agents; Arteries; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass;

2017
Tranexamic Acid Effectively Reduces Blood Loss and Transfusion Rates during Simultaneous Bilateral Total Knee Arthroplasty.
    The journal of knee surgery, 2018, Volume: 31, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2018
Efficacy and Safety of Topical Use of Tranexamic Acid in Reducing Blood Loss During Primary Lumbar Spinal Surgery: A Retrospective Case Control Study.
    Spine, 2017, Dec-01, Volume: 42, Issue:23

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Transfusion; Case-Control Studi

2017
Reducing Postoperative Bleeding After Craniosynostosis Repair Utilizing a Low-Dose Transexamic Acid Infusion Protocol.
    The Journal of craniofacial surgery, 2017, Volume: 28, Issue:5

    Topics: Adolescent; Antifibrinolytic Agents; Blood Transfusion; Child; Child, Preschool; Craniosynostoses; D

2017
An Aprotinin Containing Fibrin Sealant Does Not Reduce Blood Loss in Total Hip Arthroplasty.
    The Journal of arthroplasty, 2017, Volume: 32, Issue:11

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Aprotinin; Arthroplasty, Replacement, Hip; Blo

2017
Quantitative efficacy of topical administration of tranexamic acid on postoperative bleeding in total knee arthroplasty.
    British journal of clinical pharmacology, 2017, Volume: 83, Issue:11

    Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Computer Simulati

2017
What Should Define Preoperative Anemia in Primary THA?
    Clinical orthopaedics and related research, 2017, Volume: 475, Issue:11

    Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Blood Loss, Surgical;

2017
Limitations of Preoperative PFA-200 as a Predictor of Postoperative Blood Loss in Total Knee Arthroplasty: According to Use of Tranexamic Acid.
    Clinical laboratory, 2017, Jul-01, Volume: 63, Issue:7

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Blood Loss, Surgical; Blood Tr

2017
Periarticular Injection of Tranexamic Acid Reduces Blood Loss and the Necessity for Allogeneic Transfusion After Total Knee Arthroplasty Using Autologous Transfusion: A Retrospective Observational Study.
    The Journal of arthroplasty, 2018, Volume: 33, Issue:1

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi

2018
Tranexamic Acid Should be Considered in Fracture Surgery.
    Journal of orthopaedic trauma, 2017, Volume: 31, Issue:10

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Drug Administration Routes; Fracture Fixation; Fractu

2017
Epsilon Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Hip and Total Knee Arthroplasty.
    The Journal of arthroplasty, 2018, Volume: 33, Issue:1

    Topics: Aged; Aminocaproic Acid; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Repl

2018
Topical use of tranexamic acid can effectively decrease hidden blood loss during posterior lumbar spinal fusion surgery: A retrospective study.
    Medicine, 2017, Volume: 96, Issue:42

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusi

2017
Clinical Research of Combined Intravenous Administration and Topical Application of Tranexamic Acid to a Surgical Wound During Posterior Lumbar Fusion.
    Surgical innovation, 2018, Volume: 25, Issue:2

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Blood Loss, Sur

2018
Low-Dose Epinephrine Infusions and Tranexamic Acid During Lower-Extremity Total Joint Arthroplasty: Commentary on an article by Wei-Nan Zeng, MD, et al.: "Low-Dose Epinephrine Plus Tranexamic Acid Reduces Early Postoperative Blood Loss and Inflammatory Re
    The Journal of bone and joint surgery. American volume, 2018, 02-21, Volume: 100, Issue:4

    Topics: Antifibrinolytic Agents; Arthroplasty; Epinephrine; Humans; Postoperative Hemorrhage; Tranexamic Aci

2018
Matched cohort study of topical tranexamic acid in cementless primary total hip replacement.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2018, Volume: 28, Issue:7

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss,

2018
Supportive topical tranexamic acid application for hemostasis in oral bleeding events - Retrospective cohort study of 542 patients.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2018, Volume: 46, Issue:6

    Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Anticoagulants; Blood

2018
Intravenous tranexamic acid only versus combined intravenous and intra-articular tranexamic acid for perioperative blood loss in patients undergoing total knee arthroplasty.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2018, Volume: 28, Issue:7

    Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replace

2018
Letter to the Editor. Tranexamic acid for reducing intra- and postoperative blood loss in posterior lumbar interbody fusion: Is it safe enough?
    Journal of neurosurgery. Spine, 2018, Volume: 29, Issue:2

    Topics: Antifibrinolytic Agents; Humans; Lumbosacral Region; Postoperative Hemorrhage; Tranexamic Acid

2018
Effect of tranexamic acid on intra- and postoperative haemorrhage in dogs with surgically treated hemoperitoneum.
    Schweizer Archiv fur Tierheilkunde, 2018, Volume: 160, Issue:5

    Topics: Animals; Antifibrinolytic Agents; Blood Pressure; Dog Diseases; Dogs; Hemoperitoneum; Postoperative

2018
Minimizing Blood Loss and Transfusions in Total Knee Arthroplasty.
    The journal of knee surgery, 2018, Volume: 31, Issue:7

    Topics: Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; Epoetin Alfa; Fibrin Tissu

2018
[Effect on time of temporarily-closed wound drainage on blood loss of primary total knee arthroplasty after intravenous and intra-articular injection of tranexamic acid].
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2017, 04-15, Volume: 31, Issue:4

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; D

2017
Tranexamic acid administration to older patients undergoing primary total hip arthroplasty conserves hemoglobin and reduces blood loss.
    Canadian journal of surgery. Journal canadien de chirurgie, 2018, Volume: 61, Issue:3

    Topics: Age Factors; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood

2018
Effectiveness of a patient blood management protocol on reduction of allogeneic red blood cell transfusions in orthopedic surgery.
    Medicina clinica, 2019, 02-01, Volume: 152, Issue:3

    Topics: Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplas

2019
Transfusion rate using intravenous tranexamic acid in hip revision surgery.
    Hip international : the journal of clinical and experimental research on hip pathology and therapy, 2018, Volume: 28, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss,

2018
DIAGNOSTICS AND CORRECTION OF THROMBOHEMORRHAGIC DISORDERS IN PATIENTS WITH GIANT UTERINE MYOMA AT THE PERIOPERATIVE STAGE OF TREATMENT.
    Anesteziologiia i reanimatologiia, 2016, Volume: 61, Issue:6

    Topics: Antifibrinolytic Agents; Drug Administration Schedule; Female; Humans; Leiomyoma; Middle Aged; Perio

2016
Intravenous Tranexamic Acid Reduces Postoperative Blood Loss After High Tibial Osteotomy.
    Clinical orthopaedics and related research, 2018, Volume: 476, Issue:11

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Humans; Infusions, Intravenous; Male; Mid

2018
Intravenous Tranexamic Acid Reduces Postoperative Blood Loss After High Tibial Osteotomy.
    Clinical orthopaedics and related research, 2018, Volume: 476, Issue:11

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Humans; Infusions, Intravenous; Male; Mid

2018
Intravenous Tranexamic Acid Reduces Postoperative Blood Loss After High Tibial Osteotomy.
    Clinical orthopaedics and related research, 2018, Volume: 476, Issue:11

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Humans; Infusions, Intravenous; Male; Mid

2018
Intravenous Tranexamic Acid Reduces Postoperative Blood Loss After High Tibial Osteotomy.
    Clinical orthopaedics and related research, 2018, Volume: 476, Issue:11

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Female; Humans; Infusions, Intravenous; Male; Mid

2018
Management of Single Uncomplicated Dental Extractions and Postoperative Bleeding Evaluation in Patients With Factor V Deficiency: A Local Antihemorrhagic Approach.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2018, Volume: 76, Issue:11

    Topics: Adult; Aged; Antifibrinolytic Agents; Factor V Deficiency; Female; Gelatin Sponge, Absorbable; Hemos

2018
Comment on: "Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: A prospective clinical study".
    Acta orthopaedica et traumatologica turcica, 2018, Volume: 52, Issue:4

    Topics: Administration, Intravenous; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Humans; Postoper

2018
CORR Insights®: Intravenous Tranexamic Acid Reduces Postoperative Blood Loss After High Tibial Osteotomy.
    Clinical orthopaedics and related research, 2018, Volume: 476, Issue:11

    Topics: Antifibrinolytic Agents; Humans; Osteotomy; Postoperative Hemorrhage; Tranexamic Acid

2018
Management of dental extractions in patients on warfarin and antiplatelet therapy.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2018, Volume: 117, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Clopidogrel; Female; Hum

2018
Tranexamic acid is effective for blood management in open-wedge high tibial osteotomy.
    Orthopaedics & traumatology, surgery & research : OTSR, 2018, Volume: 104, Issue:7

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Blood Volume; Case-Control Studies

2018
Dose optimization of topical tranexamic acid for primary total hip arthroplasty: A prospective cohort study.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2019, Volume: 24, Issue:2

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Cohort Studi

2019
Nebulized Tranexamic Acid Use for Pediatric Secondary Post-Tonsillectomy Hemorrhage.
    Annals of emergency medicine, 2019, Volume: 73, Issue:3

    Topics: Administration, Inhalation; Antifibrinolytic Agents; Child, Preschool; Humans; Male; Postoperative H

2019
Tranexamic Acid in Total Hip Arthoplasty: Management of Complications and Use.
    Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses, 2017, Volume: 26, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Drug Dosage Calculations; Drug-Relat

2017
Tranexamic acid and post-tonsillectomy hemorrhage: propensity score and instrumental variable analyses.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2019, Volume: 276, Issue:1

    Topics: Adolescent; Adult; Antifibrinolytic Agents; Databases, Factual; Female; Humans; Incidence; Japan; Ma

2019
The efficacy and safety of tranexamic acid in reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis: A retrospective observational study.
    Medicine, 2018, Volume: 97, Issue:50

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Bone Transplantation; China; Decom

2018
Blood loss of total knee arthroplasty in osteoarthritis: an analysis of influential factors.
    Journal of orthopaedic surgery and research, 2018, Dec-22, Volume: 13, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement,

2018
[Preliminary analysis of the effect of different administration routes of tranexamic acid on blood loss after total hip arthroplasty for female femur neck fractures].
    Zhongguo gu shang = China journal of orthopaedics and traumatology, 2018, Dec-25, Volume: 31, Issue:12

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Repl

2018
Total Knee Arthroplasty Is Safe in Jehovah's Witness Patients-A 12-Year Perspective.
    The journal of knee surgery, 2020, Volume: 33, Issue:1

    Topics: Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Los

2020
Role of intravenous tranexamic acid in reducing blood loss during caesarean section: Study at tribal-dominated area hospital in Chhattisgarh, India.
    The journal of obstetrics and gynaecology research, 2019, Volume: 45, Issue:4

    Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section;

2019
Do tourniquet and drainage influence fast track in total knee arthroplasty? Our results on 151 cases.
    Acta bio-medica : Atenei Parmensis, 2019, 01-10, Volume: 90, Issue:1-S

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi

2019
Tranexamic Acid Reduces Postoperative Blood Loss in Distal Femoral Osteotomy.
    The journal of knee surgery, 2020, Volume: 33, Issue:5

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Bone Malalignment; Female; Femur; Humans; Male; M

2020
[Case-control study on effect of early intermittently closing drainage tube for blood loss after total knee arthroplasty].
    Zhongguo gu shang = China journal of orthopaedics and traumatology, 2019, Jan-25, Volume: 32, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2019
[Effect of tranexamic acid on blood loss and soft-tissue swelling following cemented total hip replacement].
    Orvosi hetilap, 2019, Volume: 160, Issue:12

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Humans; Length of Sta

2019
A comparison of the effects on postoperative bleeding of the intra-articular application of tranexamic acid and adrenalin in total knee arthroplasty.
    JPMA. The Journal of the Pakistan Medical Association, 2019, Volume: 69, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Epinephrine; Female; Hematocrit; Hem

2019
Effects of topical tranexamic acid during open reduction and internal fixation of acetabular fractures: A retrospective study.
    Acta orthopaedica et traumatologica turcica, 2019, Volume: 53, Issue:3

    Topics: Acetabulum; Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusio

2019
Utilization and Real-world Effectiveness of Tranexamic Use in Shoulder Arthroplasty: A Population-based Study.
    The Journal of the American Academy of Orthopaedic Surgeons, 2019, Oct-01, Volume: 27, Issue:19

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Shoulder; Blood Loss, Surgical; Blood Tran

2019
Topical tranexamic acid in elderly patients with femoral neck fractures treated with hemiarthroplasty: efficacy and safety? - a case-control study.
    BMC musculoskeletal disorders, 2019, May-17, Volume: 20, Issue:1

    Topics: Administration, Topical; Aged; Aged, 80 and over; Blood Loss, Surgical; Blood Transfusion; Case-Cont

2019
Short-term safety of tranexamic acid use in posterior cervical decompression and fusion surgery.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2019, Volume: 66

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Ce

2019
Implementation of tranexamic acid reduces red blood cell utilization in orthopedic surgeries.
    Transfusion, 2019, Volume: 59, Issue:9

    Topics: Academic Medical Centers; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgi

2019
Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty.
    BMC musculoskeletal disorders, 2019, Jul-27, Volume: 20, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2019
Intra-articular 1 g tranexamic acid administration during total knee arthroplasty is safe and effective for the reduction of blood loss and blood transfusion.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2019, Volume: 29, Issue:8

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Blood Volume; Con

2019
Can local administration of tranexamic acid during total knee arthroplasty reduce blood loss and transfusion requirements in the absence of surgical drains?
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2014, Volume: 24, Issue:3

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement

2014
Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Humans; K

2014
Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Humans; K

2014
Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Humans; K

2014
Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Humans; K

2014
[Local application of tranexamic acid reduces blood less in unilateral total knee arthroplasty: a retrospective comparison analysis].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2013, Jan-01, Volume: 51, Issue:1

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Humans; M

2013
[Management of massive bleeding in 2013: seven questions and answers].
    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2013, Volume: 20, Issue:2

    Topics: Acute Disease; Blood Component Transfusion; Combined Modality Therapy; Disease Management; Erythrocy

2013
The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:2

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Repl

2014
The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:2

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Repl

2014
The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:2

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Repl

2014
The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:2

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Repl

2014
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
    The Journal of arthroplasty, 2013, Volume: 28, Issue:9

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty

2013
Evaluation of the efficacy and safety of tranexamic acid for reducing blood loss in bilateral total knee arthroplasty.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:3

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L

2014
Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:4

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Repl

2014
Antifibrinolytic thereapy.
    Thrombosis research, 2014, Volume: 133, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Female; Fi

2014
Utility of thromboelastography in managing acquired Factor VIII inhibitor associated massive haemorrhage.
    Anaesthesia and intensive care, 2013, Volume: 41, Issue:6

    Topics: Antifibrinolytic Agents; Blood Coagulation Factors; Blood Transfusion; Endometrial Neoplasms; Factor

2013
A prospective study on role of tranexamic acid in reducing postoperative blood loss in total knee arthroplasty and its effect on coagulation profile.
    The Journal of arthroplasty, 2014, Volume: 29, Issue:4

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Coagulation; Case-Control Studies; D

2014
Tranexamic Acid Tamponade to Control Postoperative Surgical Hemorrhage.
    The Journal of oral implantology, 2015, Volume: 41, Issue:3

    Topics: Anticoagulants; Blood Loss, Surgical; Humans; Postoperative Hemorrhage; Tooth Extraction; Tranexamic

2015
Does tranexamic acid reduce blood loss in total knee arthroplasty? Commentary on an article by X. Aguilera, MD, et al.:"Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty. A randomized con
    The Journal of bone and joint surgery. American volume, 2013, Nov-20, Volume: 95, Issue:22

    Topics: Arthroplasty, Replacement, Knee; Female; Fibrin Tissue Adhesive; Hemostatics; Humans; Male; Postoper

2013
Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.
    Clinical orthopaedics and related research, 2014, Volume: 472, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Bioma

2014
Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.
    Clinical orthopaedics and related research, 2014, Volume: 472, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Bioma

2014
Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.
    Clinical orthopaedics and related research, 2014, Volume: 472, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Bioma

2014
Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.
    Clinical orthopaedics and related research, 2014, Volume: 472, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Bioma

2014
Tranexamic acid: more evidence for its use in joint replacement surgery.
    Transfusion, 2014, Volume: 54, Issue:1

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Tran

2014
Risk of bleeding after dentoalveolar surgery in patients taking anticoagulants.
    The British journal of oral & maxillofacial surgery, 2014, Volume: 52, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Apicoectomy; Dental Implant

2014
Can tranexamic acid and hydrogen peroxide reduce blood loss in cemented total knee arthroplasty?
    Archives of orthopaedic and trauma surgery, 2014, Volume: 134, Issue:7

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi

2014
Effect of intra-articular injection of tranexamic acid on postoperative hemoglobin in total hip arthroplasty.
    Orthopedics, 2014, Volume: 37, Issue:6

    Topics: Aged; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; He

2014
Repeated doses of intravenous tranexamic acid are effective and safe at reducing perioperative blood loss in total knee arthroplasty.
    Bioscience trends, 2014, Volume: 8, Issue:3

    Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Female; Humans; Male; Middle Aged; Postope

2014
Von Willebrand factor, a versatile player in gastrointestinal bleeding in left ventricular assist device recipients?
    Transfusion, 2015, Volume: 55, Issue:1

    Topics: Aged; Combined Modality Therapy; Deamino Arginine Vasopressin; Embolization, Therapeutic; Erythrocyt

2015
Intra-articular injection of tranexamic acid to reduce blood loss after total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2014, Volume: 22, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Dose-Response Rel

2014
Intravenous use of tranexamic acid reduces postoperative blood loss in total knee arthroplasty.
    Archives of orthopaedic and trauma surgery, 2014, Volume: 134, Issue:11

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Fibrin Ti

2014
[A rare case of thalassemia concomitant with chronic decompensated tonsillitis].
    Vestnik otorinolaringologii, 2014, Issue:3

    Topics: Adolescent; Anemia, Hypochromic; Antifibrinolytic Agents; Chemoprevention; Chronic Disease; Female;

2014
Cost analysis of use of tranexamic Acid to prevent major bleeding complications in hip and knee arthroplasty surgery.
    American journal of orthopedics (Belle Mead, N.J.), 2014, Volume: 43, Issue:10

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss

2014
Assessment of the introduction of a blood management program in orthopaedic surgery.
    Revista espanola de anestesiologia y reanimacion, 2015, Volume: 62, Issue:8

    Topics: Aged; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Blood Ban

2015
Topical versus intravenous tranexamic acid in total knee arthroplasty.
    The Journal of arthroplasty, 2015, Volume: 30, Issue:3

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2015
Letter to the Editor: Intra-articular injection of tranexamic acid to reduce blood loss after total knee arthroplasty.
    Journal of orthopaedic surgery (Hong Kong), 2014, Volume: 22, Issue:3

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Humans; Male; Osteoarthritis, Knee

2014
[Effectiveness of tranexamic acid in total knee arthroplasty].
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2014, Volume: 28, Issue:11

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi

2014
Topical tranexamic acid was noninferior to intravenous tranexamic acid in controlling blood loss during total knee arthroplasty.
    The Journal of bone and joint surgery. American volume, 2015, Feb-18, Volume: 97, Issue:4

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Female; Humans; Male

2015
Authors' reply.
    Journal of orthopaedic surgery (Hong Kong), 2014, Volume: 22, Issue:3

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Female; Humans; Male; Osteoarthritis, Knee

2014
Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2015, Volume: 26, Issue:3

    Topics: Antifibrinolytic Agents; Child; Child, Preschool; Fibrinolysis; Heart Defects, Congenital; Hemorrhag

2015
Pharmaceuticals: private prescription.
    British dental journal, 2015, Volume: 218, Issue:6

    Topics: Antifibrinolytic Agents; Antithrombins; Dabigatran; Formularies, Dental as Topic; Humans; Postoperat

2015
Effect of a single injection of tranexamic acid on blood loss after primary hybrid TKA.
    The Knee, 2015, Volume: 22, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion, Autologous; Dose-

2015
Prophylactic intraoperative tranexamic acid administration and postoperative blood loss after transapical aortic valve implantation.
    Journal of cardiothoracic surgery, 2015, Mar-28, Volume: 10

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Aortic Valve Stenosis; Drug Administration

2015
Does Tranexamic Acid Reduce Blood Loss and Transfusion Requirements Associated With the Periacetabular Osteotomy?
    Clinical orthopaedics and related research, 2015, Volume: 473, Issue:8

    Topics: Acetabulum; Adolescent; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Dru

2015
CORR Insights(®): Does Tranexamic Acid Reduce Blood Loss and Transfusion Requirements Associated With the Periacetabular Osteotomy?
    Clinical orthopaedics and related research, 2015, Volume: 473, Issue:11

    Topics: Acetabulum; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Female; Hip Dislocatio

2015
Minimizing Blood Transfusion in Total Hip and Knee Arthroplasty Through a Multimodal Approach.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:2

    Topics: Aged; Aged, 80 and over; Algorithms; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip

2016
The effectiveness of tranexamic acid at reducing postoperative blood loss following cesarean section: a systematic review of quantitative evidence protocol.
    JBI database of systematic reviews and implementation reports, 2015, Jul-17, Volume: 13, Issue:6

    Topics: Antifibrinolytic Agents; Cesarean Section; Female; Humans; Postoperative Hemorrhage; Pregnancy; Preg

2015
An In Vivo Study of Low-Dose Intra-Articular Tranexamic Acid Application with Prolonged Clamping Drain Method in Total Knee Replacement: Clinical Efficacy and Safety.
    BioMed research international, 2015, Volume: 2015

    Topics: Aged; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Drainage; Female; Humans; Injections, I

2015
Tranexamic acid decreases blood loss after total shoulder arthroplasty.
    Journal of shoulder and elbow surgery, 2016, Volume: 25, Issue:4

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement; Blood Loss, Surgical; Blood Transfusion; Female;

2016
Comparison between topical and intravenous administration of tranexamic acid in primary total hip arthroplasty.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2016, Volume: 21, Issue:1

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss,

2016
Does tranexamic acid reduce blood loss and transfusion rates in unicompartmental knee arthroplasty?
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2016, Volume: 21, Issue:2

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; F

2016
"Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial".
    The Journal of arthroplasty, 2016, Volume: 31, Issue:4

    Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgic

2016
Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:4

    Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgic

2016
Is there a need for routine post-operative hemoglobin level estimation in total knee arthroplasty with tranexamic acid use?
    The Knee, 2016, Volume: 23, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2016
Low dose tranexamic acid reduces blood transfusion rate after total knee arthroplasty: A population-based study in Taiwan.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2017, Volume: 116, Issue:1

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L

2017
Topical Tranexamic Acid May Improve Early Functional Outcomes of Primary Total Knee Arthroplasty.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:7

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Trans

2016
In Reply: Tranexamic Acid Benefits Total Joint Arthroplasty Patients Regardless of Preoperative Hemoglobin Value.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:5

    Topics: Antifibrinolytic Agents; Arthroplasty; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood

2016
Postoperative cerebral bleeding in a boy with suspected mild deficiency of fibrinogen and FXIII.
    Thrombosis research, 2016, Volume: 141

    Topics: Adolescent; Afibrinogenemia; Antifibrinolytic Agents; Blood Coagulation; Factor XIII Deficiency; Fib

2016
The impact of mild peri-operative hypothermia on the effectiveness of tranexamic acid in total hip arthroplasty.
    International orthopaedics, 2017, Volume: 41, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Cohort Studies; Female; Humans; Hypot

2017
Tranexamic acid in total joint arthroplasty.
    ANZ journal of surgery, 2016, Volume: 86, Issue:4

    Topics: Antifibrinolytic Agents; Arthroplasty; Arthroplasty, Replacement; Blood Loss, Surgical; Humans; Post

2016
Topical administration of tranexamic acid in hip arthroplasty.
    International orthopaedics, 2017, Volume: 41, Issue:2

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement

2017
Major transfusions remain frequent despite the generalized use of tranexamic acid: an audit of 3322 patients undergoing cardiac surgery.
    Transfusion, 2016, Volume: 56, Issue:7

    Topics: Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Databases, Factu

2016
Controversy in Tranexamic Acid Administration Route Continues: Commentary on an article by Zeng Yi, MD, et al.: "Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Si
    The Journal of bone and joint surgery. American volume, 2016, 06-15, Volume: 98, Issue:12

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2016
Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2017, Volume: 25, Issue:11

    Topics: Administration, Intravenous; Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replace

2017
The Efficacy Comparison of Tranexamic Acid for Reducing Blood Loss in Total Knee Arthroplasty at Different Dosage Time.
    The Journal of arthroplasty, 2017, Volume: 32, Issue:1

    Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood L

2017
Chemical Thromboprophylaxis Is Not Necessary to Reduce Risk of Thromboembolism With Tranexamic Acid After Total Hip Arthroplasty.
    The Journal of arthroplasty, 2017, Volume: 32, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Trans

2017
CASE 12-2016 Ascending Aorta Dissection in a Jehovah's Witness Patient on Warfarin.
    Journal of cardiothoracic and vascular anesthesia, 2016, Volume: 30, Issue:6

    Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aorta; Aortic Aneurysm; Aortic Dissection; Blood Coag

2016
Effects of tranexamic acid on coagulation indexes of patients undergoing heart valve replacement surgery under cardiopulmonary bypass.
    International journal of immunopathology and pharmacology, 2016, Volume: 29, Issue:4

    Topics: Adolescent; Blood Coagulation; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary By

2016
Topical Tranexamic Acid in Total Knee Arthroplasty Patients with Increased Thromboembolic Risk.
    The journal of knee surgery, 2017, Volume: 30, Issue:5

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss,

2017
A comparative, retrospective study of peri-articular and intra-articular injection of tranexamic acid for the management of postoperative blood loss after total knee arthroplasty.
    BMC musculoskeletal disorders, 2016, 10-19, Volume: 17, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion; Drainage; Female;

2016
Surgery: Use of tranexamic acid in coronary surgery.
    Nature reviews. Cardiology, 2017, Volume: 14, Issue:1

    Topics: Antifibrinolytic Agents; Arteries; Humans; Postoperative Hemorrhage; Tranexamic Acid

2017
Comparative effectiveness of epsilon-aminocaproic acid and tranexamic acid on postoperative bleeding following cardiac surgery during a national medication shortage.
    Journal of clinical anesthesia, 2016, Volume: 35

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Cardiac Surgical Procedures; Cohort Studies; Comparative

2016
High-dose tranexamic acid reduces intraoperative and postoperative blood loss in posterior lumbar interbody fusion.
    Journal of neurosurgery. Spine, 2017, Volume: 26, Issue:3

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Case-Cont

2017
Prospective observational study of the effect of dual antiplatelet therapy with tranexamic acid treatment on platelet function and bleeding after cardiac surgery.
    British journal of anaesthesia, 2016, Volume: 117, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Platelets; Card

2016
Intraarticular Administration of Tranexamic Acid is Safe and Effective in Total Knee Arthroplasty Patients at High-Risk for Thromboembolism.
    Surgical technology international, 2016, Dec-16, Volume: 30

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss

2016
Tranexamic acid versus fibrin sealant in primary total hip replacement: a comparative study.
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2017, Volume: 27, Issue:7

    Topics: Aerosols; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Blood

2017
Can tranexamic acid reduce blood loss in cervical laminectomy with lateral mass screw fixation and bone grafting: a retrospective observational study.
    Medicine, 2017, Volume: 96, Issue:5

    Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Bone Screws; Bone Transplantation; Cervical Ver

2017
The Effectiveness and Safety of Tranexamic Acid in Orthotopic Liver Transplantation Clinical Practice: A Propensity Score Matched Cohort Study.
    Transplantation, 2017, Volume: 101, Issue:7

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Databases, Factual; Erythrocyte Transfusion; Female;

2017
Reply to letter to the editor on "Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: A double-blinded randomised controlled noninferiority trial".
    The Knee, 2017, Volume: 24, Issue:3

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S

2017
Letter to editor "Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: A double-blinded randomized controlled noninferiority trial".
    The Knee, 2017, Volume: 24, Issue:3

    Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, S

2017
Other benefits of intra-articular injection of tranexamic acid in primary total knee arthroplasty apart from reducing blood transfusion rates.
    Eklem hastaliklari ve cerrahisi = Joint diseases & related surgery, 2017, Volume: 28, Issue:1

    Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusion

2017
Safety of aprotinin (again).
    Lancet (London, England), 2008, Jul-05, Volume: 372, Issue:9632

    Topics: Aprotinin; Cardiac Surgical Procedures; Hemostatics; Humans; Italy; Postoperative Hemorrhage; Safety

2008
Perioperative coagulation management and blood conservation in cardiac surgery: a Canadian Survey.
    Journal of cardiothoracic and vascular anesthesia, 2008, Volume: 22, Issue:5

    Topics: Anticoagulants; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedures; Heparin; Human

2008
Routine preoperative coagulation screening detects a rare bleeding disorder.
    Anesthesia and analgesia, 2009, Volume: 108, Issue:1

    Topics: Antifibrinolytic Agents; Blood Component Transfusion; Blood Loss, Surgical; Child; Factor X Deficien

2009
Evaluation of a fibrin preparation containing tranexamic acid (Adhexil) in a rabbit uterine horn model of adhesions with and without bleeding and in a model with two surgical loci.
    Fertility and sterility, 2010, Mar-01, Volume: 93, Issue:4

    Topics: Animals; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Female; Fibrin; He

2010
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2009, Volume: 35, Issue:3

    Topics: Heart Valve Prosthesis Implantation; Hemostasis, Surgical; Humans; Platelet Aggregation Inhibitors;

2009
Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery.
    Acta anaesthesiologica Scandinavica, 2009, Volume: 53, Issue:5

    Topics: Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Aprotinin; Blood Coagulation; Blood Loss, Surg

2009
[Type A hemophilia in a man undergoing liver resection for metastasis: implications for anesthetic management].
    Revista espanola de anestesiologia y reanimacion, 2009, Volume: 56, Issue:3

    Topics: Adenocarcinoma; Aged; Anesthesia, General; Blood Loss, Surgical; Colorectal Neoplasms; Deamino Argin

2009
[Tranexamic acid and dentoalveolar surgery].
    Ugeskrift for laeger, 2009, May-18, Volume: 171, Issue:21

    Topics: Anticoagulants; Blood Loss, Surgical; Fibrinolytic Agents; Hemostatics; Humans; Oral Surgical Proced

2009
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Spine 2008; 33: 2577-80.
    Spine, 2009, Jul-15, Volume: 34, Issue:16

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; Humans; Orthopedic Procedures; P

2009
Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2009, Volume: 36, Issue:5

    Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Aprotinin; Blood Component Transfusion; Cardiac Surgic

2009
The effect of the suspension of the license for aprotinin on the care of patients undergoing cardiac surgery: a survey of cardiac anesthesiologists' and surgeons' opinions in the United Kingdom.
    Journal of cardiothoracic and vascular anesthesia, 2010, Volume: 24, Issue:3

    Topics: Anesthesiology; Antifibrinolytic Agents; Aprotinin; Attitude of Health Personnel; Health Care Survey

2010
[Successful use of recombinant factor VIIa in the control of a massive bleeding in two patients with biventricular assist device (Thoratec)].
    Annales francaises d'anesthesie et de reanimation, 2010, Volume: 29, Issue:1

    Topics: Adult; Anticoagulants; Aprotinin; Blood Transfusion; Blood Transfusion, Autologous; Cardiac Tamponad

2010
Efficiency of preoperative tranexamic Acid in coronary bypass surgery: an analysis correlated with preoperative clopidogrel use.
    The heart surgery forum, 2010, Volume: 13, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Blood Transfusion; Clopidogrel; Confidence Intervals; Coronary Artery

2010
Efficient strategy for controlling postoperative hemorrhage in total knee arthroplasty.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2011, Volume: 19, Issue:6

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Arthroplasty, Replacement, Knee; Blood Loss, Surgical

2011
ε-Aminocaproic acid and clinical value in cardiac anesthesia.
    Journal of cardiothoracic and vascular anesthesia, 2011, Volume: 25, Issue:1

    Topics: Algorithms; Aminocaproic Acid; Anesthesia; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical;

2011
Commentary on an article by Jean Wong, MD, FRCPC, et al.: "Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial".
    The Journal of bone and joint surgery. American volume, 2010, Nov-03, Volume: 92, Issue:15

    Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Humans; Postopera

2010
Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
    Interactive cardiovascular and thoracic surgery, 2011, Volume: 12, Issue:2

    Topics: Aged; Antifibrinolytic Agents; Aprotinin; Blood Coagulation; Blood Loss, Surgical; Blood Transfusion

2011
Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2011, Volume: 39, Issue:6

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Blood Transfusion; Cardiac Surgical Procedures; Cardiopu

2011
High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2011, Volume: 39, Issue:5

    Topics: Aged; Aged, 80 and over; Aminocaproic Acid; Antifibrinolytic Agents; Aortic Valve; Drug Administrati

2011
Conference discussion: Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
    Interactive cardiovascular and thoracic surgery, 2011, Volume: 12, Issue:2

    Topics: Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiopulmonary Bypass;

2011
Comparison of blood-sparing efficacy of ε-aminocaproic acid and tranexamic acid in newborns undergoing cardiac surgery.
    The Thoracic and cardiovascular surgeon, 2011, Volume: 59, Issue:5

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgica

2011
Safety of tranexamic acid in pediatric cardiac surgery: what we do not know.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2011, Volume: 40, Issue:6

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Cardiac Surgical Procedures; Female; Humans; Male; Posto

2011
Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement.
    Journal of orthopaedic surgery and research, 2011, May-21, Volume: 6

    Topics: Antifibrinolytic Agents; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Blood Loss, Surgica

2011
Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery.
    The Journal of thoracic and cardiovascular surgery, 2012, Volume: 143, Issue:5

    Topics: Age Factors; Analysis of Variance; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac

2012
Use of tranexamic acid in pediatric cardiac surgery: we really need more.
    Journal of anesthesia, 2012, Volume: 26, Issue:2

    Topics: Blood Loss, Surgical; Cardiac Surgical Procedures; Female; Humans; Male; Postoperative Hemorrhage; T

2012
Comparative analysis of antifibrinolytic medications in pediatric heart surgery.
    The Journal of thoracic and cardiovascular surgery, 2012, Volume: 143, Issue:3

    Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Cardiac Surgical Procedures; Chi-Square Distribu

2012
Congenital diaphragmatic hernia: to repair on or off extracorporeal membrane oxygenation?
    Journal of pediatric surgery, 2012, Volume: 47, Issue:4

    Topics: Antifibrinolytic Agents; Extracorporeal Membrane Oxygenation; Female; Hernia, Diaphragmatic; Hernias

2012
Management of a dentigerous cyst in a medically compromised geriatric patient: a case report.
    Gerodontology, 2012, Volume: 29, Issue:2

    Topics: Aged; Anesthetics, Local; Antifibrinolytic Agents; Aspirin; Bicuspid; Dental Care for Chronically Il

2012
Successful in vitro fertilization and pregnancy in Glanzmann thrombasthenia.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2012, Volume: 18, Issue:5

    Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Fertilization in Vitro; Humans; Infant, Ne

2012
[Local use of tranexamic acid in ENT surgery].
    HNO, 2012, Volume: 60, Issue:11

    Topics: Antifibrinolytic Agents; Humans; Otorhinolaryngologic Surgical Procedures; Postoperative Hemorrhage;

2012
[Haemorrhage and morbidity associated with the use of tranexamic acid in cardiac surgery: a retrospective, multicentre cohort study].
    Revista espanola de anestesiologia y reanimacion, 2013, Volume: 60, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Cardiac Surgical Procedures; Cohort Studies; Female; Humans; Male; Mi

2013
Tranexamic acid therapy in pediatric cardiac surgery: a single-center study.
    The Annals of thoracic surgery, 2012, Volume: 94, Issue:4

    Topics: Antifibrinolytic Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child, Preschool; Dose

2012
Tranexamic acid for routine use in off-pump coronary artery bypass surgery: evidence base "fait accompli" or more research needed?
    Anesthesia and analgesia, 2012, Volume: 115, Issue:2

    Topics: Antifibrinolytic Agents; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Female; Humans;

2012
Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty.
    Journal of orthopaedic surgery and research, 2012, Sep-29, Volume: 7

    Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Bone Cements; Constriction; Drainage; Fema

2012
[Pharmacological reduction of bleeding during hip endoprosthetic replacement].
    Orvosi hetilap, 2012, Oct-14, Volume: 153, Issue:41

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss,

2012
Coronary artery bypass grafting after aprotinin: are we doing better?
    The Journal of thoracic and cardiovascular surgery, 2013, Volume: 145, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiopulmonary B

2013
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
    Thrombosis research, 2013, Volume: 131, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom

2013
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
    Thrombosis research, 2013, Volume: 131, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom

2013
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
    Thrombosis research, 2013, Volume: 131, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom

2013
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
    Thrombosis research, 2013, Volume: 131, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom

2013
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
    Thrombosis research, 2013, Volume: 131, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom

2013
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
    Thrombosis research, 2013, Volume: 131, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom

2013
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
    Thrombosis research, 2013, Volume: 131, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom

2013
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
    Thrombosis research, 2013, Volume: 131, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom

2013
Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
    Thrombosis research, 2013, Volume: 131, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biom

2013
[Perioperative management based on kinetics of bleeding during total primary arthroplasty].
    Annales francaises d'anesthesie et de reanimation, 2013, Volume: 32, Issue:3

    Topics: Aged; Anesthesia, General; Anesthesia, Spinal; Anticoagulants; Arthroplasty, Replacement, Hip; Arthr

2013
Otolaryngologic surgery in children with von Willebrand disease.
    Archives of otolaryngology--head & neck surgery, 2002, Volume: 128, Issue:12

    Topics: Adenoidectomy; Adolescent; Antifibrinolytic Agents; Child; Child, Preschool; Deamino Arginine Vasopr

2002
Strategies for managing anticoagulated patients requiring dental extractions: an exercise in evidence-based clinical practice.
    Journal of the Massachusetts Dental Society, 2002,Winter, Volume: 50, Issue:4

    Topics: Anticoagulants; Antifibrinolytic Agents; Dental Care for Chronically Ill; Evidence-Based Medicine; H

2002
More information on patients with factor XI deficiency.
    Anesthesiology, 2004, Volume: 101, Issue:5

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Factor XI Deficiency; Hemostasis; Humans; Postoperati

2004
Identifying patients at risk of intraoperative and postoperative transfusion in isolated CABG: toward selective conservation strategies.
    The Annals of thoracic surgery, 2004, Volume: 78, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Aminocaproic Acid; Anticoagulants; Blood Component Transfusion; Bloo

2004
Management options for dental extraction in hemophiliacs: a study of 55 extractions (2000-2002).
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2005, Volume: 99, Issue:3

    Topics: Adolescent; Adult; Aged; Child; Clinical Protocols; Deamino Arginine Vasopressin; Dental Care for Ch

2005
Continuous infusion of factor VIIIc during heart surgery in a patient with haemophilia A.
    European journal of anaesthesiology, 2004, Volume: 21, Issue:12

    Topics: Anticoagulants; Antifibrinolytic Agents; Blood Loss, Surgical; Cardiac Surgical Procedures; Coronary

2004
Treatment of postoperative bleeding after fondaparinux with rFVIIa and tranexamic acid.
    The Netherlands journal of medicine, 2005, Volume: 63, Issue:5

    Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Drug Therapy, Combina

2005
Haemostatic management of intraoral bleeding in patients with von Willebrand disease.
    Oral diseases, 2005, Volume: 11, Issue:4

    Topics: Adolescent; Adult; Child; Deamino Arginine Vasopressin; Dental Care for Chronically Ill; Factor VIII

2005
[Dental avulsions and blood coagulation disorders].
    Revue de stomatologie et de chirurgie maxillo-faciale, 2005, Volume: 106, Issue:5

    Topics: Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Disorders; Deamino Arginine Vasopressin;

2005
[CRASH-2: the Clinical Randomization of an Antifibrinolytic in Significant Haemorrhage trial].
    Revista espanola de anestesiologia y reanimacion, 2005, Volume: 52, Issue:10

    Topics: Adult; Antifibrinolytic Agents; Child; Hemorrhage; Humans; Multicenter Studies as Topic; Patient Sel

2005
The risk associated with aprotinin in cardiac surgery.
    The New England journal of medicine, 2006, Jan-26, Volume: 354, Issue:4

    Topics: Adult; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Pr

2006
The risk associated with aprotinin in cardiac surgery.
    The New England journal of medicine, 2006, Jan-26, Volume: 354, Issue:4

    Topics: Adult; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Pr

2006
The risk associated with aprotinin in cardiac surgery.
    The New England journal of medicine, 2006, Jan-26, Volume: 354, Issue:4

    Topics: Adult; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Pr

2006
The risk associated with aprotinin in cardiac surgery.
    The New England journal of medicine, 2006, Jan-26, Volume: 354, Issue:4

    Topics: Adult; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Pr

2006
Perioperative management of a heterozygous carrier of Glanzmann's thrombasthenia submitted to coronary artery bypass grafting with cardiopulmonary bypass.
    Anesthesia and analgesia, 2006, Volume: 103, Issue:2

    Topics: Aged; Cardiopulmonary Bypass; Coronary Artery Bypass; Heterozygote; Humans; Male; Postoperative Hemo

2006
[The "Seville" Consensus Document on Alternatives to Allogenic Blood Transfusion. Sociedades españolas de Anestesiología (SEDAR), Medicina Intensiva (SEMICYUC), Hematología y Hemoterapia (AEHH), Transfusión sanguínea (SETS) Trombosis y Hemostasia (SETH)].
    Medicina clinica, 2006, Jul-18, Volume: 127 Suppl 1

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Substitutes; Bloo

2006
If you prick us, do we not bleed?
    Anesthesiology, 2006, Volume: 105, Issue:5

    Topics: Aprotinin; Hemostatics; Humans; Orthopedic Procedures; Postoperative Hemorrhage; Tranexamic Acid

2006
CABG-procedures in patients with pretreatment with the GPIIb/IIIa-receptor antagonist tirofiban (Aggrastat): modification of perioperative management?
    International journal of cardiology, 2008, Jul-04, Volume: 127, Issue:2

    Topics: Antifibrinolytic Agents; Aprotinin; Coronary Artery Bypass; Fibrinolytic Agents; Hemostatics; Humans

2008
[Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
    Annales de cardiologie et d'angeiologie, 2007, Volume: 56, Issue:6

    Topics: Adult; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical

2007
Acquired transitory factor XI inhibitor after gynaecological surgery.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2008, Volume: 14, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Blood Coagulation Factor Inhibitors; Blood Coagulation Tests; Factor

2008
Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene.
    Anesthesiology, 2008, Volume: 108, Issue:4

    Topics: Aged; Cardiopulmonary Bypass; Female; Homozygote; Humans; Male; Middle Aged; Plasminogen Activator I

2008
Amoxicillin-related postextraction bleeding in an anticoagulated patient with tranexamic acid rinses.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1996, Volume: 82, Issue:6

    Topics: Aged; Amoxicillin; Anticoagulants; Antifibrinolytic Agents; Dental Care for Chronically Ill; Drug In

1996
Use of tranexamic acid mouthwash to prevent postoperative bleeding in oral surgery patients on oral anticoagulant medication.
    Quintessence international (Berlin, Germany : 1985), 1997, Volume: 28, Issue:6

    Topics: Administration, Oral; Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Drug Evaluation; Female;

1997
[Mouth-washing with tranexamic acid in patients treated with oral anticoagulants subjected to oral surgery procedures].
    Investigacion clinica, 1998, Volume: 39, Issue:2

    Topics: Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Loss, Surgical; Dental S

1998
Re: Devani et al. Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary?
    The British journal of oral & maxillofacial surgery, 1998, Volume: 36, Issue:6

    Topics: Anticoagulants; Antifibrinolytic Agents; Drug Administration Schedule; Hemostatic Techniques; Humans

1998
Dental extractions in patients maintained on continued oral anticoagulant: comparison of local hemostatic modalities.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1999, Volume: 88, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Femal

1999
Severe hyponatraemia secondary to desmopressin therapy in von Willebrand's disease.
    Anaesthesia and intensive care, 2000, Volume: 28, Issue:2

    Topics: Acute Disease; Adult; Deamino Arginine Vasopressin; Female; Hemostatics; Humans; Hyponatremia; Hyste

2000
Dental extractions in patients maintained on oral anticoagulant therapy: comparison of INR value with occurrence of postoperative bleeding.
    International journal of oral and maxillofacial surgery, 2001, Volume: 30, Issue:6

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Chi-Square Distribution; Couma

2001
[A patient with thrombocytopenia: what do I do?].
    Nederlands tijdschrift voor tandheelkunde, 1999, Volume: 106, Issue:12

    Topics: Adult; Antifibrinolytic Agents; Humans; Male; Methylprednisolone; Oral Hemorrhage; Postoperative Car

1999